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the Geriatric Unit at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico (Milan, Italy). 
His research activities are focused on healthy aging and the management of frailty in “biologically 
old” individuals. He is listed by Clarivate Analytics among the worldwide Highly Cited Researchers 
(http://highlycited.com). Dr. Cesari is Editor-in-Chief of The  Journal  of  Frailty  &  Aging, and 
Associate Editor of the Journal  of  the  American  Medical  Directors  Association  (JAMDA). He is 
the coordinator of the European Geriatric Medicine Society (EuGMS) Special Interest Group on 
“Frailty in older persons”. Dr. Cesari has also been regularly collaborating with the World Health 
Organization on the themes of aging and integrated care in older people.
Emanuele Marzetti is a board-certified Geriatrician, Clinical Assistant Professor in Geriatrics, and 
leader of the orthogeriatric consultation team at the Department of Geriatrics, Neurosciences and 
Orthopaedics (Fondazione Policlinico Universitario ”Agostino Gemelli”, Università Cattolica del 
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Preface to ”Dietary Protein and Muscle in 
Aging People”
Over recent years, evidence has accumulated that protein intake above the current 
recommended dietary allowance (RDA, 0.8 g kg−1 d−1) may help preserve muscle mass and function 
in old age. Opinion articles and consensus statements have argued that older people should be 
advised to ingest 1.0–1.5 g of protein kg−1 d−1. This recommendation is mainly based on findings 
from observational studies showing that protein consumption above the RDA is associated with 
reduced risk of frailty, loss of lean body mass, slow walking speed, dynapenia, and poor balance. 
Notwithstanding, only a handful of clinical trials have tested the impact of specific protein ingestion 
regimens on body composition, physical performance, and frailty status of older people, with mixed 
results.
The purpose of this book was to convene experts and opinion leaders in nutrition, sarcopenia, 
frailty, and exercise science in the attempt to bring order in the field of protein requirements for 
muscle health in late life. The book showcases original articles, reviews, and meta-analyses 
addressing the relationship between dietary protein intake and muscle aging through clinical and 
translational approaches. Selected contributions also cover procedures aimed at increasing the 
palatability of protein supplements, the use of circulating amino acids as biomarkers for sarcopenia 
and frailty, and the impact of protein dysmetabolism in chronic conditions. The variety of the topics 
and the interdisciplinary content make the book appealing to a large readership, from clinicians 
interested in implementing nutritional interventions in their daily practice to researchers who may 
take cues for future studies on the subject.
      Lastly, we would like to take to opportunity to thank the contributors, the reviewers, and the 
MDPI editorial staff, whose scientific excellence, time, and dedication made this book a reality.
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Abstract: Proteins are macro-molecules crucial for cell life, which are made up of amino acids (AAs).
In healthy people, protein synthesis and degradation are well balanced. However, in the presence
of hypercatabolic stimulation (i.e., inflammation), protein breakdown increases as the resulting
AAs are consumed for metabolic proposes. Indeed, AAs are biochemical totipotent molecules
which, when deaminated, can be transformed into energy, lipids, carbohydrates, and/or biochemical
intermediates of fundamental cycles, such as the Krebs’ cycle. The biochemical consequence
of hyper-catabolism is protein disarrangement, clinically evident with signs such as sarcopenia,
hypalbuminemia, anaemia, infection, and altered fluid compartmentation, etc. Hypercatabolic protein
disarrangement (HPD) is often underestimated by clinicians, despite correlating with increased
mortality, hospitalization, and morbidity quite independent of the primary disease. Simple, cheap,
repeatable measurements can be used to identify HPD. Therefore, identification and treatment of
proteins’ metabolic impairment with appropriate measurements and therapy is a clinical strategy that
could improve the prognosis of patients with acute/chronic hypercatabolic inflammatory disease.
Here, we describe the metabolism of protein and AAs in hypercatabolic syndrome, illustrating the
clinical impact of protein disarrangement. We also illustrate simple, cheap, repeatable, and worldwide
available measurements to identify these conditions. Finally, we provide scientific evidence for HPD
nutritional treatment.
Keywords: protein metabolism; sarcopenia; muscle wasting; amino acids; catabolism; inflammation
1. Metabolism of Proteins and Amino Acids: Essential Cellular Blocks
Proteins are macronutrients crucial for various cellular activities, as well as body metabolism.
Protein synthesis is primarily controlled by amino acid (AA) availability in stoichiometric quantities
proportional to the number of proteins needed for synthesis and energy requirements needed to
sustain the synthetic process.
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AAs serve many functions within the body. Being the only source of nitrogen for mammals,
AA-derived nitrogen is pivotal for synthetizing precursors (purine and/or pyrimidine) of major energy
molecules (i.e., ATP, ADP, IMP) and/or nucleic acids (i.e., DNA/RNA), and/or to produce compounds
that can regulate major biochemical signaling pathways, such as nitric oxide (NO). Moreover,
deamination of AAs released from skeletal muscle and/or circulating visceral proteins generate
a carbon skeleton rich in oxygen and hydrogen suitable for subsequent biochemical transformation.
This carbon skeleton can be used by the liver to produce glucose through gluconeogenesis and
other macromolecules, such as lipids. The AA-derived carbon skeleton is also relevant in producing
intermediaries fueling the Kreb’s cycle that are thereafter transformed into energy and/or other
metabolic intermediaries (Figure 1). Therefore, AAs can be considered “biochemical totipotent
molecules” able to be converted into energy, carbohydrates, lipids, and biochemical intermediates,
dependent on body metabolic demands [1,2] (Figure 2).
Figure 1. Amino acid-derived intermediates fueling the tri-carboxilic acid cycle (TCA) (Kreb’s
cycle). FFA = free fatty acids. Ala = alanine, Arg = arginine, Asa = aspartic acid, Asn = asparagine,
Cys = cysteine, Gln = glutamine, Glu = glutamic acid, Gly = glycine, His = histidine, Ile = isoleucine,
Leu = Leucine, Lys = lysine, Met = methionine, Phe = phenylalanine, Pro = proline, Ser = serine,
Thr = threonine, Trp = tryptophan, Tyr = tyrosine, Val = valine.
Figure 2. Amino acids (AAs) as biochemical totipotent molecules.
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From a nutritional point of view, AAs are categorized as either “non-essential” (NEAAs) or
“essential” (EAAs). NEAAs are synthetized within the body from carbohydrates and lipids deriving
nitrogen from other AAs. EAAs, however, cannot be synthesized and need to be adequately introduced
with the diet, and they are also the most relevant nutritional input for protein synthesis [3]. For instance,
leucine is considered the primary nutritional regulator of muscle protein anabolism [4] due to its
ability to trigger the mammalian target of the rapamycin (mTOR) pathway and inhibit the proteasome
system [4].
Interestingly, under conditions such as injury, surgery, or chronic diseases, there is increased
demand for AAs as a consequence of higher resting energy expenditure [5]. The consumption of EAAs
into the Kreb’s cycle and its competition with the oxidation of glucose or of fatty acids via β oxidation
has been suggested as a strategy to maintain efficient energy production in pathological conditions.
This is due to fat oxidation being less energy efficient than glycolysis and to the entry of AA-derived
pyruvate into the mitochondrial Kreb’s cycle [6].
Indeed, β oxidation, which is mostly cytoplasmic, reduces the ratio of ATP/available O2,
and obliges large amounts of EAAs to be used as intermediates of the Kreb’s cycle. Interestingly,
EAAs are used as substitutes for pyruvate-derived oxaloacetate shortened by the large amounts of
NADH produced out of mitochondria due to β-oxidation [7].
Such a metabolic shift is one of the main alterations leading to an imbalance between
nitrogen request and nitrogen intake observed in patients with chronic altered metabolic conditions
and measured as the nitrogen balance. This ultimately triggers muscle and circulating protein
disarrangement that become clinically evident in several muscle-wasting conditions (e.g., sarcopenia
and cachexia) and/or hypoalbuminemia with or without anemia [8].
2. The Pathogenesis of Protein Disarrangement: The Hypermetabolic Syndrome
The pathophysiology of syndromes characterized by protein disarrangement is multi-factorial
and dishomogeneous. Indeed, both the elderly and patients with chronic diseases (such as infections
and sepsis) show a pattern of circulating mediators with altered ratios between catabolic molecules
(e.g., TNF-α, cortisol, catecholamines, glucagons, cytokines) inducing protein degradation and anabolic
factors (e.g., insulin, insulin-like growth factors, and growth hormone) that stimulate protein synthesis.
Increased catabolic stimuli and the consequent impaired anabolic/catabolic stimulation is a condition
that can be referred to as the “hypercatabolic syndrome” (HS). This severely impacts whole-body
metabolism and causes an imbalance between nutritional input and synthetic/energy needs [9,10].
Muscle contractile proteins and circulating visceral proteins are the major reservoir of AAs within
the body. Indeed, these proteins can be degraded by catabolic stimuli and/or physical exercises [11]
and other AAs can be re-used by cells for de novo protein synthesis. However, a large amount of AAs
are deaminated to produce energy and other metabolic intermediates via the Kreb’s cycle and/or are
released into the blood stream to maintain a ready-to-use pool of AAs [10] (Figure 3). In this context,
the role of skeletal muscle and circulating visceral proteins goes well beyond that of ensuring posture
maintenance and locomotion and transporting molecules or atoms.
The proteins of skeletal muscle and the circulatory system are in continuous turnover. Several
studies indicate that about 250–350 g of proteins per day are metabolized in healthy individuals.
However, this amount increases dramatically under conditions with higher metabolic demand.
For instance, aged muscles have reduced anabolic response to low doses (e.g., less than 10 g) of
EAAs [12]; yet, higher doses (e.g., 10–15 g, with at least 3 g of leucine) are sufficient to induce a protein
anabolic response comparable to that observed in younger adults [12]. Therefore, it is recommended
that older people consume food rich in high-quality proteins with higher proportions of EAAs, such as
lean meat and other leucine-rich foods (e.g., soybeans, peanuts, chickpeas, and lentils) [13].
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Figure 3. The fate of amino acids (AAs) in muscle cell: physiologic (top) and hypercatabolic syndrome
(HS) and/or insulin resistance (IS) (bottom). The increase in catabolic stimuli enhances protein
breakdown and AA release in the blood stream. These AAs are used almost exclusively for energy
production and gluconeogenesis, but not for de novo protein synthesis. This favors the onset and
aggravation of muscle wasting.
Recently, protein intake above the current recommended dietary allowance (RDA; 0.8 g/kg/day)
has been proposed to preserve muscle health in later life [14–17]. It, therefore, appears appropriate to
promote protein intake of 1.0–1.2 g/kg/day, while 1.2–1.5 g/kg/day of protein may be required in
older adults with acute or chronic conditions [16–18]. Finally, older people with severe illnesses or
overt malnutrition may need as much as 2.0 g/kg/day of protein [17].
It is also important to consider that HS induces “insulin resistance” (IR), a condition which reduces
cytoplasmic and mitochondrial cell protein synthesis and impaired cell metabolism. This reinforces
the protein-amino acid disarrangement [10,19].
3. Clinical Impact of Protein Disarrangements
Alterations in protein balance have been associated with muscle wasting in patients aged 65+,
hospitalized for a variety of chronic disease conditions [20]. Furthermore, approximately 30% of
patients with chronic heart failure exhibit reduced serum albumin (<3.5 g/dL) [21]. Notably, these
conditions are related to increased morbidity, hospitalization, and mortality, independent of primary
diseases, and so increases health-related costs and worse prognosis [11,22].
The central role of muscle proteins for the maintenance of whole-body metabolism, especially
in response to stress (e.g., HS following chronic disease conditions) has recently gained support [23].
Indeed, the maintenance of muscle mass and protein metabolism has been suggested as being a
relevant parameter to include in future studies because of its clinical relevance [23].
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Therefore, the concept of dietary protein intake being calculated as a fixed and limited ratio
(<20%) of total calories has also been questioned. Two major points should be considered: (1) nitrogen
needs may significantly increase independent of caloric demand. This is often overlooked in large
populations (i.e., the elderly with or without chronic diseases); and (2) nitrogen should not be calculated
by using total protein nitrogen content, but by considering individual AAs. This is because dietary
proteins are enriched in NEAAs, which are not fundamental to support global metabolism but do
increase urea synthesis, and EAAs, which are crucial for refuelling proteins and global metabolism.
Thus, insufficient intake of EAAs despite increased need may be a mechanism in obese patients with
chronic disease (i.e., heart failure), further worsening protein metabolism [24].
Dietary intake providing adequate protein amount and, consequently, AAs to match organ
demand, preserves the integrity of organs essential for life, as witnessed by peripheral muscle
homeostasis and, ultimately, patient survival. Conversely, insufficient EAA intake induces muscle and
circulating visceral protein degradation to release AAs to cope for this deficit. Thus, sarcopenia/muscle
wasting and hypoalbuminemia become clinically evident.
HS also reduces the appetite, as well as nausea and digestive disorders in patients with chronic
conditions leading to inadequate nutrition and consequent reduced availability of nutrients, including
AAs [25]. Anamnesis would suggest that eating-related disorders can be found in chronic patients and
specific therapeutic strategies can be implemented. Up to 50% of patients with severe chronic disease
show altered protein metabolism, which is often underestimated by clinicians despite influencing cell
life and having relevant clinical implications [25].
The consequences of protein disarrangement in various body organs and/or systems are
illustrated in Figure 4. Altered protein metabolism in patients with chronic diseases, especially
older ones, may increase the risk of developing life-threatening complications (e.g., infection due
to reduced or circulating T cells and secretion of protein Ig or imbalance of the Na+/K+ ratio)
with consequent water retention, respiratory failure, and pulmonary edema. Furthermore, cardiac
dysfunction, ventricular arrhythmias, and renal insufficiency may also occur [25].
Figure 4. Effects of protein disarrangements on various systems and electrolyte balance.
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4. Clinical Steps to Evaluate Protein Disarrangement
We have recently proposed a panel of practical and inexpensive tools for the clinical evaluation
of protein disarrangement [26]. A set of indirect measurements evaluating body composition
(anthropometric parameters), visceral protein composition (serum albumin, pre-albumin, transferrin,
retinol binding protein, nitrogen balance), muscle protein degradation (serum or urinary excretion of
3-metil histidine), and immuno-competence (total lymphocyte count) has been proposed. However,
a rapid, inexpensive, and easy assessment of protein disarrangements at the bedside is still lacking.
As such, the evaluation of anthropometric parameters should be considered [26].
A simple way to evaluate body composition is to measure tricipital skin-fold thickness (TST,
an index of fat mass) and arm muscle area (AMA, an index of lean mass) as described elsewhere [27,28].
Notably, TST and AMA are not modified by extracellular fluids, so they are useful tools even in patients
with fluid retention. Interestingly, the presence of reduced AMA less than 5th percentile by age and
sex, together with hypoalbuminemia, in the absence of liver and/or renal insufficiency, confirms the
presence of muscle sarcopenia and altered protein metabolism. [29]
Whenever protein disarrangement associated with muscle wasting and hypoalbuminemia is
suspected, the following additional evaluations can be considered.
4.1. Circulating Visceral Proteins
The concentration of serum proteins such as albumin, pre-albumin, transferrin, and retinol
binding proteins are influenced by extra-cellular fluid composition.
Albumin concentration can be included in routine clinical blood measurements as it is easy
to measure, non-invasive, and a repeatable marker. Its concentration correlates with worsening
morbidity and mortality independent of the disease index [30]. Albumin half-life in circulation is about
20 days and the fractional replacement rate is 10% per day. In the absence of chronic stress, increased
serum albumin levels appear within 14 days and a serum concentration <3.5 g/dL indicates impaired
protein metabolism associated with muscle wasting [30]. Concentrations lower than 3.2 g/dL suggest
more pronounced protein metabolism disarrangement. Notably, severe nephrosis, protein-losing
enteropathy, or severe liver insufficiency reduce serum albumin concentrations. Consequently, these
conditions should be excluded when albumin is used as an index of protein status.
Pre-albumin responds quickly to short-term (24–36 h) energy restriction and re-feeding. Repeated
measurements of pre-albumin levels over a week could be a useful measure of both protein depletion
and repletion. This is particularly useful to monitor treatment [30].
Transferrin correlates with mortality and is also influenced by iron metabolism. It has a half-life
of about eight days and can, therefore, be used to monitor the effects of specific intervention.
Retinol-binding protein has a turnover of 12 h. Consequently, it is a measure of rapid protein
metabolism modification.
4.2. Nitrogen Balance
Nitrogen balance (NB) is an indirect measure of dynamic processes of endogenous protein
synthesis (anabolism) and demolition (catabolism). NB is expressed as: NB g/day = NI − NV + 2 g.
This formula includes nitrogen intake/supply in g/day (NI) and urinary nitrogen excretion (NV)
in g/day + 20% NV for non-urea N excretion. Two grams correspond to the nitrogen lost in feces
and sweat.
NB is in equilibrium if its balance equals ± 1 g/day. NB > 1 g/day indicates prevalent protein
synthesis. NB < 1 g/day suggests ongoing protein degradation with AAs used for general metabolic
purpose instead of protein synthesis. Therefore, NB < 1 g/day represents an index of proteins
disarrangement [8,26]. Notably, NB depends on urea excretion that is influenced by the daily amount
of NEAAs that are routed to urea excretion. To obtain reliable information, this parameter should be
monitored frequently.
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4.3. 3-Methylistidine
Methylation of histidine is a marker of protein degradation derived from contractile actin and
myosin. A simple and rapid method to estimate the fractional catabolic rate of myofibrillar protein is
the evaluation of 3-methylhistidine: creatinine excretion in the urine. The presence of 3-MeH shows
the presence of proteolysis over the immediate period-hours [8,31,32].
4.4. Blood Lymphocyte Count
The loss of circulating cell-mediated immune competence is present in patients with advanced
heart failure with sarcopenia and metabolism disarrangements. Indeed, the lymphocyte count could
be considered an indirect index of cell proliferation, protein synthesis, and energy availability and can
be used to confirm protein and global metabolic impairment [33].
5. Possible Therapeutic Interventions
Protein intake and AA availability are key to maintaining protein synthesis in living organisms.
Healthy individuals absorb AAs from the diet after protein digestion by pancreatic enzymes. However,
the pancreas uses large amounts of AAs and energy to produce digestive enzymes [10]. The efficiency
of pancreatic and mesenteric circulation may be progressively reduced in HS and/or in chronic
diseases with water retention [34]. In addition, gut microbiota alterations and impaired intestinal
function, including altered nutrient digestion and absorption, have been reported in patients with
chronic disease [34]. These conditions lead to impaired AA digestion and absorption and, consequently,
to reduced AA plasma levels that may become insufficient to maintaining protein synthesis and energy
demand in HS patients [10]. In contrast, individual AAs derived from nutritional supplements are
immediately available after absorption and transit into the bloodstream to be delivered to cells [35].
EAAs stimulate protein synthesis in both young and the elderly [36]. However, it has recently
been shown that specific diets containing blends of individual EAAs in stoichiometric ratios are crucial
for providing AAs for various metabolic needs, such as protein synthesis, mitochondrial biogenesis,
and other important metabolic pathways crucial for cell life [6,37,38]. Indeed, specific EAA mixtures
control protein synthesis in myocytes by activating AMP-activated protein kinase (AMPK) and mTOR,
which regulate energy production/use, protein synthesis, cell proliferation, mitochondrial biogenesis,
and anti-apoptotic process [39].
Clinical and experimental data suggest that oral supplements with specific individual
EAA mixtures ensuring metabolic energy supply, administered traditionally, counteract protein
disarrangement and cellular energy impairment without influencing renal function [40–43]. The clinical
consequences of this is that the percentage of nitrogen and calories provided by diet should be
calculated separately according to metabolic needs. Moreover, the amount of EAAs should be provided
as a function of their intrinsic capacities to maintain proteins and body metabolism. In addition,
individual AAs should be provided so they are not rapidly absorbed, thus increasing their blood
viability [44].
Taken together, these observations could explain why previous studies were unable to show any
effects of simple total protein dietary supplementation on protein and energy metabolism in patients
with chronic diseases [45]. Such findings support the indication that the elderly need increased EAA
to stimulate muscle protein synthesis. This also introduces the concept of evaluating protein AA
composition (protein quality) [46]. A modification of the Dietary Guidelines of Americans (DG of A),
which provides nutrient advice to avoid/reduce age-related nutritional problems, has been proposed
as follows: (1) protein (and more importantly specific AAs) should be a part of the adult/aged
people diet; (2) protein (and more importantly specific AAs) needs for adult/aged people should
be proportional to body weight and/or clinical condition and not as a percentage of total energy
intake; (3) most adult/aged people benefit from protein intake above the minimum recommended
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daily allowance. Indeed, to maintain healthy muscles and bones, at least 30 g of high-quality protein
(and more importantly specific EAAs) should be ingested at more than one meal.
The effect of dietary administration of different EAAs blends has been actively investigated in
the recent years [42–44]. Existing findings on the molecular pathways elicited by proteins and AA
metabolism in chronic disease conditions could allow the development of therapeutic strategies to
contrast metabolic impairment, especially in the elderly.
6. Conclusions
The evaluation of protein disarrangement deserves greater attention to manage chronic diseases,
especially in old age (see Box 1). Readily available and inexpensive anthropometric and blood
parameters, such as TST, AMA, and albuminemia, can be obtained routinely at the bedside.
Additional research could unveil the causes of these conditions and monitor the outcome of specific
therapeutic interventions.
Clinicians should consider protein homeostasis as essential to maintaining metabolic competence
in patients with chronic diseases. This is fundamental for any further therapeutic approaches.
The identification and treatment of protein metabolic impairment with appropriate therapies may be
at least as important as any other evaluation and therapeutic strategy implemented in improving the
prognosis of chronically ill patients.
Box 1. Main Messages from the text.
• Proteins are building blocks for living organisms consisting of amino acids (AAs).
• AAs are totipotent biochemical molecules essential for cellular activity.
• Pathological conditions increase protein/AA demand.
• Hypercatabolic syndromes, due to increased inflammation and catabolic hormones, cause
significant changes in body metabolism and lead to an imbalance between nutritional input and
synthetic/energy needs.
• Both circulating (i.e., albumin) and muscle proteins are a reservoir of AAs (above all, essential AAs) within
the body.
• Altered protein metabolism in patients (especially those with chronic diseases and/or older), can increase
the risk of developing life-threatening complications (e.g., infection, cardiac and/or renal dysfunction).
• The pathophysiology of conditions characterized by protein disarrangements (i.e., muscle wasting and/or
hypoalbuminemia) need to be fully clarified to develop adequate therapeutic (nutritional) strategies.
• Clinicians need to consider protein metabolism as a critical aspect for the management of patients with
chronic diseases.
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Abstract: It remains unclear as to what extent resistance training (RT) can attenuate muscle loss during
caloric restriction (CR) interventions in humans. The objective here is to address if RT could attenuate
muscle loss induced by CR in obese elderly individuals, through summarized effects of previous
studies. Databases MEDLINE, Embase and Web of Science were used to perform a systematic
search between July and August 2017. Were included in the review randomized clinical trials (RCT)
comparing the effects of CR with (CRRT) or without RT on lean body mass (LBM), fat body mass
(FBM), and total body mass (BM), measured by dual-energy X-ray absorptiometry, on obese elderly
individuals. The six RCTs included in the review applied RT three times per week, for 12 to 24 weeks,
and most CR interventions followed diets of 55% carbohydrate, 15% protein, and 30% fat. RT reduced
93.5% of CR-induced LBM loss (0.819 kg [0.364 to 1.273]), with similar reduction in FBM and BM,
compared with CR. Furthermore, to address muscle quality, the change in strength/LBM ratio
tended to be different (p = 0.07) following CRRT (20.9 ± 23.1%) and CR interventions (−7.5 ± 9.9%).
Our conclusion is that CRRT is able to prevent almost 100% of CR-induced muscle loss, while
resulting in FBM and BM reductions that do not significantly differ from CR.
Keywords: exercise; training; aging; sarcopenia; muscle mass; strength training; caloric restriction; diet
1. Introduction
Caloric restriction (CR) has been shown to increase lifespans and attenuate the harmful effects of
aging across the evolutionary spectrum [1,2]. Retrospective studies also demonstrate an association
between CR and health span in humans [3]. The exact mechanism underlying the benefits of CR
remains unknown, but it involves changes in nutrient-sensing pathways, metabolic homeostasis, and
body composition [1,4–6]. Weight loss is a normal feature of CR, and some groups claim that it is
necessary for beneficial effects, including a reduction of chronic inflammation, which is an important
trigger of non-communicable diseases [7–9]. However, weight loss via CR is accompanied by a
significant decrease in lean body mass (LBM) [10], which may be deleterious to elderly individuals
suffering from sarcopenia. Sarcopenia is often associated with frailty and increased mortality at
advanced ages, and is a challenge for successful aging [11].
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Resistance training (RT), associated or not with a high protein intake, has been shown to increase
LBM, promote strength, and attenuate sarcopenia in elderly individuals [12,13]. However, it is unclear
whether RT represents a good strategy to prevent muscle loss during CR (which includes dietary
protein restriction). Some studies have reported no change or even reduced LBM following CR when
RT is included in the intervention program [7,14–18]. On the other hand, randomized clinical trials
(RCT) comparing CR with and without RT have shown the preservation of LBM with RT [19,20].
This inconsistency could be due to different protocols, populations, methods of analysis, lack of
statistic power, or methodological rigor (i.e., control group, randomization, and weight stabilization
periods). Here, we performed a meta-analysis, based on data from RCTs, in order to determine the
level of LBM that can be preserved when RT is associated with CR interventions in elderly obese
humans. We hypothesized that elderly individuals treated with CRRT will lose less LBM compared to
elderly treated with only CR.
2. Materials and Methods
2.1. Data Source
A systematic search was conducted between July and August 2017 using MEDLINE, Embase
and Web of Science. There was no restriction on the publication’s date, and the terms were searched
within all words in titles and abstracts. The following terms were searched: “caloric restriction”,
“resistance training” (including “weight training”, “weight lifting”, “strength training”, “resistance
exercise”, “strength exercise”, “resistance program” and “strength program”), and “muscle mass”
(including “muscle body mass”, “lean mass” and “lean body mass”). Two reviewers selected the
studies independently, and the disagreements were solved with further discussion. The data extraction
was also made independently, and further compared to avoid errors. To isolate the effects of RT over CR,
only RCTs comparing the CR with (CRRT) or without RT (CR) were included. Details of the data
selection process are described in Figure 1. Non-original studies, non-human studies, and studies
without a control intervention were the only exclusion criteria. Considering that only one study assessed
body composition by hydrostatic weighing in young adults [21] (instead of the DEXA in older adults),
and another one prescribed RT only for abdomen muscles [22] (instead of the whole body), they were not
included in the meta-analyses. Six RCTs were included for the final meta-analysis [7,15,16,20,23]. One of
these studies [24] reported part of its data from a previous publication [25], so both studies were
included as one.
2.2. Study Selection
The RCTs included strictly similar samples, RT protocols, and CR protocols (Table 1). In summary,
the samples were composed of older adults or elderly people (mean > 57 years old), including men,
women, obese, sedentary, healthy, dyslipidemic, hyperglycemic, and diabetic individuals. Most CR
diets were nutritionally balanced (55% carbohydrate, 15% protein, 30% fat) [15,16,19,20], while others
had increased protein [7] or reduced fat intake [24]. Percentages of CR varied among studies, as shown
in Table 1. RT protocols lasted from 12 to 24 weeks, and applied a general warm-up on a treadmill or
cycle ergometer, followed by two or three trials of 8 to 15 repetitions, with a minimum of 65% of one
repetition maximum (1RM) for each exercise, three times per week.
2.3. Assessment of Risk of Bias
The researchers assessed the studies’ qualities using the PEDro scale [26]. As patients and care
providers could not be blinded in exercise interventions, these questions were nullified. Thus, scores
on the PEDro scale ranged from 0 (very low methodological quality) to 9 (high methodological quality).
The risk of publication bias was assessed through the Egger test.
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Figure 1. Flowchart of study selection. RCT: randomized control trials; RT: Resistance training; DXA:
Dual X-ray Absorbance; CRRT: caloric restriction with resistance training group.
2.4. Statistical Analysis
The meta-analyses were performed using Comprehensive Meta-Analysis (CMA) software, version
3.3.070. We performed three meta-analyses: lean body mass (LBM), fat body mass (FBM), and total
body mass (BM). The effect size was calculated based on the raw mean difference (RMD) of the
delta (pre- to post-intervention) between CRRT and control groups (CR). As the studies tested
were significantly homogeneous (p < 0.05), the authors used the fixed effect model in all three
meta-analyses. Despite the existence of particular differences between the samples studied and
RT and CR protocols deserving comparisons, the absence of between-studies variance precluded
further subgroup analysis. A conservative pre–post correlation of 0.5 was assumed [27]. In addition
to the main results, an analysis of whole-body muscle quality was performed. The percent delta
of muscle quality (strength/LBM ratio) following CRRT and CR was calculated, excluding only
one study that did not report strength values [7], by the following equation: percent delta of
muscle quality = (average strength/average LBM pre-intervention) − (average strength/average
LBM post-intervention) × (100)/(average strength/average LBM pre-intervention). The ratio was
calculated from whole-body LBM and muscle group strength presented by each original study, which
count six lower limb measurements and two upper limb measurements. The Mann Whitney test was
used to compare the mean differences between groups.
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3. Results
3.1. Studies’ Features
The quality of studies were homogeneous, as observed by their scores of 5 [7,16,20], 6 [19,24],
and 7 [15] on the PEDro scale. Egger tests (p > 0.1 for all) for the different analyses did not indicate
any publication bias. The studies’ main features are detailed in Table 1. Some studies reported
using a weight stabilization period to ensure that subjects were maintaining their weight before the
intervention. All studies selected included sedentary and obese individuals, and prescribed resistance
exercise for the main muscle groups, including upper and lower limbs, three times per week. LBM,
FBM, and BM in kg were assessed by dual-energy X-ray absorptiometry.
3.2. Evidence Synthesis
Figure 2 shows the forest plot comparing the different reductions of LBM, FBM and BM for
CRRT and CR. Although the reduction of BM and FBM in the CRRT group was not different from
the CR group, the LBM loss in the CRRT group was 93.5% less than the CR group (RMD = 0.819 kg,
95% CI = 0.364 to 1.273, p < 0.001). The means standard deviations (SD) of deltas for LBM, FBM, and BM
were 0.05 ± 0.3 kg, −3.86 ± 1.3 kg, and −4.16 ± 1.2 kg for CRRT, and −0.76 ± 0.1 kg, −3.73 ± 1.2 kg, and
−4.73 ± 1.2 kg for CR, respectively (Figure 3a). The percentage of muscle quality changes, defined as
force production per unit of muscle tissue [23], was calculated as strength divided by LBM following
CRRT (20.9 ± 23.1%) and CR (−7.5 ± 9.9%), and there was a tendency for a significant difference
between the groups (p = 0.07) (Figure 3b).
Figure 2. Cont.
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Figure 2. Forest plot for differences between caloric restriction plus resistance training (CRRT) and
caloric restriction (CR) reductions of LBM (A); FBM (B); and BM (C). RMD: raw mean difference (kg);
LL: lower limit of 95% CI; UP: upper limit of 95% CI; CI: confidence interval.
Figure 3. (A) Illustrative change in body mass after CRRT and CR; (B) percentage of muscle quality
change after CRRT and CR. Data is presented in mean and standard deviation. P: p-value for difference
between groups (Mann Whitney test).
4. Discussion
The main finding of the present meta-analyses was that CRRT prevents 93% of the LBM loss
induced by CR, although it does not affect BM and FBM reductions as compared to CR without RT.
A previous meta-analysis showed only 50% LBM loss attenuation when different types of exercise
were added to CR in sarcopenic obese individuals over 50 years old [10]. However, since endurance,
resistance, and combined types of training were included in this analysis, it was not possible to identify
which type of exercise led to the preventive effect. Endurance exercise is the most efficient type to
increase energy expenditure and induce weight loss, mainly when associated with CR [28–31]. On the
other hand, we propose that RT is an excellent alternative to prevent CR-induced LBM loss in elderly
individuals. Furthermore, future studies should compare the preventive effect of different modalities
of exercise training on CR-induced LBM loss.
A proposed mechanism to explain such protection relies on the energy costs of protein synthesis.
During CR without RT, the blunted muscle protein synthesis with elevated proteolysis might allow
energy maintenance [32]. Alternatively, CRRT induces muscle protein synthesis [33], likely shifting
energy towards LBM maintenance while stimulating fat depletion, to allow for fuel availability to cope
17
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with the increased energy demand. Indeed, Murphy and colleagues have shown that RT restores the
depressed rates of myofibrillar protein synthesis induced by CR [33].
Preservation of LBM with CR could also be obtained by additional protein intake. Longland
and colleagues [34] have shown that CRRT with high protein consumption induces an increase in
LBM and promotes larger fat loss, if compared to CRRT with low protein consumption. The only
study that has investigated the CR effects in combination with higher protein intake (30% compared
to 15% of the rest) found lower LBM loss than the others (RMD 1.3 kg compared to the main effect
of RMD 0.6 kg) [7]. However, whether or ot the beneficial effects of CR are dependent on protein
restriction is not clear, and deserves further attention. Although the evidence towards a longer lifespan
in humans is still unclear [35], decreased protein intake is often beneficial and increases lifespan in
other animals [36]. Moreover, the mammalian target of rapamycin (mTOR) pathway, which is induced
by amino acids, growth factors, and RT, is often inhibited during CR, and mediates CR-induced health
benefits in model organisms [37]. However, while chronic mTOR activation during obesity or aging
might be deleterious [37], like in CRRT, mTOR activation concurrent with decreased energy balance
may preserve protein synthesis, while stimulating fat depletion.
Cross-sectional studies have shown potential detrimental effects of higher muscle mass on insulin
sensitivity in sedentary older adults [38], which oppose the well-known beneficial effects of exercise
on glucose metabolism [39,40]. However, it is likely that the exercise-induced LBM increase may not
lead to such impairments in insulin sensitivity [41]. While reduced glucose disposal, total cholesterol,
and LDL were maintained or even improved upon implementing CRRT [7,15,16,24], in two studies
blood triglyceride levels were reduced after CR, but not after CRRT [15,16]. In one of them, HDL
was decreased following CRRT [15], and fasting insulin was reduced only in the CR group [16].
The authors suggest these controversial findings may be due to the presence of a varied pool of
diabetic, dyslipidemic, or hypertensive patients among the study populations. These observations
reinforce the need for further comparisons of CR effects and exercise training on overall health markers
in healthy and diseased populations.
It goes beyond the scope of this study to determine whether CR-induced LBM reduction can
be as harmful to muscle function as aging-induced LBM reduction. Sarcopenia is characterized not
only by an LBM reduction, but also a reduction in muscle function [11]. Despite the fact that larger
muscle areas are associated with higher muscle strength, LBM is not the only determinant [42,43].
Thus, despite the marked LBM reduction following CR in some species, CR delays age-associated
muscle dysfunction in D. melanogaster [44] and rhesus monkeys [45], and delays the onset of sarcopenia
in the latter [46].
CR intervention in elderly humans results in a reduction [18,19] or maintenance [15,16,20,24] of
muscle strength. Even though the present study was not designed to test muscle function, we showed
a trend towards the increase in whole body muscle quality when RT was added to CR (p = 0.07),
suggesting that in humans, RT improves muscle function regardless of muscle mass changes during
CR. It is noteworthy that muscle group strength was related to whole LBM, instead of local muscle
mass, which is a limitation of the method. In agreement with our findings, in a study with elderly
individuals, when CRRT was compared to RT alone, the addition of CR to RT improved mobility
(400 m of walk time) without compromising other functional adaptations of RT alone [14].
Another concern regarding body composition following CR interventions is the bone mass
loss, which exercise is shown to prevent, at least in rodent models of male senile osteoporosis [47].
RT is known to be highly effective to increase bone mineral density after long-term interventions in
humans [48]. However, the only intervention that assessed bone mass in this review was too short to
address either positive or negative effects from CRRT or CR [20]. In this sense, despite the anti-aging
potential of CR to humans, future studies are required to test its long-term effects in a comprehensive
health perspective.
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5. Conclusions
CRRT almost stopped CR-induced LBM loss completely, while resulting in similar FBM and
BM reductions as seen with CR alone. The confidence intervals showed there was a wide range of
responsivity among individuals; therefore, future studies should investigate which factors are different
between groups of responders and non-responders for LBM prevention after CRRT, in order to address
the possible mediators of this process.
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Abstract: Muscle mass, strength, and physical function are known to decline with age.
This is associated with the development of geriatric syndromes including sarcopenia and frailty.
Dietary protein is essential for skeletal muscle function. Resistance exercise appears to be the most
beneficial form of physical activity for preserving skeletal muscle and a synergistic effect has been
noted when this is combined with dietary protein. However, older adults have shown evidence
of anabolic resistance, where greater amounts of protein are required to stimulate muscle protein
synthesis, and response is variable. Thus, the recommended daily amount of protein is greater
for older people. The aetiologies and mechanisms responsible for anabolic resistance are not fully
understood. The gut microbiota is implicated in many of the postulated mechanisms for anabolic
resistance, either directly or indirectly. The gut microbiota change with age, and are influenced by
dietary protein. Research also implies a role for the gut microbiome in skeletal muscle function.
This leads to the hypothesis that the gut microbiome might modulate individual response to protein in
the diet. We summarise the existing evidence for the role of the gut microbiota in anabolic resistance
and skeletal muscle in aging people, and introduce the metabolome as a tool to probe this relationship
in the future.
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1. Introduction
Skeletal muscle has several important functions beyond locomotion, including insulin-stimulated
glucose uptake, influence on bone density via mechanical force on bones, and whole-body protein
metabolism [1]. Age associated loss of muscle mass starts as early as age thirty, and is a gradual
process [1]. Older people lose more skeletal muscle with bedrest and show an attenuated response
to retraining after immobilisation, in comparison to younger individuals [2–4]. Sarcopenia is a
geriatric syndrome defined as the age-related loss of skeletal mass and function, quantified by objective
measures of muscle mass, strength, and physical function [5]. One major risk factor for the development
of sarcopenia is protein-energy malnutrition [6]. A number of factors can lead to reduced protein intake
in older age, as summarised in Figure 1 [7–18]. Patients with sarcopenia are often frail (vulnerable
to minor stressors) and the two concepts (frailty and sarcopenia) share an increased risk of adverse
outcomes [19]. As life expectancy worldwide has more than doubled over the past two centuries,
the importance of understanding and optimising muscle function in older age is paramount.
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Figure 1. Factors leading to lower protein intake in older adults.
Three large observational studies have supported an association between protein intake and
muscle strength and mass [20–22], but multiple trials carried out in healthy, replete, older adults,
without an exercise intervention, have been negative [23–25]. In those with suboptimal protein intake,
the most promising results are for specific essential amino acids, particularly leucine, but also its
metabolite β-hydroxy β-methylbutyric acid (HMB) [25–29]. Supplementation with these more targeted
regulators of muscle protein synthesis (MPS) may be most effective for overcoming anabolic resistance
in this cohort, especially if combined with exercise, a potent stimulator of anabolic response in muscle
at all ages [28,30–32]. Anabolic resistance refers to the phenomenon whereby older adults require a
higher dose of protein to achieve the same response in MPS as a younger adult [1]. The aetiologies and
mechanisms for this are not understood, but we propose that the gut microbiome may be implicated
in one or many of those suggested in the literature.
The gut microbiome is composed of bacteria, archaea, viruses, and eukaryotic microbes that reside
in the gut. Its role in maintaining a healthy physiology and contributing to disease is a rapidly evolving
field of enquiry. The gut microbiome has a collective genome size that may be as much as 150-fold
that of the human host [33], and it has been argued that the metabolic capacity of microbiota merits its
consideration as an organ of the human body in its own right, with its own intrinsic functions and
metabolic needs [34]. With age and frailty in particular, the resilience of the gut microbiome is reduced,
as it becomes more vulnerable to medications, disease, and changes in lifestyle, with changed species
richness and increased inter-individual variability [35–37]. The potential of the gut microbiota to
alter physiology has been shown by landmark animal studies assessing faecal transplant, which have
demonstrated body composition changes in the recipient reflective of the phenotype of the donor [38].
This highlights the role of microbiota in characterising metabolic phenotypes, which we are only now
beginning to understand.
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Ageing is associated with chronic inflammation [39], often referred to as ‘inflammaging’.
Here we suggest that this ‘inflammaging’, in combination with altered gut microbiome composition
and/or diversity [40], leads to changes in protein metabolism, absorption and availability;
ultimately contributing to anabolic resistance and therefore to reduced MPS and the development of
sarcopenia. Proposed interventions such as protein supplementation, probiotics or faecal transplants
should address this rationale. This review summarises the available literature on anabolic resistance in
older adults, with a particular focus on the role of the gut microbiome and its metabolome.
2. Anabolic Resistance
Skeletal muscle mass is regulated by the processes of muscle protein synthesis and breakdown
(MPS and MPB). MPS rates are largely controlled by responsiveness to anabolic stimuli, such as
consumption of food, and physical activity. Catabolic stressors include illness, physical inactivity,
and inflammation, of which the older population tend to have higher rates (Figure 2). Ageing does not
seem to influence MPB to the same degree as MPS, and so much of the focus of the aging literature is
on MPS [27,41–43]. Older adults have shown evidence of ‘anabolic resistance’, whereby a higher dose
of protein is required to achieve the same MPS response as a younger person [1,28,39,40,44]. While this
concept has been questioned, especially in the context of healthy older adults [45], it is now considered
consensus that a higher recommended daily amount of 1–1.3 g/kg/day should be consumed by older
people to offset catabolic conditions [1,46–49]. In the context of illness or injury, older adults may
require as much as 2 g/kg/day, as recommended by the PROT-AGE Study Group [50].
Figure 2. Factors leading to loss of skeletal muscle and sarcopenia in older adults.
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The aetiology of anabolic resistance is complex, involving aging physiology, accumulation
of chronic disease, and changes in physical inactivity (see Table 1). The multiple mechanisms
postulated involve impairments at most levels of protein metabolism (see Table 2). There may also be
sex-differences in anabolic resistance [51–54], which has received little attention in the literature.
Table 1. Factors influencing anabolic resistance.
Anabolic Resistance Aetiology References
Declining activity levels [1,6,55–57]
Protracted disuse events [6,58–61]
Chronic inflammation [31,41,56,62,63]
Insulin resistance [1,27,41,62,64,65]
Higher circulating oxidative and inflammatory stressors [1,27,56]
Obesity [62,66]
Reduced oestrogen/testosterone [1,67]
Increased production of catabolic hormones such as cortisol [27]
Alcohol [68]
Smoking [1]
Poor vitamin D status [56]
Reduced food intake [56]
Metabolic acidosis [1]
More chronic & acute disease in older adults (increased catabolic conditions) [50]
Table 2. Molecular mechanisms implicated in anabolic resistance.
Anabolic Resistance Mechanisms References
Differences in gene expression of proteins involved in MPS [69–73]
Dysregulation of key signalling proteins in the mTOR pathway [1,41,70,71,74,75]
Decreased phosphorylation of mTORC1 [41,74,76–79]
Impaired transport of amino acids into muscle/peripheral tissues [56,75,80,81]
Diminished mRNA translational signalling [74,78,82,83]
Inflammation (raised TNFα/IL-6/hs-CRP/NFkB) [1,41,74,84,85]
Decreased phosphorylation of transcription factors (e.g., p70S6K, S6K1) [41,74,75,82]
Dysregulation of nutritive blood flow to skeletal muscle [56,65,86]
Attenuated protein digestion & absorption [56,87–89]
Mitochondrial dysfunction [1,35,72]
Autophagy/mitophagy dysfunction [1,72]
Denervation of muscle fibres [56,90]
Higher splanchnic extraction of protein [50,88]
Lipid-induced muscle insulin resistance [35,91]
Increased AMPKα phosphorylation (leads to increased MPB) [70]
Increased cortisol generation within muscle by 11bHSD1 [92]
Loss of skeletal muscle stem cells [93]
3. The Role of the Gut Microbiome
The composition of the human gut microbiome is dependent on, amongst other things, age, diet,
health, and geographical location, with significant individual variability [94,95]. It is dynamic across
the lifespan, changing rapidly between birth and early childhood, and then becoming more stable [36].
In older life, however, research shows that the propensity for compositional change accelerates once
again [36,96,97]. Multiple cross-sectional studies have found associations between gut microbiome
composition and frailty [98–100], while the ELDERMET study showed significant loss of diversity
amongst people in a care-home setting versus community dwellers [95]. Among older hospitalised
patients, polypharmacy has been associated with gut microbiota dysbiosis [99]. It is well established
that antibiotics cause significant changes in microbiota composition [101], and older adults tend to
have more frequent antibiotic therapy.
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Age-related chronic inflammation (‘inflammaging’), is implicated in the development of
sarcopenia [102,103]. Changes in the gut microbiota have been suggested to contribute to
inflammaging [37,103–105]. A recent animal study showed that transferring gut microbes of
young killifish to older ones ameliorates ageing conditions, and extends the lifespan of the older
fish [106]. Notably, the transplanted older fish also displayed increased ‘spontaneous exploratory
behaviour’ [106], essentially physical activity. Few studies to date have had the ability to delve into
the operational capacity and functional readout of the gut microbiome in relation to aging, but this is
likely to shed more light on possible mechanisms of the interaction between dietary intake and host
utilisation of protein in skeletal muscle.
3.1. Gut Microbiota and Skeletal Muscle
The influence of the gut microbiome in metabolic health has been one of the primary focuses
of research in this area thus far, particularly in the context of obesity and insulin resistance [107].
Studies have used faecal transplants in germ-free mice to demonstrate changes in body fat,
insulin resistance and glucose tolerance [108], highlighting the key role of the microbiome in
these metabolic pathways. Considering the role of skeletal muscle in glucose metabolism,
animal studies have investigated the relationship between gut microbiota and skeletal muscle
metabolism. For example, skeletal muscle from colonised versus germ free mice appears to have altered
metabolic efficiency, with higher levels of the enzyme adenosine monophosphate (AMP)-activated
protein kinase, a central regulator of metabolism at both a cellular and organismal level, found in the
skeletal muscle of germ-free mice [109]. CD-14 mutant mice, who lack an endotoxin receptor on their
innate immune cells, have increased levels of circulating lipopolysaccharide (LPS), and this LPS was
found to induce skeletal muscle inflammation, as well as insulin resistance [36]. This is important
because the healthy gut microbiome is considered to contribute to gut barrier function (Section 3.3
below), providing gut enterocytes with essential nutrition [110] and reducing LPS levels in the blood.
Lastly, Yan et al. (2016) carried out a study in which gut microbiota was transferred from obese pigs
to germ free mice [111]. Fibre characteristics and the metabolic profile of the skeletal muscle were
replicated in the recipients [111], again implicating the gut microbiome in skeletal muscle composition
and metabolism. Some of the fibre changes noted were similar to those seen in aging skeletal muscle
(e.g., increased proportion of slower contracting fibres). This raises the possibility that faecal microbial
transplantation could be used as a means to transmit muscle fibre characteristics between humans,
perhaps even from young to old, as a means of improving skeletal muscle function.
Gut microbiota modulation in animal models has also produced preliminary supportive data
for effect on skeletal muscle. This includes lower intestinal permeability and lower plasma LPS and
cytokines noted in prebiotic-treated mice [112], reduced expression of muscle atrophy markers in
mice models of leukaemia supplemented with a Lactobacillus species [113], and increased muscle
mass and function (measured by grip strength and swim time) in healthy mice supplemented with
L. plantarum [114]. These studies and others [115,116], suggest that targeting the gut microbiota may
be used as a tool to modulate muscle mass.
In terms of human data, two probiotic trials have shown improvements in athletic performance
amongst elite athletes. A small, four week trial of probiotic capsules in male runners reported
increased run time to fatigue in the probiotic group [117], while a trial of probiotic yoghurt in teenage
female endurance swimmers reported improved aerobic performance, measured by maximal oxygen
consumption (VO2 max) [118]. Dietary standardisation was carried out in the male runner study,
however in the swimmer study participants continued their regular diet which may have confounded
results. These studies build on evidence from observational studies for an association between exercise
and gut microbiota [119–124]. Clark et al. (2014) compared the gut microbial diversity of professional
male athletes to healthy controls and reported significantly higher diversity amongst the athletes [125].
Furthermore, moderate exercise has been shown to increase intestinal mobility [126], which is known to
affect gut microbiota [127,128]. These changes in gut health with exercise implicate skeletal muscle as
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a potential regulator of gut microbiota composition and suggest a bi-directional relationship between
skeletal muscle and the gut microbiome.
Amongst older adults, a single randomised controlled trial has explored the effect of modulating
the gut microbiota on muscle function and frailty. Here, 60 older adults received a prebiotic (F-GOS)
or placebo for 13 weeks. While the study remains to be replicated, promisingly, both exhaustion and
handgrip strength were significantly improved in the treatment arm [129], highlighting the potential
role for the gut microbiome in future interventions. The science of pre- and probiotic use is in its
infancy, as are studies of faecal transplantation, with much scope for further investigation of these
therapeutic options.
3.2. Gut Microbiota and Dietary Protein
The digestive system consists of a complex interaction between digestive secretions, intestinal
conditions, and the gut microbiome. Nutrients, especially dietary proteins, provide energy sources
for the host, as well as substrates for the gut microbiota [130]. A significant proportion of undigested
peptides and proteins can reach the colon, and this is increased in the context of a high protein diet [131].
Consumption of proteins with high digestibility, or a low protein diet, results in less protein reaching
the colon, limiting the amount available for protein-fermenting bacteria [130]. Furthermore, changes in
the gut microbiota can impact the bioavailability of dietary amino acids [104,132].
Studies carried out in mice, rats, and hamsters have shown higher microbial diversity in those fed
soy protein versus animal protein [133,134] and increased abundance of Bacteroidales family S24-7 in
those fed soy protein versus other diets [79]. Li et al. (2017) assessed high protein, low carbohydrate
diets in dogs and found decreased Bacteroidetes to Firmicutes ratio, increased Bacteroides to Prevotella
ratio and increased abundance of Clostridium hiranonis, Clostridium perfringens, and Ruminococcus
gnavus, the latter of which has been proposed to have beneficial effects in the human gut [135].
It has been reported that protein consumption is correlated positively with gut microbiota
diversity [136]. This is based on studies carried out on healthy volunteers [137], elite athletes [125],
and obese/overweight individuals [138]. The source of protein appears influential, with plant protein
associated with more Bifidofacterium, Lactobacillus, Roseburia, Eubacterium rectale, and Ruminococcus
bromii; and less Bacteroides and Clostridium perfringens [136,137]. Meanwhile animal protein was
associated with higher levels of Bacteroides, Alistipes, Bilophila and Ruminococcus, and lower levels
of Bifidobacterium [136,137]. High levels of Bacteroides have also been reported with Western diets,
which are high in protein and animal fat [33], although it has been suggested that differences in fat
content, rather than protein, is the major influencing factor here [139]. Significant associations have
been reported between increased levels of faecal short chain fatty acids (SCFAs), Prevotella and some
Firmicutes, with consumption of a Mediterranean diet [35,140], which is typically lower in protein
than animal-based diets, although may contain high levels of plant-source protein. Dietary fibre is an
important factor in gut microbiome diversity and composition and it is important to note that most
plant sources of protein are also high in fibre, whereas animal source protein are not. This is likely to
be an influential factor in the findings of these studies.
The gut microbiomes of critically ill patients on average display enrichment of virulent pathogens,
and loss of health-promoting microbes [141]. Protein supplementation has shown some benefits
for muscle parameters in this population [142,143], but whether this effect is modulated by the gut
microbiome remains to be tested. Evidently dietary protein has a significant effect on gut microbiota
composition and vice versa, however more research is needed to further characterise this relationship.
It is notable that almost exclusively, studies to date have focused on composition of the microbiota
rather than functional capacity of the microbiome. Investigation into the differences in microbial genes
involved in protein metabolism between individuals differing in anabolic response to protein could
lead to the engineering of new probiotics with specific capacity to influence MPS.
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3.3. Gut Microbiota and Anabolic Resistance
A healthy gut microbiome plays a role in many of the physiological processes implicated in the
various mechanisms proposed for the development of anabolic resistance (see Table 2 and Figure 3).
These include suppression of chronic inflammation, prevention of insulin resistance, modulation of host
gene expression, enhancement of antioxidant activity, and maintenance of gut barrier function [35,104].
Figure 3. Mechanisms by which the gut microbiome may influence anabolic resistance. LPS:
Lipopolysaccharide; SCFA: Short chain fatty acids.
Inflammation has been proposed as a contributing factor to anabolic resistance in aging,
and indeed inflammaging has been suggested as a major aetiological factor in the development
of sarcopenia. Biagi et al. (2010) studied age-related differences in both the gut microbiota and
the inflammatory status among different stages of the whole adult life, including centenarians,
and reported dysbiosis in the older population, which correlated with increased inflammatory status,
as determined by peripheral blood inflammatory markers [37].
Work in animal models has shown evidence of increased intestinal permeability in association
with age-associated microbial dysbiosis [36,104,144]. This can facilitate translocation of microbial
byproducts into the circulation, including endotoxins, and may influence a number of the mechanisms
listed in Table 2, such as protein digestion and absorption. It has been suggested that pathogenic drivers
of inflammation and muscle atrophy may enter the system via this process [132]. Within humans,
a randomised controlled trial of probiotic use in athletic men reported reduced zonulin in faeces,
a surrogate marker of enhanced gut permeability [145], suggesting that modulation of the gut
microbiota can affect the gut’s barrier function.
Older adults tend to have reduced intestinal motility, which may unfavourably affect the
utilisation of dietary protein by the gut [104]. Indeed it has been reported that the proteolytic potential
of the gut microbiota appeared to be enhanced in older age [146], and may therefore contribute to
anabolic resistance to ingested protein. There is also some evidence that probiotics may improve
amino acid absorption from protein [147,148], which adds weight to the suggestion that targeting the
gut microbiota may ameliorate anabolic resistance in older adults. Production of SCFAs by the gut
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microbiota has been associated with anabolism itself [110] and depletion of taxa producing SCFAs
may promote anabolic resistance [149]. Of note, an age-related reduction of the abundance of genes in
pathways that are involved in SCFA production has been reported [146]. SCFAs are mainly produced by
the fermentation of dietary fibre, so the fibre content of dietary protein sources is likely too, to influence
protein metabolism.
Treatment with butyrate (a SCFA), which is associated with Bifidobacterium, was found to be
protective of muscle atrophy in mice [116]. Notably, studies showing correlation between frailty and
gut microbiota composition have also reported dysbiotic shifts in higher functioning older adults
towards a greater abundance of butyrate-producing bacteria such as Faecalibacterium prausnitzii [95,150],
which suggests these microbes may have a positive role in protection against muscle loss and frailty.
Butyrate also has a role in intestinal barrier function [151], and therefore may be implicated in intestinal
permeability. Notably, a randomised controlled trial of symbiotic (a combination of pre- and probiotic)
use in older people noted an increase in butyrate production in those given the synbiotic [152].
Mitochondrial dysfunction and impaired autophagy have both been suggested as possible
mechanisms for anabolic resistance (see Table 2). Interestingly, they have also been implicated in
animal models of aging [153] and in the development of sarcopenia and cachexia [154,155]. A recent
paper has postulated that dysfunctional mitochondria may represent a key link between chronic
inflammation and age-related muscle loss, and that dysbiosis of the gut microbiota may be a key
mediator in this gut-muscle crosstalk [104].
Evidently, there are multiple mechanisms by which the gut microbiome may influence anabolic
resistance in older adults (see Figure 3), and it is likely to be a complex interaction between a number
of, if not all, of these postulated processes. The hypothesis that the dysbiotic gut plays a role in the loss
of skeletal muscle and response to protein is yet to be tested. If supported, the gut microbiota could
represent a target for interventions aiming to overcome anabolic resistance, to maintain muscle mass
and strength in older adults, with the aim of ultimately preventing the development of sarcopenia
and/or frailty.
3.4. The Metabolome
Studies use multiple ways of estimating dietary protein intake. The validity and reliability of these
dietary measures has usually been verified in younger populations and may not be relevant to older
people. Indeed reduced reliability coefficients of the Food Frequency Questionnaire have been reported
with increasing age [156]. In order to overcome this, researchers have sought objective estimates of
dietary intakes. Protein is the major nitrogen-containing substance in the body, and therefore urinary
excretion of nitrogen is used as a marker of protein loss [23,40]. Urinary [31,131] and blood urea
concentration [131], and urinary HMB levels [157] have also been used with the aim of objectively
verifying compliance. These methods are not without limitations, as they may not consider subtle
changes with protein metabolism that occur with age, such as increased splanchnic uptake [50].
The amount of fermentation metabolites detectable in the urine depends on the digestibility of the
protein [130], so this too needs to be considered. Another way to study gut microbiota composition
is altered fermentation products. Promisingly, the faecal metabolome has been shown to be largely
reflective of gut microbial composition [158]. Trials using 1H-nuclear magnetic resonance (NMR)
technology have shown a shift in bacterial metabolism with different metabolite profiles according
to the source of protein [131]. A growing number of studies are using 1H-NMR technology to assess
faecal, urinary, and plasma metabolomes as measures of metabolic health (e.g., [159]). More research is
needed into the use of the metabolome in the context of dietary protein intake, and the significance of
metabolome changes for skeletal muscle mass and function.
4. Discussion
As the world’s population ages, it has become imperative to gain more understanding of the aging
process. Declines in muscle mass and function with age have significant associated morbidity and
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mortality, and the prevalence of both sarcopenia and frailty is increasing. The care of older people is
complex, and a multitude of factors influence lower protein intake and loss of skeletal muscle with age
(see Figure 1). Studies show that supplementing protein, particularly in combination with resistance
exercise, is beneficial for aging muscle. However, trials have had conflicting results. Perhaps a more
personalised approach is warranted? Attempting to answer this question is a large randomised
controlled trial, currently being carried out, on personalised dietary recommendations as part of a
multi-component intervention in the management of sarcopenia [160].
Anabolic resistance is likely to result from cumulative declines across multiple physiological
systems, with effects on both MPS and MPB, a dynamic interaction of multiple factors (see Figure 2).
Current thinking must not be limited to one or two mechanisms but focus on anabolic resistance
as a complex and multidimensional construct. The aetiologies and mechanisms involved are not
understood and may be different for each aging individual, again suggesting a potential need for
personalised medicine within this population to guide future interventions. The potential role of the
gut microbiota in a substantial number of postulated mechanisms for anabolic resistance warrants
further investigation (Figure 3). Targeting the gut microbiota to overcome anabolic resistance holds
promise in maximising responses in participants who can undertake exercise programs, but where
resources and time limit such programs. Moreover, the potential ability to influence skeletal muscle
function via gut microbiota in the context of those who cannot feasibly carry out vigorous exercise
programs is also an attractive idea.
Few human studies have evaluated the effects of the gut microbiome on dietary protein
metabolism, and the ensuing metabolome or vice versa. Studies addressing the role of the gut
microbiota in skeletal muscle function are also limited in number. Animal studies have shown promise,
and one human trial in older adults showed positive improvements in muscle function with prebiotic
gut microbiome modulation [129]. Furthermore, in light of difficulties in accurately capturing an
individual’s dietary intake from questionnaire data [161], the use of the metabolome may represent
an objective and reliable way of assessing compliance with dietary interventions going forward [162],
and provide a functional readout for the gut microbiome.
To date there is some supporting evidence for a hypothesis that the gut microbiome may influence
the health of skeletal muscle and vice versa [35,36,104], however this remains to be formally tested.
In particular, processes such as muscle metabolism and inflammation may be susceptible to modulation.
Research is needed to establish whether deleterious changes in the gut microbiome contribute to
skeletal muscle loss in the context of acute or chronic illness, or changes detected in apparently healthy
aging. The plasticity and diversity of the gut microbiome and its metabolome, represent exciting
prospects to individualise the response of skeletal muscle in older adults to dietary protein.
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Abstract: There is an ongoing debate as to the optimal protein intake in older adults. An increasing
body of experimental studies on skeletal muscle protein metabolism as well as epidemiological
data suggest that protein requirements with ageing might be greater than many current dietary
recommendations. Importantly, none of the intervention studies in this context specifically
investigated very old individuals. Data on the fastest growing age group of the oldest old (aged
85 years and older) is very limited. In this review, we examine the current evidence on protein
intake for preserving muscle mass, strength and function in older individuals, with emphasis on
data in the very old. Available observational data suggest beneficial effects of a higher protein
intake with physical function in the oldest old. Whilst, studies estimating protein requirements in
old and very old individuals based on whole-body measurements, show no differences between
these sub-populations of elderly. However, small sample sizes preclude drawing firm conclusions.
Experimental studies that compared muscle protein synthetic (MPS) responses to protein ingestion in
young and old adults suggest that a higher relative protein intake is required to maximally stimulate
skeletal muscle MPS in the aged. Although, data on MPS responses to protein ingestion in the oldest
old are currently lacking. Collectively, the data reviewed for this article support the concept that there
is a close interaction of physical activity, diet, function and ageing. An attractive hypothesis is that
regular physical activity may preserve and even enhance the responsiveness of ageing skeletal muscle
to protein intake, until very advanced age. More research involving study participants particularly
aged ≥85 years is warranted to better investigate and determine protein requirements in this specific
growing population group.
Keywords: ageing; octogenarians; nonagenarians; centenarians; anabolic resistance; protein
requirements; exercise; amino acids; skeletal muscle health
1. Introduction
The age-related loss of muscle mass, function and strength—termed either as sarcopenia or
dynapenia—has a profound impact on mobility in the elderly. This loss of physical function capabilities
compromises the ability to independently perform every-day activities [1–3]. Less immediately obvious
but also of significance, is the link between the loss of muscle mass and function with increased risk of
type 2 diabetes, cardiovascular diseases, some cancers and neuro-degenerative disorders, including
Alzheimer’s disease and dementia [4–6]. Most developed economies are experiencing rapid population
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ageing. Yet it is the oldest aged humans, individuals aged 80 years and older, which is the fastest
growing of the age sectors [7]. The increasing number of exceptionally long-lived people and the
fact that mortality rates beyond 105 years plateaus across these cohorts suggests that longevity is
continuing to increase over time and that a limit has not been reached yet [8]. Therefore, it is important
to consider the unique characteristics of the oldest old and develop potential strategies to sustain and
enhance their quality of life.
Commencing from the mid-twenties muscle mass and muscle strength decline through
middle-age, particularly in habitually sedentary individuals [9–11]. This is initially a slow process, with
a strength loss of approximately 10% per decade. Strength loss further accelerates after the age of 60 to
70 years. Thus, the oldest in our society have only 30–40% of their peak adult strength. Putative cellular
mechanisms of ageing include oxidative stress, chronic low-grade inflammation/impaired immune
function, increased macromolecular damage and genomic instability, cellular senescence and reduced
stress resistance [12–15]. However, malnutrition in the elderly is very common, with significant risk of
micronutrient deficiencies [12–14,16]. It is likely then that malnutrition itself also exerts an impact on
muscle loss.
Whilst all elements of dietary intake are critical for the maintenance of muscle mass, it is the regular
adequate consumption of protein, that is essential to stimulate protein synthesis [17–19]. Current
official nutritional recommendations for protein intake in the elderly vary between 0.8 g (see official
WHO, US and UK guidelines) and 1.2 g/kg BW/day (e.g., guidelines from Nordic countries, Australia,
New Zealand). However, there is recent evidence that in healthy elderly a higher intake of up to twice
this amount could be beneficial, in the absence of side effects [17–20]. Studies to date have shown that
a daily protein intake between 1.5 g up to 3 g (under special conditions)/kg BW/d is beneficial and
safe in the elderly [21].
The purpose of this review is to analyse available evidence on protein intake for preserving muscle
mass, strength and function in the very old. Further aims are to also identify opportunities to address
knowledge gaps in this area. As yet, the exact protein needs for those aged 85 years and older has not
been analysed in sufficient detail to allow formulation of nutritional guidelines. It then is important to
review the current national and international recommendations for elderly (aged 70 years and above)
and the position stands by varying expert groups, in order to identify if these recommendations are
applicable to the very oldest in the community. Further, possible behavioural strategies that can be
targeted to assist in successfully increasing protein intake in the oldest old will be examined.
2. Protein Recommendations for Elderly Humans
The global recommendations for daily protein intake, as proposed by the World Health
Organization (WHO), is 0.8 g/kg BW/day, equally for all age groups and regardless of gender,
physical activity or health status [22]. These recommendations were published in 2007 and have not
been updated since. This position is then based on publications from the 1980s and 90s, with relatively
small sample sizes, particularly in individuals aged over 70, with protein-balance methods likely
underestimating protein requirements [23].
2.1. Global versus National Recommendations
Compared to the “one-for-all” recommendations for protein intake by the WHO, many countries
have revised and increased protein intake recommendations for the elderly. Yet the guidelines of
the US and the UK remain similar to the WHO, with the recommendation that a protein intake
of 0.8 g/kg BW/d is sufficient for all age-groups [24]. This differs from what has now been
adopted in many other countries. The Australian recommended dietary intake (RDI) for protein
for people aged 65 years and older is about 25% higher, than the recommendations for younger
adults. Their general recommendations for healthy elderly is to consume 1.1–1.2 g/kg BW/day
of protein, with greater protein required during periods of increased physical activity (endurance
and/or resistance exercise) and in the presence of acute or chronic diseases [24]. The recently updated
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Nordic Nutrition Recommendations also suggest a slightly higher protein intake of 1.1–1.3 g/kg
BW/day for healthy older adults [25]. Yet other countries, including the nutritional guidelines in
German speaking countries (Austria, Germany, Switzerland), revised and only slightly increased
protein recommendations from 0.8 g to 1.0 g/kg BW/day for healthy elderly [26]. There is therefore
a wide range of protein recommendations for the elderly, from the lowest 0.83 g/kg BW/day to the
highest of 1.3 g/kg BW/day (61% greater daily intake) highlighting the marked discrepancies that
exist. Importantly, none of these national recommendations specifically address the possible protein
requirements of the very old.
2.2. What Experts Are Saying
Over the last decade, a number of expert groups have reviewed available data and made
recommendations for the nutritional needs of older persons. Most expert groupings broadly agree that
existing official recommendations might underestimate the physiological protein needs of the elderly.
These opinions are influenced by recent RCTs from elderly cohorts, combined with the data generated
using the latest methods to determine protein requirements [23].
The nutritional recommendations for the treatment and/or prevention of sarcopenia, formulated
by the Society for Sarcopenia, Cachexia and Wasting Disease (SCWD), recommend a protein intake of
at least 1.0–1.5 g/kg BW/day in combination with adequate exercise as a key concept to prevent the
loss of muscle mass and function with age [27]. Their multifactorial suggestions, including exercise,
nutrition, specific nutrients, nutritional supplements and medical drugs, are based on a large literature
review conducted and evaluated by experts.
The European Union Geriatric Medicine Society (EUGMS) invited experts from other
groups/societies, including the International Association of Gerontology and Geriatrics-European
Region (IAGG-ER), the International Association of Nutrition and Aging (IANA) and the Australian
and New Zealand Society for Geriatric Medicine (ANZSGM), to establish the basis of the PROT-AGE
study group [28]. In the context of increased emphasis on physical activity, the EUGMS recommend
a protein intake of 1.2 g/kg BW/day or higher to enhance their physical function and health status and
reduce risks for early mortality. This opinion is similarly shared by the European Society for Clinical
Nutrition and Metabolism (ESPEN) Expert group which recommend the consumption of 1.0–1.2 g/kg
BW/day of protein for healthy elderly (65+ years) and a further increased intake to 1.2–1.5 g/kg
BW/day when people are chronically ill or malnourished [20].
As physical activity and therefore muscle strength and mass also contribute to the prevention
of osteoporosis, the European Society for Clinical and Economic Aspects of Osteoporosis and
Osteoarthritis (ESCEO) have also formulated a consensus statement regarding musculoskeletal health,
including recommendations for protein intake. A dietary protein intake of 1.0–1.2 g/kg BW/day is
recommended by ESCEO for the elderly. However, these suggestions were limited to postmenopausal
women [29].
One of the major concerns against the adequacy of current protein recommendations is that these
guidelines are based on the nitrogen-balance method, which has been shown to possibly drastically
underestimate protein requirements [23,30]. The Indicator Amino Acid Oxidation (IAAO) approach
and its variation, the 24h-IAAO and balance (24h-IAAO/IAAB) model, are minimally invasive
methods to measure protein requirements in nearly all age-groups [23]. These techniques have
demonstrated, that the current recommendations may be underestimating the actual requirements by
30–50%, especially in the elderly [19,23,30].
Although expert groupings have in the past few years focused on the possible protein needs of
active, unwell and sarcopenic elderly, their considerations and recommendations to date have not
differentiated between the old (65+ years) and the very old (85+ years).
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2.3. Protein Consumption in Very Old Humans
Studies investigating dietary characteristics and nutrients intake of the very old (85+ years) are
scarce and to date the limited evidence is only from Europe and Asia (Japan and China) [31–36].
The largest and most comprehensive study is the Newcastle 85+ Study, which has evaluated nutritional
intake of over 700 individuals aged 85 years old. Overall dietary protein intake was reported to
be approximately 1.0 g/kg BW/day, with men (1.04 g/kg BW/day) consuming more protein than
the women (0.86 g/kg BW/day) [35]. Interestingly, however, 28% of the study participants had
protein intakes below the WHO recommendation (<0.8 g/kg BW/day), which was associated with
lower physical function and strength, in comparison to those consuming more protein (>1.0 g/kg
BW/day) [34].
Similar conclusions have been established in studies examining well-being in China and Japan.
Again, there was positive associations between frequent protein intake (fish, meat, egg, soybean
derived products) and physical function, independent living, with higher survival rates and better
self-rated health [31–33]. Interestingly, however, in one study a higher protein intake was associated
with increased mortality [36]. Table 1 summarizes available studies linking protein intake with physical
function and health parameters in elderly 80 years old or older.
In a recent review, Granic et al. [37] identified eight studies with data from nutritional surveys
in elderly cohorts including very old participants aged 80 years and older. Collectively these studies
showed comparable data regarding protein intake with about 15–16% of total energy from protein,
which equals 0.8–1.0 g protein per kg bodyweight per day.
Table 1. Available studies on the oldest old with extracted results linking dietary protein intake with




Nationality Main Outcome for Protein
Newcastle 85+ Study
[34,35] 793 85 UK
Protein intake over 1 g/kg adjusted
BW/day was associated with better
grip strength and timed-up-and-go
performance compared to a lower
intake; physically active elderly had







A slower walking speed was
associated with a lower occlusion
force and both linked to a lower
protein intake.
The Japanese Centenarian Study
[32] 1907 101.1 ± 1.5 Japan
A more frequent protein consumption
was associated with autonomously
living centenarians.









High frequency intake of protein rich
foods (fish, bean and eggs) were
associated with increased mortality.
Physical activity was beneficial for
preventing pre-mature death.




Frequent consumption of meat, fish
egg, soy products, fruit, vegetable, tea
and garlic was linked to higher
survival and better self-rated health
Acknowledging these data, as well as the steadily increasing age of the human population,
it should be of general interest to review and critically challenge general recommendation regarding
protein intake, requirements and factors influencing muscle metabolism in the ageing process.
3. Muscle Protein Synthetic Response to Protein Ingestion in Young and Older Adults
Evidence that protein requirements with ageing might be greater than many recommendations is
largely based on experimental data on protein metabolism in skeletal muscle in young versus older
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individuals. Central for the notion of greater protein requirements in the elderly is the demonstration
of impairments in the muscle protein synthesis (MPS) in response to protein intake in elderly as
compared with young adults [19,38]. In this context, it is important to note that the progressive decline
of muscle mass with ageing ultimately results from an imbalance between MPS and muscle protein
breakdown (MPB), regardless of the mechanisms that are discussed to contribute to sarcopenia [39–41].
The proposed reduction in the muscle protein synthetic response to protein or amino acid ingestion
in older adults, also known as age-related anabolic resistance, is therefore a critical aspect with
wide-ranging implications for physiological function and health of older humans.
Protein/amino acid-based food intake and muscle contractions (i.e., resistance and endurance
exercise) are the main physiological anabolic stimuli for MPS [39]. The ingestion of protein/amino
acids increases MPS. While our understanding on MPB is limited due to methodological complexities,
protein/amino acid ingestion also suppresses MPB in most studies [41]. This then results in a greater
positive net protein balance. Furthermore, as discussed below, the combination of protein intake
and exercise acts synergistically on skeletal muscle anabolism, thus improving net muscle protein
accreditation [39,41].
Most of the experimental studies that compared MPS responses between young and old
individuals involved only short-term dietary and/or exercise interventions (i.e., protein/amino
acid ingestion, exercise, or both). Furthermore, none of these intervention studies have specifically
investigated very old individuals. Nevertheless, these experimental trials provide important
information on potential age-related differences in skeletal muscle anabolism. In a systematic review,
Shad et al. [41] examined experimental studies that compared the muscle protein synthetic response
to anabolic stimuli between young and older individuals by using tracer technology and calculation
of the muscle fractional synthetic rate. Twenty-one studies were included for the data synthesis that
investigated the MPS response to protein/amino acid intake as the only anabolic stimulus. Of these
21 studies, only eight provided sufficient evidence of age-related muscle anabolic resistance. However,
when the studies used for this systematic review were pooled together, the authors noted that the
magnitude of the MPS response was 28% lower in older compared with younger individuals.
Previous dose-response studies in healthy young individuals demonstrated that 20 g of
high-quality protein is sufficient to maximize MPS rates during recovery from lower-body resistance
exercise [42,43]. Moore et al. [40] retrospectively analysed data from their own studies that measured
dose-dependent MPS responses to protein as single bolus in healthy older (~71 years) and younger
adults (~22 years). These data suggest that the relative (to body weight) amount of protein required to
maximally stimulate MPS is ~0.4 g/kg in older adults, as compared with ~0.24 g/kg in the young [40].
In support of this finding, Shad et al. [41] reported that four of five studies that provided ≥0.4 g/kg of
amino acids/protein did not provide sufficient evidence of muscle anabolic resistance in older age.
The picture that emerges from these findings is that skeletal muscle of older individuals does not lack
the capacity for inducing a robust MPS response to protein ingestion but rather is less efficient. In other
words, higher relative protein intake is required to maximally stimulate MPS in older adults [19,38,40].
To address the question of whether a higher protein intake is effective in maintaining muscle
mass in older individuals, our own group has recently investigated the effects of a controlled diet
containing either 0.8 or 1.6 g protein/kg BM/d on muscle mass and function [21]. The data from this
10-week parallel-group randomized trial involving 29 men aged >70 years, show that consuming a diet
providing 1.6 as compared with 0.8 g protein/kg/d increased whole-body lean mass and improved
leg power.
4. Estimated Protein Requirements in Old versus Very Old Individuals Based on Whole-Body
Measurements
Importantly, however, the lack of intervention studies in very old individuals precludes us
from drawing firm conclusions on whether MPS responses in the oldest old (aged ≥85 years) are
different from than that of younger groups of older adults. A limited number of metabolic studies that
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used the minimally invasive indicator amino acid oxidation (IAAO) technique suggest that protein
requirements for older women and men aged 65–87 years are in a range between 1.2–1.3 g protein/kg
BM/d [30,44,45]. As compared with the studies that involved six men aged 71.3 ± 4.5 years [45] and
12 women aged 74.3 ± 7.4 [44] (for both, means ± SD), no substantial differences were observed in six
women aged 82 ± 1 years (means ± SEM) [30]. An obvious limitation when comparing these studies is
the relatively small sample sizes. Despite the complexities associated with muscle biopsies particularly
in the vulnerable group of very old adults, muscle measurements may be required to examine MPS
responses to protein ingestion in the oldest old.
5. Effect of Exercise on the Muscle Protein Synthetic Response to Protein Ingestion
A potential key strategy for improving the muscle protein synthetic response in the elderly
is performing exercise in close temporal proximity to high-quality protein intake. It is a relatively
consistent finding that the combined stimulus of acute exercise with protein/amino acid ingestion
synergistically enhances MPS responses above rates observed to protein administration alone in
young and older adults [41]. In agreement with this concept, Shad et al. [41] reported that eight of
ten reviewed studies that investigated MPS responses to combined exercise and protein/amino acid
provision did not provide evidence of muscle anabolic resistance in the older individuals.
In a study by Pennings et al. [46], 24 young (aged 21 ± 1 years) and 24 older individuals
(aged 73 ± 1 years) were investigated after the ingestion of 20 g of protein at rest and during recovery
from combined endurance and resistance-type exercise. In contrast to other studies suggesting that the
muscle protein synthetic response to amino acid administration is reduced in older individuals [41],
MPS did not differ between older and younger individuals. The authors observed a greater plasma
insulin response and a more rapid increase in postprandial plasma amino acid concentration in the
elderly that might represent a compensatory mechanism to preserve a robust postprandial MPS
response and as such, could be regarded as an early indication of anabolic resistance at rest [46].
Importantly, postprandial MPS rates were higher after exercise than compared with resting conditions
in both age groups [46]. This finding supports the notion that exercising before protein intake promotes
postprandial muscle protein accretion independent of age [38,39,47]. While some data suggest that
a certain “threshold” in exercise intensity and/or volume is required to overcome the age-related
blunting of MPS [41], other findings have shown that even moderate exercise increases the muscle
anabolic response to protein intake in older adults [48]. Another factor that might explain inconsistent
results is the assessed time frame [41]. For example, Drummond et al. [49] reported that MPS following
resistance exercise and ingestion of essential amino acids increased in young men at 1–3 h and at 3–6 h
post exercise but only during the 3–6 h post exercise period in older men. This might suggest that the
acute MPS response after exercise and essential amino acid ingestion is delayed rather than attenuated
with advancing age [49,50].
Data on the long-term combined effects of regular exercise training and protein intake in older
adults are limited and studies with very old individuals are lacking. There is some evidence suggesting
that protein supplementation enhances adaptive responses of skeletal muscle to (resistance) training in
healthy and frail older adults [51,52]. However, this does not automatically suggest that an additional
protein intake cannot be achieved through the natural diet and protein-rich foods [38]. More long-term
studies are warranted to determine the impact of exercise on protein requirements in older adults and
in particular, in the very old.
Whilst anabolic sensitivity improves with physical activity, physical inactivity induces an anabolic
resistance. In a relatively modest reduction in daily step-count for 14 days, in 10 healthy older men
and women (aged 72 ± 1 years), the resulting reduction in postprandial MPS was a contributing factor
to the significant loss of muscle mass [53]. With more severe immobilization, using a 7-day bed rest
study in healthy older adults, the reduction in postprandial MPS was accompanied by attenuated
anabolic cell signalling and muscle amino acid transporter expression [54].
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The question that emerges in perspective of these findings is to which extent the proposed
“age-related” muscle anabolic resistance is a consequence of the inherent biological ageing process.
Rather it seems reasonable to suggest that impairments in the anabolic responsiveness of skeletal
muscle of older adults, at least in part, are due to reduced levels of physical activity. Potential
mechanisms underlying muscle anabolic resistance in old persons include impaired protein digestion
and amino acid absorption resulting in a reduced availability of dietary protein-derived amino acids in
the circulation, impaired muscle perfusion reducing amino acid delivery to the muscle, reduced uptake
of amino acids by the muscle and impaired anabolic signalling in the muscle [19,39]. At least some of
these mechanisms such as blood flow and oxygen/nutrient delivery in skeletal muscle in older adults
can be preserved (or restored) through exercise training [55]. This further supports the hypothetical
concept that physical inactivity, rather than the ageing process alone, contributes to muscle anabolic
resistance with older age.
There is strong evidence that regular physical activity/exercise training contributes to maintaining
function of different physiological systems, particularly of skeletal muscle, during ageing, even until
very old age [56,57]. Hypothetically, regular physical activity might, to a certain extent, also preserve
the sensitivity of skeletal muscle to anabolic stimuli with advancing age.
It is important to note that the adaptability of skeletal muscle in very advanced age differs from
that of late middle-aged/older adults, partially due to impaired up-regulation of molecular pathways
underlying metabolic and functional adaptations [58]. Studies in men aged 82 ± 1 years [59] and
women aged 85 ± 1 years [60] show that skeletal muscle remodelling and plasticity in response to
resistance training were limited. However, more recent comparative data from the same laboratory
also suggest single muscle fibre quality improvements in octogenarians [61]. The authors concluded
that the improved quality of remaining single muscle fibres may be a compensatory mechanism to
help offset decrements in whole muscle function [61]. Another conclusion that might be drawn from
these findings is that efforts to maintain skeletal muscle mass and function with ageing should begin
before very old age. Whether specifically the anabolic sensitivity of skeletal muscle of the very old
is different from groups of younger older adults and to which extent this is modulated by regular
physical activity needs to be addressed in future research.
6. Effect of Protein Quality, Intake Patterns and the Protein Distribution Throughout the Day
In addition to the synergistic effects of exercise, the protein quality is a key determinant that
contributes to the potential of dietary protein for skeletal muscle anabolism with ageing [38]. Important
factors that have an impact on the quality and anabolic potential of dietary protein include the amino
acid composition, digestibility and amino acid availability [38]. Similar as in young adults [62],
whey protein stimulated postprandial protein accreditation in healthy older men more effectively
than casein or casein hydrolysate [46]. This effect has been attributed to a combination of faster
digestion, absorption kinetics, postprandial amino acid availability and higher leucine content of
whey [46]. The leucine content of dietary protein has been shown to be a critical factor in this context,
due to the role of leucine as a potent activator of anabolic signalling in skeletal muscle [63]. In many
previous studies, isolated amino acids or protein were provided to assess postprandial MPS [41]. More
recent investigations have adopted a more natural dietary approach by focusing on the potential of
protein-rich whole foods to promote muscle protein anabolism in older individuals [38]. For example,
it was shown that minced beef was more rapidly digested and absorbed than beefsteak in older men,
which resulted in an increased amino acid availability and a greater whole-body protein balance [64].
This shows the relevance of the matrix of protein sources (such as the food texture) for postprandial
protein metabolism and retention particularly in older adults. Furthermore, the consumption of a liquid
protein-based meal elicited a more rapid and greater increase in plasma amino acid concentration
compared with a solid macronutrient-matched test meal in older adults [65]. Liquid protein foods,
such as milk and yoghurt, are therefore considered as effective sources of high quality protein for
older and likely also, for very old adults [66]. While plant-based proteins are considered less anabolic,
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partly due to their lower content of essential amino acids and leucine, an adequate protein intake
can still be achieved by consuming plant-based diets or a combination of plant and animal protein
sources [19,38,66]. The consumption of multiple plant and animal protein whole-food sources provides
a broad variety of macro- and micronutrients, fibre, plant bioactive compounds and so forth, all of
which might be particularly important for individuals aged ≥85 years [37,66]. However, more research
is needed to compare the anabolic effects of plant- versus animal-based protein in older and very old
adults. Additional aspects concerning protein quality and the particular importance of leucine have
been covered in other reviews [38,63,67].
In this review, we rather focus on the distribution of the daily protein intake that has recently
received increased interest as an important factor in enhancing the potential for skeletal muscle
anabolism in older adults. In accordance with the concept that a certain threshold of ingested protein
is required to maximize the acute muscle protein synthetic response, recent studies have indicated
that the amount of the protein intake with each of the main meals may play a significant role in
counteracting sarcopenia [38,68–70].
In a crossover study in young adults, a greater 24-h muscle protein synthesis was observed after
a 7-d diet with an even (i.e., 32, 30 and 33 g protein with breakfast, lunch and dinner, respectively)
compared with a skewed intake (i.e., 11, 16 and 63 g protein/meal) [68]. Farsijani et al. [69,70] used
data from older adults aged 67 to 84 years enrolled in a longitudinal study to examine whether this
short-term result translate into preservation of lean mass and physical performance with ageing.
The findings of these longitudinal studies suggest that an even protein intake distribution across
meals was associated with higher muscle mass and greater muscle strength in older women and
men [69,70]. While there are also conflicting results [71], the available data collectively suggest that
a balanced distribution of adequate amounts of protein intake is the most favourable for muscle protein
anabolism [68–70,72]. It is also important to note, that an optimal per-meal amount of dietary protein
to maximally stimulate MPS in older adults (~0.4 g/kg/meal) can only be achieved at higher daily
protein intakes (i.e., ca. 1.2 g/kg BW/day) [19].
There are no studies investigating the daily protein intake distribution in the very old (85+ years).
Based on the limited data comparing old and very old adults by using the IAAO technique [30,44,45],
we can only speculate that the oldest old would benefit from the same distribution and daily amount
of protein as younger elderly.
7. Conclusions
The numbers of elderly and exceptionally long-lived people is steadily increasing. Based on
a raising body of evidence from both epidemiological and experimental data, several expert groups
have argued that higher protein intake of at least 1.0 g to 1.5 g/kg BW/day may be optimal for skeletal
muscle and overall health in older adults [19,38]. Importantly, the age range of older participants in
these physiological intervention studies was ~65 to 80 years [37]. There is a lack of data to conclude,
whether for example the dose-dependent relationship between protein ingestion and MPS rates in
very old differ from those observed in younger groups of older adults. More studies that include study
participants aged ≥85 years are warranted to investigate and determine protein requirements in this
population group.
Additional research is also required to verify the hypothetical concept that “age-related” anabolic
resistance represents a combination of the ageing process interacting with the detrimental effects of
inactivity. The metabolic and functional adaptability of skeletal muscle of older individuals aged
between 65 and 75 years is different to individuals over 75 years [58]. Available data in octogenarians
suggest that muscular adaptations to resistance training might be limited at a very old age [59,60].
However, the superior skeletal muscle and cardiovascular profiles of even octogenarian endurance
athletes show that life-long exercise training provides a large functional reserve above the aerobic
frailty threshold and is associated with lower risk for disability and mortality [56]. Furthermore,
evidence from prospective exercise intervention trials in late middle-aged/older adults suggests
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that increasing physical activity later in life can preserve or even restore physiological function with
ageing [15]. Regular exercise training may therefore also preserve the responsiveness of ageing skeletal
muscle to protein intake, possibly up to a very advanced age. In this context, it should be noted that
the proposed protein requirements for structural exercise training in young and middle-aged adults
are in a similar range as those that are currently discussed for older adults, that is, ≥1.2 g protein/kg
BW/d [20,73–75].
It is also important to note that many elderly could have difficulties in optimizing/increasing
dietary protein intake and physical exercise. Dietary adherence might be negatively influenced by
oral health problems, altered sensory function, reduced thirst sensation, as well as gastrointestinal
malfunction [76]. Considering that adherence to fitness enhancing exercise is generally poor in people
older than 80 years, previous and acute injuries might initially cause (more) pain when starting
exercise programs, could be a large negative motivator and impede voluntary implementation of
healthy ageing strategies [77]. It therefore remains critical to develop innovative, evidence-based,
more effective and feasible lifestyle-behavioural approaches for old and very old adults to facilitate
adopting and maintaining function- and health-preserving strategies [15].
The assertions about possible detrimental health effects of a diet high(er) in protein—for example,
development of kidney dysfunction, impaired bone health—are, however, not supported by clinical
data in humans [78]. Only in patients with pre-existing kidney dysfunction a high protein intake is
associated with accelerated deterioration in renal health [19]. Moreover, an increased protein intake is
positively associated with bone health [78], which is also supported by the guidelines of the ESCEO
suggesting at least 1.0–1–2 g/kg BW/day to prevent osteopenia and osteoporosis [29]. A protein
consumption of up to 2 g/kg BW/day and even higher seems to be safe for healthy adults and
elderly [79]. Still there is a lack of data in very old humans.
Taken together, the data reviewed for this article support the notion that there is a close interaction
of physical activity, diet, function and human ageing. Optimizing the timing and distribution of protein
ingestion, with an intake of at least ~25–30 g protein per meal and in close temporal proximity to
exercise/physical activity, appears to be a promising strategy for promoting healthy ageing of skeletal
muscle in the elderly and likely also in the oldest old, aged 85 years and older.
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Abstract: To promote healthy aging and minimize age-related loss of muscle mass and strength,
adequate protein intake throughout the day is needed. Developing and commercializing
protein-enriched foods holds great potential to help fulfill the nutritional demands of older
consumers. However, innovation of appealing protein-enriched products is a challenging task since
protein-enrichment often leads to reduced food palatability. In this study, rye bread and cream cheese
prototypes fortified by whey protein hydrolysate (WPH), whey protein isolate (WPI), and/or soy
protein isolate (SPI) were developed. Both sensory properties and consumer liking of prototypes
were evaluated. Results showed that different proteins had various effects on the sensory characters
of rye bread and cream cheese. The taste and texture modification strategies had positive effects
in counteracting negative sensory changes caused by protein-enrichment. Consumers preferred
7% WPH and 4% WPH + 4% SPI-enriched breads with taste and texture modified. Sour taste and
dry texture had considerable effects on consumer liking of rye bread. Addition of WPI and butter
enhanced the flavor of cream cheese and increased consumer acceptance. Protein-enrichment doubled
the protein content in the most liked prototypes, which have the potential to be incorporated into
older consumers’ diets and improve their protein intake substantially.
Keywords: whey protein; soy protein; older consumers; sensory; descriptive analysis; rye bread;
cream cheese; protein-enrichment; muscle
1. Introduction
The aging of population is accelerating worldwide, creating a great challenge for societal health
care systems [1]. Sufficient intake of a variety of dietary nutrients is required to promote active and
healthy aging [2–4]. Protein is an essential nutrient to maintain muscle mass and strength during
aging. Inadequate protein intake is associated with functional problems such as sarcopenia, which
is the age-related loss of skeletal muscle mass, leading to functional decline or even a reduction
in independence among 30% of individuals aged above 60 [5–8]. It has been repeatedly shown
that physical exercise and adequate high-quality protein intake throughout the day are two of the
most potent stimulators for counteracting the sarcopenic process [5,8–10]. Given this background,
developing and commercializing appealing protein-enriched foods is a way by which the food industry
can assist senior consumers in meeting their nutritional needs [11].
High-quality proteins, e.g., soy-based protein and milk-based whey protein, are popular protein
supplements to sufficiently support muscle protein synthesis and accretion, since they are all
nutritionally complete, highly digestible proteins with high contents and good composition of essential
amino acids [12,13]. Consumption of foods enriched with high-quality proteins may not only increase
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the quantity of protein intake but also potentially improve the quality of protein in the consumer diet
through e.g., modifying the amino acid composition of meals. However, the addition of different
proteins alters sensory properties of food carriers in different ways, which might lead to reduced
palatability for some products or be advantageous for some other products [11,14]. Wendin et al. [11]
found that whey protein-fortified muffins were high in bitter taste and astringency mouthfeel and were
perceived as very dry in texture. Höglund et al. [14] reported that off flavors were detected for muffins
with extra whey protein. Tang and Liu [15] found that the addition of whey protein disrupted the gluten
structure of wheat dough and affected cookie texture negatively. On the contrary, soy protein conferred
a protective network on partial gluten structure which increased the overall acceptability of the cookies.
Soy protein addition to gluten-free bread caused higher crumb hardness, while whey protein-fortified
bread had higher crumb porosity [16]. In this context, to develop appealing protein-enriched products,
exploring strategies to counteract the disadvantageous sensory influences of protein enrichment is a
crucial task.
Moreover, selecting appropriate food carriers based on the “voice of target consumers” is of
great importance for successful innovation of protein-enriched products. It was found that most older
consumers perceived the healthy, traditional meal component food carriers as most appropriate for
protein-enrichment, which they were most willing to trial purchase as well [17,18]. In the present
study, rye bread and cream cheese were chosen for fortification with protein powder, since both rye
bread and cream cheese are healthy, traditional foods in Denmark which play an important role in the
diet of older Danish adults. Rye bread is one of the most commonly consumed staple foods on a daily
basis, especially during breakfast and lunch, primarily among Danish adults. Cream cheese can be
combined with meals and a variety of snacks. Through consumption of protein-enriched rye bread
and cream cheese, senior consumers could gain a substantial increase in protein intake throughout the
day without changing diet habits and meal frequency or size.
When developing protein-enriched food items for senior citizens, acceptability, which is normally
measured in terms of product liking, is of great importance. The correlation between consumer liking
and sensory properties could provide developers with a better understanding of product performance
and optimization [19]. Consumer acceptance is assumed to be an indicator for prospective purchase
intentions and intake as well [19,20]. Furthermore, product-evoked emotions and terms reflecting
consumption desire and product satisfaction could be additional measures providing information on
how the senior citizen would engage in consuming the product. For instance, product satisfaction
could reflect the “confirmation” or “disconfirmation” between consumer expectation and actual food
liking, which might influence the final acceptance due to the contrast effect [21]. Food-evoked desire
might affect the subsequent food intake [20]. When developing nutrient-enriched products, such
parameters may provide additional information beyond liking [19–24].
This study aims to: (1) compare the effects of whey protein hydrolysate (WPH), whey protein
isolate (WPI), and/or soy protein isolate (SPI) enrichment on the sensory attributes of rye bread
and cream cheese; and (2) develop protein-enriched rye bread and cream cheese with moderately
high protein content and appealing sensory properties. Additionally, older consumers’ liking and
product-evoked emotion attributes, including satisfaction and desire, were evaluated to obtain a
perspective on consumer experience and engagement in consuming the products.
2. Materials and Methods
2.1. Proteins
The following proteins were applied in this study: soy protein isolate (SPI, 90.0% protein
content; Body-kraft, Hørning, Denmark), whey protein isolate (WPI, 87.0% protein content; Arla
Foods Ingredients, Aarhus, Denmark), and whey protein hydrolysate (WPH, 86.4% protein content;
Arla Foods Ingredients, Aarhus, Denmark).
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2.2. Rye Bread
2.2.1. Preparation of Rye Bread Sample
In total, 15 rye bread prototypes were developed. Table 1 shows the details of the formulations
per loaf of each prototype. The initial dough was prepared mainly according to the guidelines of
Amo’s rye bread mix, with additional sunflower seeds added. The amount of initial dough, additional
proteins, and/or other ingredients to adjust the bread texture and taste can be seen in Table 1. Numbers
in the sample labels indicate the amount of added whey or soy protein (4 = 4%, and 7 = 7%), while T
means texture-modified samples and TS represents texture and taste-modified samples.
Wheat gluten, dried sourdough, and water were selected for texture and taste modifications,
mainly because they are ingredients that rye bread already contains, thus avoiding too much taste
or flavor interference in the bread. Moreover, wheat gluten contains 71.0% protein and sourdough
contains 10.0% protein, thus also promoting the protein content of the prototypes. Blends of WPI/WPH
and SPI were added in samples WPI 4 + SPI 4 and WPH 4 + SPI 4, respectively. This is because whey
protein and soy protein have opposite effects on the texture of rye bread and could potentially
counteract with each other’s negative effects on bread texture. During the formula development
period, pilot tasting tests were organized in order to investigate the optimal ratio of protein ingredients,
wheat gluten, and dried sourdough. Besides, additional sunflower seeds were added to control and
protein-enriched breads for improvement of flavor and texture properties, based on results of pilot tests.
Moreover, the pH value of leavened bread dough was measured using a handheld pH meter (VWR pH
10, Malmö, Sweden). The heights of baked rye breads were also measured. The data were used to help
optimize the addition of dried sourdough, water and wheat gluten for taste and texture modification.
The total weights of all bread dough before baking were the same. The bread dough was prepared
and put in 1.2-liter silicone baking tins (length 22 cm/width 8 cm/height 7 cm) to rise at room
temperature (around 22 ◦C) for two hours. Control bread and SPI-enriched breads were baked at
185 ◦C for 65 min. Breads enriched with WPI, WPH, and blends of whey protein and SPI were baked
at 175 ◦C for 65 min. Breads were weighed before and after baking. The total protein contents per
prototype (%) and per slice (g) after baking were calculated and shown in Table 1. Rye breads were cut
into 0.85-cm-thick and approximately 2.0 cm × 2.0-cm-sized cubes and put into 60-mL-sized sample
cups with lids. Each cup contained two pieces of bread cubes, and each cube had one side of crust.
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2.2.2. Descriptive Analysis of Rye Bread
Panelists
The descriptive sensory analysis of rye bread was conducted in the sensory laboratory at the
university. In total, 10 screened trained assessors, aged between 23 and 49 years of age, were recruited
from the external panel at the Department of Food Science. They had more than one year of experience
in sensory evaluation of foods and were familiar with consumption of rye bread. All panelists signed
the informed consent of the study and were paid for their participation.
Training
Four 2-h training sessions were conducted. In the first session, panelists tasted samples and
described odor, appearance, texture, mouthfeel, flavor, and taste of rye breads. They could select
attributes from a list of rye bread sensory attributes provided to them, or they could generate new
attributes. In the second and third sessions, reference standards of each attribute were presented
or defined and discussed by the panelists to select the final sensory vocabulary. In the last session,
a final list of odor, appearance, texture, mouthfeel, flavor, taste, and after-taste attributes of the crumb
and crust were generated by the panel. Table 2 shows the list of sensory attributes and definitions.
Trial assessments of rye breads were conducted in the last two training sessions to confirm that
the training was sufficient to ensure clear understanding and proficient judgment of each attribute
among panelists.
Table 2. Sensory attributes and corresponding definitions used in the descriptive analysis of rye breads.
Category Attributes Definitions
Odor Yeasty Odor associated with yeast fermentation in bread
Malty Odor associated with germinated cereal grains
Burned Odor associated with over-baked breads
Crumb
Appearance Brown Degree of color brownness in the crumb, ranging from light brown todark brown
Compact Appearance impression of the crumb density of the bread cross section
Porosity The extent of holes and cracks in the crumb of the bread cross section
Mouthfeel Stickiness The force needed to remove bread particles stuck to thepalate completely
Floury Degree to which the crumb contains small grainy particles
Astringent The drying and puckering sensation evoked by strong black tea
Texture Soft Degree of yielding readily to pressure between palate and tongue
Dry Amount of saliva absorbed by sample crumbs during mastication
Elasticity The ability to resist force between palate and tongue and return to itsoriginal shape
Crumbly The force with which the sample crumbles
Coarse Degree to which particles abrade palate and tongue during mastication
Flavor Buttermilk Flavor impression of cultured buttermilk
Beany The off-flavor associated with soaked beans
Grainy Flavor impression of cereal derived rye grains, wheat grains etc.
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Table 2. Cont.
Category Attributes Definitions
Taste Sweet Basic taste evoked by sucrose
Salty Basic taste elicited by sodium chloride
Bitter Basic taste of quinine
Sour Basic taste evoked by citric acid
Umami Basic taste elicited by monosodium glutamate
Balance The perceived overall balance of five basic tastes
After-taste Sour Taste sensation evoked by citric acid
Bitter Taste sensation of quinine
Crust
Appearance Brown Degree of color brownness in the crust, ranging from light brown todark brown
Texture Hardness The force needed to bite through the bread crust completelybetween molars
Taste Sour Basic taste evoked by citric acid
After-taste Bitter Taste sensation of quinine
Assessment
The 15 rye bread samples were evaluated in quadruplicate in four separate assessment sessions.
All assessments were conducted in individual sensory booths at a temperature of 22 ◦C. Rye bread
samples were served at room temperature in a randomized order. Panelists used a 15-cm line scale
to rate the perceived intensities of the sensory attributes. Water, cucumber, and plain white bread
cubes were provided for mouth cleansing between samples. Two short breaks were held during each
assessment session. Photos of the rye bread cross-sections are shown in Figure 1.
Figure 1. Example photos of cross section of rye bread samples. Labels: numbers indicate the amount
of added protein (4 = 4%, and 7 = 7%); TS = texture and taste modified sample; WPH = whey protein
hydrolysate; WPI = whey protein isolate; SPI = soy protein isolate.
60
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2.3. Cream Cheese
2.3.1. Recipes of Cream Cheese Prototypes
A total of five cream cheese samples were selected for the descriptive analysis (Table 3). To prepare
samples for sensory and consumer evaluation test, ingredients were mixed, put into a 60-mL sample
cup and preserved in the refrigerator at 4 ◦C for more than two hours before being served to assessors.
Each sample cup contained 25.0 ± 2.0 g of cream cheese. The total protein content of each prototype
(%) and per serving (g) were calculated and are shown in Table 3.











per Serving 4 (g)
WPH (g) WPI (g) Butter (g)
Control 100 0 0 0 100 4.5 1.1
WPH 9 91 9 0 0 100 11.9 3.0
WPI 9-TS 81 0 9 10 100 11.6 2.9
WPH 9 91 9 0 0 100 11.9 3.0
WPH 9-TS 81 0 9 10 100 11.6 2.9
1 Labels of the sample: numbers in the labels indicate the amount of added protein (9 = 9%); TS = texture and
taste-modified samples. 2 Arla Buko ® Natural Cream Cheese (Arla Foods, Viby J, Denmark) contains 4.5% protein,
25% fat, and 0.5% salt. 3 Butter was weighed and softened in room temperature for 0.5 h before being mixed with
cream cheese, using a hand mixer at slow speed for 1 min. The butter contains 1.0% salt and 0.9% protein. 4 Weight
per serving: 25 g.
2.3.2. Descriptive Analysis of Cream Cheese
Panelists
The descriptive analysis of cream cheese was conducted in the sensory evaluation laboratory at
the university. In total, nine trained panelists aged 23 to 29 years old participated in the training and
assessment sessions. They were recruited from the screened sensory panel at the Department of Food
Science. They had experience of at least one year in the sensory evaluation of foods and were familiar
with the consumption of cream cheese. Before the test, all panelists signed an informed consent form
for the study. Panelists were paid for their participation.
Training
To develop sensory vocabulary of the cream cheese, three 2-h training sessions were conducted.
In the first session, panelists tasted samples and generated sensory attributes to describe the cheese.
In the second and third sessions, reference standards of each attribute were presented or defined
and discussed by the panelists to select the final sensory vocabulary. In the end, the final list of
odor, appearance, texture, mouthfeel, flavor, taste, and after-taste attributes of the cream cheese was
generated by the panel (Table 4). Trial assessments of cream cheese samples were conducted in the last
training session to make sure that panelists had experienced sufficient training to consistently use the
attributes to differentiate the products.
Table 4. Sensory attributes and corresponding definitions used in the descriptive analysis of cream cheese.
Category Attributes Definitions
Odor Butter Odor associated with softened butter
Appearance Yellow Degree of color yellowness in the surface of sample
Glossy Degree to which the surface of cream cheese is shiny
Texture Smooth Absence of any particles or lumps in the sample
Firmness Extent of resistance against the palate and tongue during mastication
Meltdown rate The amount of “work” required to break down the bolus
Viscosity Stickiness between tongue and upper palate
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Table 4. Cont.
Category Attributes Definitions
Mouthfeel Astringent The drying and puckering sensation evoked by strong black tea
Coating Extent to which the cheese coats the palate and tongue during mastication
Flavor Creamy Flavor associated with whipped cream
Buttermilk Flavor impression of cultured buttermilk
Fatty Flavor associated with butter
Egg yolk Flavor associated with cooked egg yolk
Rancid Flavor associated with oxidized, rancid cooking oil
Fresh cheesy Flavor associated with fresh, mild cheese without mold flavor, e.g., freshmozzarella or ricotta
Basic taste Salty Basic taste elicited by sodium chloride
Bitter Basic taste of quinine
Sour Basic taste evoked by citric acid
Sweet Basic taste evoked by sucrose
Umami Basic taste elicited by monosodium glutamate
After-taste Bitter Taste sensation of quinine
Assessment
Cream cheese samples were evaluated in triplicate in three assessment sessions conducted at
the sensory evaluation laboratory at a temperature of 22 ◦C. Cream cheese samples were preserved
in a refrigerator at 4 ◦C for more than two hours before serving to the assessors. All samples were
labeled with 3-digit codes and served in randomized order. Panelists used the 15-cm linear scale
to rate all attributes of each sample. Water and plain crackers were provided for mouth cleansing
between samples.
2.4. Consumer Test
The consumer panel consisted of 72 independent older Danish adults (44 females and 28 males;
aged 61 to 83 years old) recruited from the external consumer panel of the Department of Food Science.
A consumer acceptance test was conducted in individual sensory booths. The test included two
sessions for rye bread tasting and cream cheese tasting, respectively. A 15-min break was held between
the two sessions.
Based on the results of the descriptive analysis, six rye bread prototypes and all five cream cheese
prototypes were selected and included for consumer evaluation. Rye bread samples were preserved
and served at room temperature. Cream cheese samples were preserved at refrigerator at 4 ◦C for
more than two hours before serving to the test persons. Samples were labeled with three-digit codes
and served in a randomized order. Water, cucumber, and plain white bread cubes were provided for
mouth cleansing between samples. Each sample was tasted and then evaluated for overall liking and
selected product-evoked emotions, which included satisfied, desire, happy, interested, pleasant, calm,
disgusted, unhappy, bored, and disappointed. The 9-point hedonic scale [25] was used to measure
overall liking (1 = extreme dislike, 5 = neither like nor dislike, 9 = extreme like). The rate-all-that-apply
method (RATA) was applied for emotion evaluation. Consumer participants ticked emotions they
felt after tasting and rated the intensity of ticked emotions using a 5-point Likert scale (1 = slightly,
3 = moderately, 5 = extremely) [26]. The emotion attributes which were not checked represented
emotions that consumers could not feel and were recorded as “0 points”. Consumer demographic
characters were also collected, which included age, gender, self-reported health status, living status,
education level, and consumption frequency of rye bread and cream cheese. Consumers’ perceived
healthiness and willingness to trial purchase protein-enriched rye bread and cream cheese were
evaluated using a 5-point Likert scale (1 = not at all, 3 = moderately, 5 = extremely). Before the test,
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all participants signed the informed consent of the study. After the test, each consumer participant
received a goodie bag as the reward.
2.5. Data Analysis
The descriptive analysis panel data were analyzed by mixed model analysis of variance (ANOVA)
to investigate the significance of each sensory attribute in discriminating products. Products were
treated as the fixed factor, and panelists and replications were set as random factors [27]. Principal
components analysis (PCA) was performed on average sensory data to relate rye bread and cream
cheese products with sensory attributes, respectively. External preference mapping (PREFMAP) was
conducted to investigate relationships among consumer acceptance and sensory attributes across
rye bread and cream cheese products, respectively. Both PCA and PREFMAP were applied to the
significant sensory attributes. Agglomerative hierarchical clustering analysis (AHC) was carried out to
investigate the existence of homogeneous clusters of consumers with similar acceptance of rye bread
or cream cheese, respectively. One-way ANOVA was conducted on consumer liking data and emotion
data with post hoc Fisher’s least significant difference (LSD) test. A penalty-lift analysis [28–31] was
performed to analyze emotion RATA data in relation to the liking scores. The XLSTAT version 2018.3
(Addinsoft, New York, NY, USA) and SPSS statistics version 24 (IBM, Armonk, NY, USA) software
packages were used for data analysis.
3. Results
3.1. Sensory Descriptive Analysis of Rye Bread
Table 2 presents the list of the 29 sensory attributes of rye bread assessed by 10 trained panelists
in four replicate sessions. The attributes covered the odor, appearance, mouthfeel, texture, flavor, taste,
and the after-taste of crumbs and crust. From an ANOVA analysis of the sensory data, it was found
that all attributes, apart from the crumb’s beany flavor, grainy flavor, salty taste, and bitter taste, were
significantly different (p < 0.05) across the rye bread samples tested. This indicated that most of the
sensory attributes were useful in characterizing differences across bread samples. Attributes which
were not significantly different among rye bread prototypes were not included in further PCA analysis.
The relationship between rye bread samples and significant sensory attributes were visualized
by principal component analysis (PCA). Figure 2 presents the PCA bi-plot of sensory attributes for
all 15 rye bread samples. The first two principal components (PCs) accounted for 72% of the total
variance (46% for PC1, 26% for PC2). PC1 separated the bread samples mainly according to yeasty
odor, the crumb’s compact appearance, and floury and sticky mouthfeel in the positive direction, and
burned odor, the crumb’s porous appearance, crumbly texture, and umami taste, and the crust’s brown
appearance, hard texture, and bitter after-taste in the negative direction. PC2 was positively linked
with the sour taste, sour after-taste, and buttermilk flavor located in the positive direction and was
negatively associated with the dry texture.
The PCA bi-plot shows that the sample groups spanned the sensory space quite well (Figure 2).
WPI-enriched samples (WPI 4, WPI 7, WPI 7-T and WPI 7-TS) were closely linked to dry texture,
and negatively related with astringent mouthfeel, sour taste, sour after-taste, and buttermilk flavor.
WPH-enriched breads (WPH 4, WPH 7, WPH 7-T, and WPH 7-TS) were characterized by a brown
and porous appearance, burned odor, crumbly and elastic texture, umami taste, and bitter after-taste.
Moreover, they had a negative correlation with the attributes of yeasty odor, compact appearance,
and floury mouthfeel. The three 7% SPI-enriched samples (SPI 7, SPI 7-T and SPI 7-TS) correlated
with a yeasty odor, compact appearance, soft texture, and floury and sticky mouthfeel. The 4%
SPI-enriched bread (SPI 4) and breads enriched by mixed proteins (WPH 4 + SPI 4 and WPI 4 + SPI
4) were characterized by sour taste, sour after-taste, buttermilk flavor, astringent mouthfeel, and soft
texture. Compared with WPI and SPI, WPH-enriched samples were located much closer to the control
sample, which demonstrated that WPH enrichment altered the sensory properties of rye bread to a
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smaller extent. Thus, WPH could be regarded as a more appropriate protein type for enrichment in
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Figure 2. Principal component analysis bi-plot of sensory attributes (red labels) and rye bread samples
(blue labels). PC1 = first principal component; PC2 = second principal component. Red labels:
sensory attributes; C = attributes for crust; attributes without “C” are attributes for crumbs; O = odor
attributes; A = appearance attributes; TA = taste attributes; TX = texture attributes; FL = flavor attributes;
MF = mouthfeel attributes; and AF = after taste attributes. Blue labels: rye bread samples; numbers
indicate amount of added protein (4 = 4%, and 7 = 7%). T = texture-modified samples; TS = texture and
taste-modified samples.
To compare the effects of different protein types on bread sensory characters, it was found that
most WPH-enriched samples were located close to burned odor and brown appearance, which could
be explained by the enhanced Maillard reactions because of the addition of WPH [32]. Moreover, the
three 7% WPI-enriched breads had a less soft and drier texture. The textures of WPH 7 and WPH 7-T
were more crumbly, hard, and elastic. Furthermore, compared to the remaining samples, the four
WPH -enriched rye breads had higher umami taste and bitter after-taste, which is in line with prior
research [32–34]. Crumbs of the three 7% SPI-enriched breads appeared more compact and less porous,
and had more floury and sticky mouthfeel and less crumbly texture- (Figure 2).
In terms of influences from taste and texture modification strategies, it was found that compared with
WPH 7 and WPH 7-T, sample WPH 7-TS was located much closer to the control sample. This indicated
that the taste and texture modification strategies (addition of gluten and sourdough) reached positive
effects in counteracting adverse sensory changes caused by the WPH-enrichment. The enrichment of
higher percentage of all three kinds of proteins decreased the buttermilk flavor and sour taste, which
could be explained by the increased pH value due to protein enrichment. The control sample had pH
value of 4.0, while the average pH values of SPI 7, WPI 7, and WPH 7 were 4.6, 4.8, and 4.8 (data not
shown), respectively. The addition of dried sourdough adjusted the sour taste in samples SPI 7-TS, WPI
7-TS, and WPH 7-TS so that they had a sour taste intensity closer to that of the control sample.
Moreover, it could be observed that whey protein and soy protein had opposing influences
on the texture characters of rye bread. It was found that the addition of 4% SPI to 4% WPI or 4%
WPH-enriched rye bread reduced the crumbly texture and increased the soft texture successfully.
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Enrichment with the blend of WPI/WPH and SPI not only counteracted each other’s effects on bread
texture but also resulted in an increase in the total amount of additional protein.
In summary, texture and taste modification strategies had positive effects in counteracting negative
sensory changes caused by the protein-enrichment, especially in correcting the crumbly texture,
compact appearance, floury mouthfeel, and/or sour taste of breads enriched with the higher percentage
of proteins. WPH was found to be the most appropriate ingredient for rye bread enrichment. The 7%
WPH-enriched, texture and taste-modified rye bread sample (WPH 7-TS) was the optimal sample,
showing little sensory difference with respect to the non-enriched control bread.
3.2. Consumer Liking of Rye Bread
In total, six bread samples (control, WPH 7-TS, WPH 7, WPI 7, SPI 7, WPH 4 + SPI 4) were
chosen for consumer evaluation based on the results of sensory descriptive analysis. The sensory space
spanned by the 15 rye bread samples (Figure 2) was well-represented by the six bread samples selected
for the consumer acceptance test. The average ratings of consumer overall liking of rye breads are
shown in Table 5. Consumers who were homogenous in their acceptance towards different rye bread
samples were grouped through agglomerative hierarchical clustering (AHC). Figure 3 represents the
external preference mapping to demonstrate the correlation between sensory attributes and the overall
liking of different consumer clusters, with average sensory data as the explanatory variables (X) and
mean liking ratings of three consumer clusters as responses (Y). The mean liking ratings of consumer
clusters are also shown in Table 5.
Table 5 showed that the average overall liking ratings of each bread sample ranged from 5.5 to
6.5. Significant differences (p < 0.05) of consumer overall liking were found across the sample of six rye
breads. WPH 7-TS rye bread (6.0) and WPH 4 + SPI 4 (5.9) were the most accepted protein-enriched
samples, amongst which WPH 7-TS showed no significant difference in terms of consumer acceptance
compared to the control bread (p > 0.05). Moreover, the taste and texture modification of WPH 7-TS
increased consumer liking by 0.4 units compared to WPH 7 (5.6). SPI 7 and WPI 7 were the least preferred
rye bread samples, with significantly lower liking ratings compared to the other four samples (p < 0.05).
Table 5. Mean ratings of consumers’ liking for rye bread samples. The size of each cluster is indicated (%).
Sample Cluster 1 (24%) Cluster 2 (50%) Cluster 3 (26%) Mean (100%)
Control 6.7abA 6.8aA 5.9bA 6.5A
SPI 7 5.8aB 5.9aB 4.4bB 5.5C
WPI 7 5.8aB 4.7bC 6.5aA 5.5C
WPH 7 5.5BC 5.6B 5.7A 5.6BC
WPH 7-TS 4.8bC 6.3aAB 6.6aA 6.0AB
WPH 4+ SPI 4 6.3A 5.7B 6.1A 5.9BC
Different lowercase letters within the same row indicate significant post hoc Fisher’s least significant difference
(LSD) differences at p < 0.05; different capital letters within the same column indicate significant LSD differences at
p < 0.05.
The external preference mapping plots are presented in Figure 3. AHC identified three consumer
clusters representing different patterns of product liking. In cluster 1, 24% of the consumers were
located relatively close to the WPH 4 + SPI 4 and control samples, which had significantly higher
overall liking ratings (6.3 and 6.7, respectively) as compared to the remaining four samples in cluster 1.
The attributes sour taste, soft texture, and sticky mouthfeel which characterized the control and WPH
4 + SPI 4 appeared to influence the consumer liking of cluster 1 positively. WPH 7 and WPH 7-TS, with
hard, crumbly, and elastic textures were the least liked in cluster 1. Cluster 2 (50%) liked the control
sample (6.8) the most, which was characterized by sour taste, sour after-taste, and a sour-related
buttermilk flavor. Cluster 2 showed the least preference towards sample WPI 7 (4.7), which had
a dry texture. Consumers of clusters 1 and 2 (74%) could be regarded as ‘sour rye bread lovers’.
Consumers in cluster 3 (26%) liked sample WPH 7-TS (6.6) the most and sample SPI 7 (4.4) the least.
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It appeared that they were attracted by WPH 7-TS with its brown (crust) and porous appearance,
burned odor, crumbly and hard (crust) texture, and umami and bitter after-taste, and disliked SPI
7, with its yeasty odor and compact appearance. Thus, it seems that the sourness levels and texture
and mouthfeel properties of rye bread might play important roles in influencing the liking of most
consumers. Demographic characters were compared across three clusters as well and no significant
differences were found. The mean rating of consumers’ willingness to trial purchase protein-enriched
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Preference map
Figure 3. External preference mapping of rye bread. Red labels: O = odor attributes; A = appearance
attributes; TA = taste attributes; TX = texture attributes; FL = flavor attributes; MF = mouthfeel
attributes; AF = after-taste attributes. Blue labels: numbers indicate amount of added protein (4 = 4%,
and 7 = 7%); TS = texture and taste-modified samples.
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3.3. Sensory Descriptive Analysis of Cream Cheese
Table 4 shows the list of the descriptive sensory attributes of cream cheese assessed by the nine
trained panelists in triplicate. The attributes characterized the odor, appearance, mouthfeel, texture,
flavor, taste, and after-taste aspects of cream cheese. The attributes meltdown rate, coating mouthfeel,
astringent mouthfeel, egg yolk flavor, and salty, sweet, and umami tastes were not significant in
discriminating cheese products (p > 0.05), and thus were excluded in further PCA and PREFMAP
analyses. Cheese prototypes enriched with SPI were not included in the sensory descriptive analysis
due to their poor sensory performance compared with WPI- and WPH-enriched samples.
Figure 4 shows the PCA bi-plot of sensory attributes for five cream cheese samples. The first
principal component accounted for 59% of the total variance, while the second principal component
explained 32% of the total variance. The first two PCs explained 91% of the total variance.
The non-enriched control sample is loaded in the fourth quadrant. It was characterized by buttermilk
flavor, sour taste, and firm and viscous texture, and was negatively linked with a yellow and glossy
appearance. The 9% WPI-enriched, butter-added sample (WPI 9-TS) is loaded in the first quadrant
and was closely correlated with fatty, creamy, and fresh cheesy flavors. WPI 9 was associated with
smooth texture, yellow appearance, and glossy appearance in the second quadrant. The two samples
enriched by 9% WPH (WPH 9 and WPH 9-TS) are located most closely to the less-desired rancid flavor,
bitter taste, and bitter after-taste in the third quadrant. All protein-enriched samples, except WPI 9-TS,


































Figure 4. Principal components analysis bi-plot of sensory attributes (red labels) and cream cheese
samples (blue labels). Blue labels: numbers indicate amount of added protein (9 = 9%); TS = texture
and taste-modified samples. Red labels: O = odor attributes; A = appearance attributes; TA = taste
attributes; TX = texture attributes; FL = flavor attributes; AF = aftertaste attributes.
The increased glossiness of cheese samples due to protein enrichment could be explained by
the texture changes: increased smoothness and decreased firmness and viscosity. Some panelists
used watery to describe the surface of protein-enriched cream cheese during the profiling session. The
decreased firmness and viscosity might be due to the effects of whey protein on the oil/water emulsion,
which led to a decreased extent of partial coalescence and increased extent of fat destabilization [35].
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The increased yellowness of protein and/or butter-enriched cheese might be explained by the
light-yellow color of dissolved protein powder and/or the higher fat content and larger fat droplets of
the cheese [36]. The bitter taste and rancid flavor in WPH-enriched samples could be explained mainly
by bitter peptides and some off-flavor compounds in WPH, respectively [37]. Moreover, in contrast
to rye bread, the addition of WPH had no significant influence on the umami taste, which could be
because the cheesy and creamy flavor masked the umami taste to a large extent. Regarding the taste
and texture modification, it appeared that addition of 10% butter in the WPI 9-TS sample helped with
the improvement of flavor [36] but not enough to counteract the softening texture effect from protein
fortification completely.
In summary, WPI was more adequate for use in cream cheese enrichment when texture and taste
treatment was applied, as compared to WPH. The texture and taste modification strategy achieved
positive effects in enhancing pleasant flavors in cream cheese.
3.4. Consumer Liking of Cream Cheese
The average ratings of consumer liking are shown in Table 6. For a better understanding
of consumer preference, agglomerative hierarchical clustering (AHC) was conducted for a group
consumers with a similar acceptance towards different cheese samples. The mean liking ratings per
cluster are also shown in Table 6. The external preference mapping plots are presented in Figure 5,
which allows a visual representation of the association between cheese samples, sensory attributes,
and consumer liking of each cluster.
In Table 6, significant differences (p < 0.05) in overall consumer liking were found among the
five cheese samples. Acceptance of WPI 9-TS and the control sample was significantly higher than
the two WPH-enriched samples (p < 0.05). Sample WPI 9-TS was the most liked protein-enriched
sample. Besides, acceptance values of WPI 9-TS (6.9) and control sample (6.3) were not significantly
different (p > 0.05). Compared to cheese enriched with 9% WPI (6.1), the addition of butter in WPI
9-TS successfully enhanced the flavor and increased consumer liking significantly (p < 0.05).
Table 6. Mean ratings of consumers’ liking towards cream cheese. Size of each cluster was indicated (%).
Sample Cluster 1 (68%) Cluster 2 (24%) Cluster 3 (8%) Mean (100%)
Control 6.2abB 7.1aA 4.8bAB 6.3AB
WPI 9 6.4aB 5.8abBC 4.5bB 6.1BC
WPI 9-TS 7.2aA 6.8aAB 5.0bAB 6.9A
WPH 9 5.1bC 6.9aA 5.5abAB 5.6C
WPH 9-TS 5.4C 5.5C 6.7A 5.5C
Different lowercase letters within the same row indicate significant LSD differences at p < 0.05; different capital
letters within the same column indicate significant LSD differences at p < 0.05.
The external preference mapping plots of cream cheese are presented in Figure 5. Agglomerative
hierarchical clustering identified three consumer clusters. Cluster 1 was the largest group, accounting
for 68% of total consumers. This cluster was located in the first quadrant and consumers most liked
WPI 9-TS (7.2) characterized by a fatty, creamy and fresh cheesy flavor and butter odor. WPH 9
(5.1), with a rancid flavor and bitter taste, was liked the least by consumer cluster 1. Cluster 2 (24%)
expressed the highest liking towards the control sample (7.1) characterized by firmness, viscosity,
and a buttermilk flavor, and lowest liking ratings were for WPH 9-TS (5.5), with a bitter taste and
rancid flavor, and WPI 9 (5.8), with a yellow and glossy appearance. Cluster 3 (8%) was a small cluster
characterized by consumers who liked WPH 9-TS, with a bitter taste, bitter after-taste, and rancid
flavor. This might be because a small percentage of older adults may not be sensitive to bitter taste [38].
Demographic data were compared across three clusters, but no significant differences were found.
Consumers had moderately high willingness (rated 3.6 on the 5-point scale) towards consumption of
protein-enriched cream cheese in general.
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Preference map
Figure 5. External preference mapping of cream cheese. Red labels: O = odor attributes; A = appearance
attributes; TA = taste attributes; TX = texture attributes; FL = flavor attributes; AF = after taste
attributes. Blue labels: numbers indicate amount of added protein (9 = 9%), TS = texture and
taste-modified samples.
The bitter taste and rancid flavor of WPH restricted its application in cream cheese. WPI-enriched
cream cheese with additional butter was regarded as the most promising prototype for its outstanding
performance in both sensory and consumer liking evaluations.
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3.5. Product-Evoked Emotions
The penalty lift analysis [28–31] was performed to demonstrate the extent that product-evoked
emotions affected consumer liking acquisition. All emotion words were applied by more than 20%
of consumers; thus, all were included in the analysis [28]. Figure 6 shows the results of penalty-lift
analysis of rye bread and cream cheese-evoked emotion data. The elicited positive emotions led to
increased consumer liking, and negative emotions indicated reductions of consumer liking, which was
in line with former research [31].
(A) Rye bread
(B) Cream cheese
Figure 6. Penalty-lift analysis of emotions’ effect on overall liking across (A) rye bread samples and
(B) cheese samples. The frequency (%) of which the emotion descriptors were checked by consumers is
also indicated. The values of the vertical axis indicate the unit of change in liking of prototypes for
which the respective emotion attribute was checked, compared to liking of prototypes for which the
emotion attribute was not checked. The upstand pillars represent the increase in consumer liking and
the downward pillars indicate the decrease in consumer liking.
Satisfaction and disappointment represent the gap between consumers’ expected liking and
experienced liking. The degree of satisfaction indicates the extent that experienced liking goes beyond
expectations, while disappointment means the experienced liking does not meet with consumer
expectations. Lower expectation and higher experienced liking result in higher satisfaction and lower
disappointment. In this study, the liking ratings of satisfied consumers were 0.7 unit and 1.4 units
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higher than all consumers’ average liking ratings of rye bread and cheese, respectively. Disappointment
was the most detrimental emotion for liking acquisition of both food matrixes, which reduced the
liking ratings for rye bread and cream cheese by 0.7 units and 0.9 units, respectively.
To further investigate the discrimination power of emotions across six rye bread samples and five
cream cheese samples, analysis of variance (ANOVA) was also performed on the ratings of emotion
descriptors. Results indicated that satisfied, happy, and disappointed performed significantly better in
discriminating rye bread samples (p < 0.05), whilst satisfied, pleasant, and disappointed went beyond
the remaining emotions for discriminating cheese samples (p < 0.05).
Moreover, it should be noted that consumers checked desire for cream cheese much more
frequently (63%) than rye bread samples (41%). This might be because high-fat foods usually stimulate
higher desire to eat and high-fiber and carbohydrate foods often evoke lower consumption desire [39].
The degree of desire often affects the subsequent food intake [20]. To design protein-enriched meals
which could stimulate stronger desire and more subsequent food intake, a combination of high-fat
foods with high-fiber and carbohydrate foods could be a good option.
In summary, for the two food matrixes, the satisfaction-related emotions satisfied
and disappointed were among the most influential emotions on both product liking and
discrimination among older consumers. Furthermore, besides experienced liking, desire and
satisfaction/disappointment could be useful measurements to indicate prospective food intake, which
may guide the design of protein-enriched dishes and meals [24].
4. Discussion
In this study, we explored the sensory and consumer acceptance changes caused by enriching rye
bread and cream cheese with whey protein hydrolysate (WPH), whey protein isolate (WPI), and/or soy
protein isolate (SPI). Descriptive analysis results showed that different proteins had various influences
on the sensory performance of the two food matrices. Consumers with homogenous acceptance
towards rye bread and cream cheese were grouped into their respective clusters. The sensory attributes
driving the liking of each consumer cluster were demonstrated.
WPH enrichment led to higher bitter after-taste in rye bread, mainly due to the increased Maillard
reaction and content of bitter peptides [30,34]. However, PREFMAP of rye bread showed that bitterness
seems had no negative effect on the acceptance of most consumers; a small group of consumers even
appeared to be attracted by the bitterness of rye breads. This might be because bitter taste is a typical
sensory character in rye bread [40]; even though WPH increased bitter after-taste to some extent,
the intensity was not beyond the accepted level among senior consumers. Moreover, the sour taste and
sour-related flavor seem to be important in affecting the acceptance among most consumers, which
explained the high liking towards WPH 7-TS. It was also noted that WPH increased the umami taste,
which might be elicited from the free amino acids released during the hydrolysis of protein [41,42].
This could have advantageous effects in food matrices requiring an umami taste, e.g., a variety of soups
and sausages. Regarding the texture changes caused by WPH- and WPI-enrichment, the increased
hardness and elasticity could be explained by the heat-induced aggregation of whey protein [43,44].
The foaming property of whey protein may lead to the porous appearance, larger volume, and crumbly
texture [45]. The high water-binding capacity of whey protein might be the reason which increases the
perceived dryness during mastication [11].
Isolated protein (WPI and SPI)-enriched rye breads had a lower bitter taste compared to WPH.
However, the texture and/or mouthfeel of WPI and SPI-enriched breads restricted their application in
rye breads. The dry texture among WPI-enriched breads might be the major problem that led to the
breads being disliked by at least half of the consumers. SPI enrichment increased the stickiness, floury
mouthfeel, and compactness of rye breads, which appeared to decrease the acceptance of more than
half the consumers. The sensory changes caused by SPI might be because the soy protein conferred
a protective network on partial gluten structure which increased the dense and sticky texture of the
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dough and bread [15,46]. Enrichment with the blend of WPI/WPH and SPI counteracted each other’s
effects on rye bread texture and contributed to consumer liking.
In contrast to rye breads, when applying WPH in cream cheese, the increased bitter taste and
rancid flavor appeared to reduce consumer acceptance significantly. WPI was regarded as more proper
for cream cheese enrichment when additional butter was added for flavor enhancement. The flavor
advantage of WPI 9-TS cream cheese might be the major reason explaining its higher liking rating.
The sour taste seems dominate consumer liking in rye breads. More diversity was found in
consumer liking towards bread texture/mouthfeel. At least half consumers disliked WPI 7 with
dry texture; a quarter of the consumers liked WPH samples characterized by a crumbly texture.
The remaining one-quarter of consumers appeared to be attracted by WPH 4 + SPI 4 with sticky
mouthfeel and soft texture to some extent. For cream cheese, the liking of most consumers (68%) seems
to be mainly affected by the odor and the flavor dimension, which led to the high liking of WPI 9-TS
cheese. The liking of the remaining consumers appeared to be dominated by appearance, texture, and
flavor aspects, amongst which the viscosity, firmness, and buttermilk flavor which characterized the
control sample attracted the most consumers in this group. Compared to cream cheese, the variety
in texture preferences towards rye breads could be due to the texture complexity of the products.
Moreover, individual differences in the ability or preferred way to manipulate food in their mouth
could also contribute to the diversity in texture preference, as shown in a recent study on texture
mouth behavior [47].
The palatability of protein-enriched foods largely depends on the protein-carrier ‘fitness’.
A precise selection of protein type and food carrier which could inhibit or even benefit from the sensory
impacts caused by protein enrichment plays a vital role in developing appealing protein-enriched
products. From a sensory point of view, in some cases, the mild flavor and taste of WPI made it more
proper for protein-enrichment, as compared to WPH [48]. However, from a nutrition point of view,
the nutritional value of WPH is relatively higher due to its higher digestibility and absorptivity than
WPI [12,13], which makes it worthwhile to put efforts into broadening the use of protein hydrolysate
through modifying its production and processing or identifying masking agents in order to improve
its sensory quality [34,42,48].
However, the quality of protein ingredients used for enrichment, such as the digestion and
absorption rate and amino acid compositions, might be partly affected by the production process of
enriched foods. The potential quality changes may further influence the enriched foods’ contribution
to muscle protein synthesis. Evaluations on the protein quality of enriched foods and clinical trials on
the biological utilization of protein-enriched foods might be needed in future studies.
In this study, screened trained panelists aged 23–49 years were used in the sensory descriptive
analysis, and provided reliable and clear characterizations of prototypes. The use of older panelists
of a similar age to the target consumers as part of the trained panel was considered, however,
descriptive analysis with older panels may introduce more noise in characterizing products due
to their highly heterogeneous sensitivity [38]. More investigations regarding the proper use of older
panels are needed. With increasing age, adults are more receptive to functional foods because of their
increased health considerations, especially in the prevention of chronic diseases [49]. In this context,
appealing protein-enriched functional products hold a bright future in the market of older consumers.
Older consumers had high prospective willingness towards consumption of protein-enriched rye
bread and cream cheese in this study. However, besides ‘good taste’, there are a number of drivers
and obstacles for consumption of protein-enriched foods. A better understanding of motivators for
consumption of protein-enriched products among target consumers could help the promotion of
protein intake.
In the present study, a lab-based consumer acceptance test was conducted to obtain a
general perspective on how consumers accept the products. To evaluate consumer acceptance of
protein-enriched foods or meals in real life, contextual aspects could be considered and included for
exploration in future consumer studies to strengthen the predictive power of the results [50].
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The most preferred enriched prototypes of the two food matrices had twice amount of protein
as compared to non-enriched controls. Per slice, the WPH 7-TS bread contained 7.0 g protein, which
was 4.0 g more than the non-enriched control bread (Table 1). Each serving of WPI 9-TS cream
cheese contained 2.9 g protein, 1.8 g more than the control cheese (Table 3). Assuming that older
adults could consume two to three slices of bread combined with two to three servings of cream
cheese in one meal, the protein intake could increase by 11.6–17.4 g/meal due to protein-enrichment,
achieving 19.8–29.7 g/meal in total, which is close to the dietary recommendation for older adults
(25–30 g/meal) [8]. However, to evaluate the increase of protein intake through consumption
of protein-enriched foods in real life, further studies are needed to investigate the effects of
protein-enrichment on food intake and satiety in target older consumers [51].
5. Conclusions
The present study evaluated different kinds of protein-enrichments of rye bread and cream
cheese for their sensory acceptability by independent senior citizens. Relationships between sensory
properties of the protein fortification in these products were established. Sensory acceptability by
senior consumers was different with respect to the sensory properties of appearance, flavor, and texture,
indicating that diverse protein fortification strategies should be considered in product development
and optimization to be able to satisfy and engage senior consumers in the consumption of such
nutritious products.
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Abstract: Menopause is an age-dependent physiological condition associated with a natural decline in
oestrogen levels, which causes a progressive decrease of muscle mass and strength and bone density.
Sarcopenia and osteoporosis often coexist in elderly people, with a prevalence of the latter in elderly
women. The profound interaction between muscle and bone induces a negative resonance between
the two tissues affected by these disorders worsening the quality of life in the postmenopausal period.
It has been estimated that at least 1 in 3 women over age 50 will experience osteoporotic fractures,
often requiring hospitalisation and long-term care, causing a large financial burden to health insurance
systems. Hormonal replacement therapy is effective in osteoporosis prevention, but concerns have
been raised with regard to its safety. On the whole, the increase in life expectancy for postmenopausal
women along with the need to improve their quality of life makes it necessary to develop specific and
safe therapeutic strategies, alternative to hormonal replacement therapy, targeting both sarcopenia
and osteoporosis progression. This review will examine the rationale and the effects of dietary protein,
vitamin D and calcium supplementation combined with a specifically-designed exercise training
prescription as a strategy to counteract these postmenopausal-associated disorders.
Keywords: postmenopausal women; sarcopenia; osteoporosis; exercise; dietary protein; vitamin D
1. Introduction
Sarcopenia was firstly described at the end of the twentieth century by Rosenberg as a degenerative
depletion in muscle mass [1] associated with age. It also involves the loss of muscle functionality
leading to mobility restriction, functional impairment and physical disability [2] and finally loss of
independence and reduced quality of life.
Even though there is still heterogeneity in diagnostic criteria and modalities to detect sarcopenia,
the most used is the definition adopted by the European Working Group on Sarcopenia in Older
People (EWGSOP) [3]. The group recommended, for the diagnosis of sarcopenia, that low muscle
mass should be associated with low muscle function (defined as strength and performance) and
proposed an algorithm for case finding in older individuals based on measurements of gait speed,
grip strength and muscle mass. They also described measurement tools and specific age/gender cut
off points to distinguish between presarcopenia, sarcopenia and severe sarcopenia [3]. Afterwards,
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an International Working Group on Sarcopenia (IWGS) incorporated sex-specific threshold values
for muscle mass [4] while the Foundation of NIH (FNIH) Sarcopenia Project proposed a different
definition for sarcopenia [5].
Although it is challenging to distinguish among sarcopenia, frailty and cachexia, they do
represent different conditions: frailty has been defined by Morley et al. as “a medical syndrome
with multiple causes and contributors that is characterized by diminished strength, endurance and
reduced physiologic function that increases an individual’s vulnerability for developing increased
dependency and/or death,” of which sarcopenia can be an aspect [6]; cachexia, characterized by
weight and muscle mass loss, can be a cause of sarcopenia having a great inflammatory component [7].
The loss of muscle mass begins substantially at the age of 50 and continues afterwards [8] with
similar gender-independent changes, such as increased inflammation and satellite cell senescence,
reduced myocyte regeneration and protein synthesis [9] and several other gender-dependent alterations
caused by the age-associated decrease of sex hormones [10]. Due to the decrease of testosterone
in men and oestrogens in women, people of both genders experience sarcopenia. Although in
general, men show a greater decay in muscle mass, women frequently present sarcopenia, since
their muscle mass level in young age is physiologically much lower [11,12]. In a recent meta-analysis,
Shafiee et al. examined the overall prevalence of sarcopenia in both women and men aged >60 years
using the EWGSOP, IWGS and Asian Working Group for Sarcopenia criteria: they reported a prevalence
of about 10% in adults, without global gender differences [13]. Hormonal replacement therapy (HRT)
aimed at preventing the modifications and chronic somatic diseases caused by age-related oestrogen
decrease, results in greater muscle strength in 50–65 years women, while in older women studies are
not conclusive [14,15].
Several studies highlighted an association between sarcopenia and osteoporosis, another
age-related disease involving low bone mineral density (BMD), bone tissue frailty and risk of
fractures [16]. Osteoporosis is diagnosed by BMD criteria or occurrence of fragility factors [17].
Osteoporosis is more prevalent among older individuals with a far higher prevalence in women, where
the onset often coincides with menopause. Indeed, it is estimated that the overall effect of menopause
is an annual bone loss of about 2% during the first six years and 0.5–1% thereafter [18]. In western
countries, the risk of osteoporotic fractures during the lifetime is about 40–50% in women and 13–22%
in men [19]. Osteoporotic fractures often require hospitalisation and long-term care; thus, osteoporosis
represents a significant health challenge worldwide. The Women’s Health Initiative is a long-term
health study focused on strategies for preventing disease in postmenopausal women, aimed to analyse
and suggest strategies to manage postmenopausal related problems effectively. During the project,
eleven clinically risk factors have been identified, providing new insights into the epidemiology of
osteoporosis [20].
Muscle-bone physiological interaction is increasingly reputed to be essential to prevent disease
and disability in the elderly: in particular, Sjöblom et al. reported that women suffering from sarcopenia
have more than a double higher risk of fracture and falls compared to those without the disease [21].
Among multiple factors, the musculoskeletal decline is also linked to protein, calcium and vitamin D
availability and decrease in physical activity level. Deterioration in muscle and bone health is majorly
caused by an inadequate protein intake associated with a significant demand due to an aging-related
increase of protein anabolic resistance, chronic inflammation and oxidative processes [22]. The lack of
physical activity, often affecting elderly people, accelerates muscle catabolism and is another major risk
factor. Collectively, these problems may lead to a vicious cycle of muscle loss, injury and inefficient
repair, causing elderly people to become progressively sedentary over time. Thus, therapeutic and/or
nutritional strategies improving muscle mass and regeneration in the aged are nowadays required.
Importantly, these strategies could also allow to maintain the capacity of sustaining and practicing
physical exercise. Indeed, exercise is known to mitigate several deleterious effects of aging, such as
insulin resistance, mitochondrial dysfunction and inflammation in muscle [23] and represent one of
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the best strategies to counteract sarcopenia. Resistance exercise is a trigger for muscle protein synthesis
and can work in synergy with adequate protein intake [24].
In the elderly vitamin D deficiency often occurs and it is associated with sarcopenia, bone loss
and disability. Vitamin D is highly interconnected with phosphate and calcium metabolism, as first
demonstrated by Harrison and Harrison in 1961 [25]. The 1,25-dihydroxyvitamin D, D (1,25(OH)2D)
the active metabolite of vitamin D, also known as calcitriol, increases intestinal phosphate absorption
enhancing the expression of type 2b sodium–phosphate co-transporter [26,27]. Moreover, a deficiency
of phosphate stimulates 1α-hydroxylase to convert vitamin D to calcitriol, which in turn stimulates
phosphate absorption in the small intestine. Furthermore, calcitriol can also induce the secretion
of Fibroblast-like growth factor-23 by osteocytes in bone, which lead to phosphate excretion in the
kidney [28], as well as feedback on vitamin D metabolism. Since vitamin D is responsible for adequate
intestinal absorption of calcium and phosphate, it maintains appropriate circulating concentrations of
these minerals, which enable normal mineralization of the bone contributing to muscle health. Thus,
adequate intake of calcium and vitamin D, associated with a correct lifestyle, is suggested during
aging [29].
On the whole, the increase in life expectancy for postmenopausal women along with the
need to improve their quality of life makes it necessary to develop specific therapeutic strategies,
in association with HRT or as an alternative to it. Here we discuss the effect of protein intake,
vitamin D supplementation, physical activity and of their synergistic administration in maintaining
musculoskeletal health in postmenopausal women.
2. Mechanisms Involved in Muscle and Bone Loss in Postmenopausal Women
One of the most responsive pathways involved in musculoskeletal health is the Mammalian target
of rapamycin (mTOR), involved in several anabolic processes in skeletal muscle [30]. mTOR is an
evolutionarily conserved serine/threonine kinase known to play critical roles in protein synthesis.
A better understanding of mTOR signalling in the maintenance of skeletal muscle mass might favour
the development of mTOR-targeted treatments to prevent muscle wasting with particular attention at
the healthy muscle in postmenopausal women conditions [31]. A well-known upstream stimulator of
mTOR in skeletal muscle is insulin-like growth factor 1 (IGF-1), recognized as indispensable for muscle
growth and regeneration [32–34] IGF-1 binds to the IGF-1 receptor (IGF1-R), a receptor tyrosine-kinase
and subsequently recruits insulin receptor substrate-1. The specific role of each IGF-1 isoform and
their post-translational modifications [35] must be taken into consideration for their effect in the
proper tissue or microenvironment context. Furthermore, IGF-1 is directly involved in mitogenesis
and neoplastic transformation, suggesting that this signalling pathway plays an important role in
cancer promotion. IGF-1-therapeutic strategies must be viewed in the appropriate tissue context and
in function of the IGF-1 circulating level and depending on IGFBP availability.
In women, the age-related decline of skeletal muscle mass and strength accelerates with the
beginning of menopause. Oestrogen signalling of muscle satellite cell activation and proliferation is
mediated via oestrogen receptor-alpha (ERα) placed on skeletal muscle and activates several signalling
pathways including IGF-1 signalling, nitric oxide signalling or activation of the phosphor-inositide-3
kinase/protein kinase B (Akt) pathway which then act to positively influence muscle satellite cells
and promote protein synthesis [31]. Recent investigations demonstrated that IGF-1 and its receptor
IGF1-R were not necessary for the induction of hypertrophy and the activation of Akt/mTOR in
mechanical loading [36]. The expression of dominant negative (DN)-IGF-1 receptor specifically in
skeletal muscle promoted muscle hypertrophy using an increased functional overload model induced
by synergistic ablation [36]. Of notice, DN-IGF-I receptor-expressing muscle showed a comparable
level of Akt and p70S6K1 activation. This data does not exclude an alternative upstream mediator for
IGF1-R that could regulate Akt/mTOR signalling in skeletal muscle hypertrophy. In women, recent
studies showed that the expression of IGF1-R in skeletal muscle cells increased in postmenopausal
period after oestrogen replacement [37]. Moreover, it is known that oestrogen has an anabolic influence
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on muscle stimulating IGF-1R [38]. ERs are also expressed in human muscles [39]. In this regard,
Wiik et al. have described the form of ERα and ERβ in both myonuclei and capillaries [40]. Their
expression and distribution in muscle fibres appear greater in men, women and children, compared to
postmenopausal women [40]. Notably, ERs can be also activated through IGF-1 that acts in stimulating
their transcriptional activity [41]. Indeed, ERs could take part in muscle strength increase through the
effect of both oestrogen and IGF-1. Despite that, both oestrogen and IGF-1 reduced at menopause,
probably affecting muscle mass and strength.
Accordingly, estradiol plays an important role in the morphological muscle status increasing
translocation of the glucose transporter, GLUT-4 to the plasma membrane through Akt pathway.
Indeed, it causes an increase of myogenin and myosin heavy chain levels, which are important in
skeletal muscles remodelling [42,43]. Estradiol also induces the Akt phosphorylation in myoblasts
and its administration in postmenopausal women up-regulates the expression of mTOR genes [44].
As known, muscle wasting occurs when catabolic states overcome anabolic states. Sex hormones
(i.e., androgens and oestrogen) play different roles in muscle mass maintenance and their decrease
during aging negatively affects musculoskeletal health. Testosterone promotes an anabolic state
activating protein synthesis and muscular regeneration through the androgen receptor, expressed in
mesenchymal stem cells, satellite cells and fibroblasts [45]. Furthermore, it acts increasing circulating
and intramuscular IGF-1 [46]. The catabolic state is promoted by the ubiquitin-proteasome system
(UPS), autophagy-lysosomal system and apoptosis. Myostatin and inflammatory cytokines promote
Forkhead box O (FOXO) protein activation that induces UPS and autophagy-lysosomal systems.
Oestrogen is likely to promote an anti-inflammatory and anti-catabolic influence on muscle, especially
after exercise, even though a complete characterization of mechanisms is lacking [10].
Several studies demonstrated an association between sarcopenia and osteoporosis, another
age-related disease characterized by low BMD leading to bone tissue frailty and risk of fractures [16],
with a higher prevalence in women. Biomechanical and biochemical interactions in the musculoskeletal
unit are of great importance in the regulation and maintenance of tissue function. As functional units,
muscles and long bones adapt to respond to metabolic and mechanical demand in health and they
deteriorate together with ageing because of the same biomechanical and biochemical link between these
two tissues [47]. The ‘mechanostat’ theory of Frost states that bone adjusts itself to sustain strain in a
physiological window [48]: bone formation occurs if a greater strain is requested (i.e., physical activity),
while lower strains (i.e., inactivity) will promote bone resorption. Accordingly, there will be an increase
or a decrease, respectively, in muscle mass. Alongside biomechanical coupling in the musculoskeletal
unit, also biochemical communication should be considered in muscle-bone crosstalk since both
muscle and bone act as endocrine organs secreting respectively “myokines” and “osteokines” [49].
Skeletal muscle releases several hundred proteins and peptides capable of influencing bone health.
The myokine [50] and osteokine [51] irisin, for example, is increased by exercise and has anabolic effects
on muscle [50] and on osteoblast lineage by enhancing differentiation and activity of bone-forming
cells [52]. Also, myostatin—that is, a negative regulator of muscle growth and interleukin-6 (IL-6)—is
reported to have effects on bone [53]. Furthermore, skeletal muscle expresses high levels of several
microRNAs that can be delivered by exosomes [54]. Information regarding the endocrine and paracrine
effects of muscle-derived exosomes is limited but they are likely to play a role also in bone [53].
Also, tendons, ligaments, cartilage and connective tissue can affect muscle bone cross-talk [49];
periosteum, that separates muscle and bone, is semi-permeable and molecules such as IGF-1, IL-5
and prostaglandin E2 could permeate this membrane [55]. Taking into account the tight connection
between muscle and bone, maintaining healthy skeletal muscles (i.e., through adequate exercise and
nutrition) can help in counteracting osteoporosis in postmenopausal women.
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Oestrogen-based HRT has an important role in maintaining and enhancing muscle mass and
strength and also in protecting against muscle damage. The benefits of oestrogen for the skeletal muscle
coupled with their additional positive actions on bone and metabolic health in older females provide
further incentives for HRT use to enhance overall health in postmenopausal women. HRT is associated
with an improved contractile function and power in 50–65-year-old women [15], while research is not
conclusive in older, postmenopausal women. Analysing coronary heart disease and mortality, HRT
showed many benefits in early observational data for use in younger healthy women (50–60 years) but
age stratification revealed no benefit and increased harm in >60 year women, together with an increased
breast cancer risk [56]. Recently the US Preventive Services Task Force recommended against the
prevention of chronic condition in menopause using a combined oestrogen and progestin therapy and
against oestrogen alone in postmenopausal women after hysterectomy [57], due to well documented
harmful effects. Marjoribanks et al., in a systematic review on long-term HRT for perimenopausal
and postmenopausal women, concluded that even though HRT is effective in osteoporosis prevention,
it should be recommended as an option only when the risk of disease is very high and no other strategy
is available [58]. They suggest that the adoption of HRT, if necessary, should be short-termed, provided
that there is no increased risk of cardiovascular and thromboembolic disease and of several types of
cancer [58]. The disadvantages related to the menopause, however, are not always manifested all
at the same time and in all women; in some it seems not to be completely, in others there are only
some disturbances, in others, finally, these disadvantages occur together and can also be very evident
and frustrating.
The risks associated with taking a pharmacological substitution therapy is much debated, but, in
light of the most recent scientific acquisitions, menopause can be tackled by acquiring healthy habits
that prevent the related disorders. Thanks to the better understanding of the causes, the ease of access
to the diagnosis and the possibility of treatment before fractures occurrence today, a real prevention
of both sarcopenia and osteoporosis and associated complications is possible. First of all, the fact is
that muscle and bone health is a process that must develop throughout life in both males and females.
Building a strong and healthy muscle-skeletal structure in childhood and adolescence can be the best
defence. The further key steps that should be pursued at all ages for a successful prevention should
consider: monitor a balanced diet rich in protein sources, calcium, magnesium and vitamin D that
could interfere with anabolic mediators for both muscle and bone; practice exercise to enhance muscle
strength, power output, neuromuscular activity and muscle mass; follow healthy lifestyles (avoiding
alcohol, smoke and drugs) and, when appropriate, perform tests to define bone mineral density and
possibly undergo appropriate treatment.
3. Exercise
Given the strict association between loss of muscle (namely, sarcopenia) and bone mass (namely,
osteoporosis) that accompany aging, physical activity and exercise represent effective preventive and
therapeutic strategies able to slow down sarcopenia progression and prevent/delay the onset of and
treat, osteoporosis. Indeed, exercise has beneficial effects on muscle mass, muscle strength and physical
performance [59–61], which counteract the reduced ability to perform activities of daily living and the
increased risk of musculoskeletal injuries related to sarcopenia [62,63]. Exercise has also been shown
to delay the onset of osteoporosis [64–66] and to improve balance [67] and muscular fitness [64–66,68]
thus it is generally regarded as the primary non-pharmacological treatment for the prevention of
osteoporosis and fall-related fractures. Since menopause occurs approximately with the onset of
sarcopenia, aging non-physically active postmenopausal women should switch as soon as possible to
an active lifestyle to prevent osteoporosis, while those already osteoporotic should exercise regularly
to improve bone health and reduce the risk of fractures. It is well known that exercise, particularly
progressive resistance exercise training (RET), is effective in increasing muscle mass, strength and
endurance. Specific recommendations and guidance to prescribe exercise to treat sarcopenia, which
update and extend those of the American College of Sports Medicine (ACSM) to promote muscle
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hypertrophy, strength and power [69], have recently appeared in literature [70]. Exercise that enhances
muscle strength and mass also increases bone mass (i.e., bone mineral density and content) and
bone strength of the specific bones stressed and may serve as a valuable measure to prevent, slow,
or reverse the loss of bone mass in individuals with osteoporosis. Although further studies are
still needed to determine optimal exercise prescription parameters for preventing osteoporosis and
fractures [64–66] a recent consensus on physical activity and exercise recommendations for adults with
osteoporosis [71] has stated the appropriateness of the current physical activity guidelines [68,72] for
those without spine fractures and has proposed safer exercise guidance and strategies for those with a
history of vertebral fractures. The ACSM’s framework for exercise prescription employs the so-called
FITT-VP principle [73], which reflects the frequency (F), intensity (I), time (T) and type (T) of exercise
and its volume (V) and progression (P) over time, in an individualized exercise training program.
A detailed description of the FITT-VP principle for each type of exercise i.e., aerobic, resistance,
flexibility and balance- adapted to postmenopausal ageing women according to the abovementioned
studies, is provided in the following tables (Tables 1–4).
Literature put a strong emphasis on resistance training for all individuals with osteoporosis [71]
and recommend moderate to high intensity RET to treat sarcopenia [70]. Therefore, since preventing
the loss of -or increasing- muscle strength and endurance is a cross-cutting goal for both sarcopenic
and osteoporotic postmenopausal women, emphasis on progressive RET has been proposed. As a
consequence of this approach, in this population there is the need to account for daily protein intake
and, even, timing of protein supplementation [74].
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4. Dietary Protein
Aged skeletal muscle possesses a reduced ability to respond to amino acid and insulin levels,
leading to the concept of anabolic resistance, influenced by dietary protein digestion and amino acid
absorption, plasma availability and hormonal response [75]. Moreau et al. reported differences in
splanchnic protein metabolism during aging, with a maintained muscle protein synthesis (MPS),
in a condition of an adequate rate of plasma levels of essential amino acids [76]. Alongside a reduced
ability to use protein, a greater demand and a reduced intake are often present [22]. Chronic low-grade
inflammation, that is often linked to oestrogen decrease and to visceral adipose tissue, favours
proteolysis over synthesis and leads to an increased MPS demand [77]. Recommendations for dietary
protein intake in general population with a moderate physical activity is 0.8 g of protein per kilogram
of body weight per day [78]; however, due to increased protein demand in healthy older people,
the European Society for Clinical Nutrition and Metabolism has proposed a daily recommended
amount of 1.0–1.2 g/kg body weight/day as optimal for a healthy older individual [79,80]. Physical
activity and exercise require a higher protein intake than sedentary condition [81].
Data from the National Health and Nutrition Examination Survey (NHANES) showed that,
despite recommendations, daily protein intake decreases in the elderly and at least 8% of women
consume an insufficient amount of protein [82]. 35% of institutionalized elderly people do not reach the
recommended daily allowance (RDA) [83]. Gregorio et al. analysed the association of dietary protein
amount with physical performance in postmenopausal women [84]. A sample of 387 healthy women
has been studied, revealing an average consumption of 1.1 g/kg body weight/day and a percentage
of 25% of subjects resulted below the RDA: they reported that subjects within the low protein group
possess an impaired upper and lower extremity functionality than those in higher consumption group
and that subjects with higher BMI and fat/lean ratio often consume protein below the RDA [84].
It should be remembered that higher fat mass is associated with impaired muscle metabolism [85] and
insulin resistance, which is recognised as precursor of frailty [86].
Increased availability of amino acids has positive effects on muscle anabolism [87] improving lean
body mass [88]. Protein intake also increases IGF-1 plasma concentration [89], together with muscle
mass and strength [90]. In addition to the bone anabolic effect of IGF-1, increased protein intake has
also been shown to reduce bone resorption [91]; furthermore, protein can act modifying calcitriol
and intestinal calcium absorption, increasing bone health [92]. As explained, protein intake above
RDA may be of benefits in postmenopausal women and Antonio et al. demonstrated the safety and
effectiveness of three-fold higher dose in increasing lean mass, in both genders in association with
resistance exercise [93]. In young women, the author also excluded a dangerous effect of high protein
intake (more than 2.2 g/kg body weight/day for six months) on bone mineral content [94].
The best daily frequency for consuming protein, that is, single versus fractionated intakes, is
still under debate. Indeed, some studies reported that daily protein should be consumed in a single
meal, since a protein pulse feeding was more efficient than protein spread feeding in improving
protein retention [95] and increasing plasma postprandial amino acid concentrations [96]. However,
Kim et al. [97] found no differences comparing the effect of protein distribution pattern on functional
outcome and protein kinetics; other studies reported that within-day protein distribution was more
efficient in improving protein synthesis [98] and was negatively correlated with frailty [99]. Finally,
a more frequent consumption of meals containing 30–45 g of protein [100] or protein supplementation
at breakfast and lunch [101] have been recently associated with better lean mass preservation in
older people.
Several factors can influence postprandial MPS: in particular, muscle disuse as a consequence of
sarcopenia or immobilization causes a decrease in basal metabolic rate and muscle strength [102] and
dietary protein consumption fails to act in this pathological condition [103]. On the contrary essential
amino acid induces an enhanced effect on MPS if ingested following a resistance training session [104].
The mechanism involved in exercise-improvement of dietary protein effect depends on an increased
amino acid delivery to the muscle through blood flow [105] and on mTOR pathway activation (after
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resistance exercise), that lead to muscle mass enhancement if an adequate amino acid pool is present:
notably, this process seems to be delayed in elderly [106].
Alongside total protein amount and within-day protein distribution, quality of protein and their
sources should be considered [107] in terms of essential amino acids and leucine content and of
digestion/absorption kinetics. Pennings et al. [108] demonstrated that whey stimulates postprandial
muscle protein accretion more effectively than casein and casein hydrolysate in older men, and
attributed this effect to whey’s faster digestion and absorption kinetics and to higher leucine content.
More recently, Zhu et al. demonstrated that in older postmenopausal well-nourished healthy
women (70–80 years old) 30 g/day of extra protein did not improve the maintenance of muscle mass
or physical function despite muscle deterioration in the upper limb. The authors attributed the lack of
effects to the high habitual protein intake of women involved in this study, suggesting that protein
intervention could be more effective in not well-nourished population. Furthermore, the intervention
was not carried out in combination with resistance exercise, which has been demonstrated to improve
protein effect [109]. Daly et al. reported that a protein-enriched diet equivalent to 1.3 g/kg body
weight/day achieved through lean red meat consumption is safe and useful for enhancing the effects of
resistance training on lean body mass and muscle strength and reducing circulating IL-6 concentrations
in elderly women [110]. In this study, women were in a broader age range (60–90) and more than 40%
had a history of HRT: these differences, in combination with training, could explain the discrepancies
in muscle response.
Figueiredo Braggion et al. compared the effects of diets rich in vegetable protein versus animal
protein in ovariectomized old female rats (a condition that may only mimic human menopause) in
association or not with resistance training. They demonstrated that animal protein diet combined with
training promoted muscle remodelling (reduction in type I and IIA fibres with an increase in type
IIB fibres in medial gastrocnemius muscle, with increased collagen volume density) more efficiently
compared to other conditions applied [111]. More importantly, a very recent human study showed
that animal derived protein consumption, combined with physical activity, is positively associated
with muscle mass and strength across ages in men and women [112].
Milk is a high-quality protein source, able of increasing muscle synthesis to a similar extent that
whey [113] and beef [114]. However, the proposed protein amount of protein/meal of 30 g would
require the consumption of one litre of milk [115]; for this reason, Orsatti et al. have recently proposed
the addition of soy protein to milk to enhance the effect of resistance training in postmenopausal
women muscle [116]. Soy represents a good alternative to animal products, even though it is less
effective in promoting muscle protein synthesis than animal sources [117], due to the high amount of
isoflavones. Isoflavones are, in turn, often used as a natural alternative to hormone therapies and have
been demonstrated to reduce the loss of bone mass and inflammation [118] that occur in menopause.
Orsatti et al. observed that the addition of soy protein to milk, in association to resistance exercise,
improves muscle strength but not muscle mass and attributed the latter to leucine content, that is
lower with respect to the values suggested for maximizing protein synthesis [116].
Besides the effect of global amino acid availability, specific amino acids such as leucine,
glutamine and arginine can play an important muscle health effect. Leucine (an essential amino
acid) supplementation has been proposed as a strategy to counteract anabolic resistance in older
muscle since it acts as a signalling molecule able to activate mTOR and thus protein synthesis [119].
Also, Xia et al. suggested an increase of leucine consumption in the diet, together with concurrent
training, to counteract sarcopenia associated with chronic low-grade inflammation, often present
during menopause [77]. Glutamine and arginine can also differentially regulate mTOR [120,121].
The nonessential amino acid glycine has anti-inflammatory and antioxidant properties and seems
to promote the preservation of muscle mass. In a mice model of inflammation, glycine has been
demonstrated to counteract anabolic resistance, since the improvement in leucine-stimulated protein
synthesis was accompanied by higher phosphorylation status of mTOR, ribosomal protein S6 kinase
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and eukaryotic translation initiation factor 4E binding protein 1 compared with L-alanine-treated
controls [122].
Taken together, the above evidence suggests that postmenopausal women need an adequate
protein intake, in association with exercise (according to the modalities described in Tables 1–4) to
counteract sarcopenia and related bone loss.
5. Vitamin D
Vitamin D is known to significantly contribute to the regulation of calcium and phosphorus
homeostasis and skeletal mineralization through endocrine effects on bone, intestine, parathyroid
glands and kidney [123]. Vitamin D has both skeletal and extra-skeletal beneficial effects. There is
growing evidence that vitamin D regulates many other cell functions and its potential effect on skeletal
muscle mass and strength is receiving greater attention. The biological actions of vitamin D on muscle
cell differentiation, metabolism and function may be multiple, acting through direct and indirect,
genomic and non-genomic pathways.
Vitamin D can be cutaneous synthesized from 7-dehydrocholesterol (7-DHC) (80–90%), a precursor
of cholesterol, after exposure to ultraviolet B light. This endogenous synthesis mainly depends on
the intensity of solar radiation. Very limited number of foods contains vitamin D such as fatty
fish (like salmon and mackerel) or mushrooms, whereas milk products and eggs contain only small
amounts of vitamin D. Calcitriol can be produced both by dietary sources and endogenous vitamin
D through two hydroxylation reactions. The diet provides about 10–20% of the daily requirement of
vitamin D. 25-hydroxyvitamin D (25(OH)D), the precursor of calcitriol, is the major circulating form of
vitamin D and is considered the best biomarker to assess the vitamin D status; it circulates bound to a
specific plasma carrier protein, vitamin D binding protein, that also transports the calcitriol.
The Institute of Medicine defines plasma concentration of 25(OH)D as adequate (25(OH)D
concentrations > 50 nmol/L or > 20 ng/mL), insufficient (25(OH)D concentration between 30–50 nmol/L
or 12–20 ng/mL), or as deficient (25(OH)D levels < 30 nmol/L or < 12 ng/mL). The committee stated
that 50 nmol/L is the serum 25(OH)D level that covers the need of 97.5% of the population. Serum
concentrations >125 nmol/L or > 50 ng/mL are associated with potential adverse effects [124].
Serum 25(OH)D levels < 50 nmol/L are associated with increased bone turnover, bone loss and
possibly mineralization defects and poorer outcomes for frailty, hip fracture and all-cause mortality [29];
furthermore, it may exacerbate osteoporosis in elderly or postmenopausal women by increasing
the rate of bone turnover. Aging decreases the capacity of human skin to produce vitamin D, in
particular, 7-DHC concentration, the precursor of vitamin D, declines in the elderly [125]. During
aging, the combined effect of a decline in intestinal calcium absorption, in the ability of the kidney
to synthesize calcitriol and an increase in its catabolism contributes to age-related bone loss [123].
In addition, with aging there is a defect in 1 α hydroxylation [123].
High levels of dietary calcium intake and/or calcium supplements can significantly improve
bone mineral content and density in postmenopausal women, however, some studies suggest that
calcium supplements alone may not be sufficient to reduce fracture risk and that additional vitamin D
supplementation is required; calcium, in combination with vitamin D supplementation, reduces the
risk of fragility fractures and increases the survival in the elderly [126,127].
Furthermore, an increased level of calcium intake during the period of childhood and adolescence
can lead to a reduction in the risk of osteoporosis during old age and post menopause [128].
Vitamin D has a pivotal role in the regulation and uptake of calcium in muscle cells, promoting
protein synthesis and calcium and phosphate transport in muscle, which is important for muscle
strength and contractile activity. Vitamin D appears to optimize the effect of dietary protein on
skeletal muscle anabolism [29]. Both direct and indirect effects of vitamin D seem to play a role in
muscle functionality, although most of them are attributed to the concomitant hypocalcaemia and
hypophosphatemia [128]. Vitamin D plays a key role in regulating calcium-dependent functions of
muscle, such as contraction, mitochondrial function and insulin sensitivity [128]. Loss of muscle
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mass is related to vitamin D deficiency [129,130]. The mechanisms by which vitamin D affects muscle
strength and function have not yet fully clarified but are likely mediated by the vitamin D receptor
(VDR); VDR and 1-alpha hydroxylase are both expressed in muscle tissue [131].
The presence of nuclear VDRs in muscle tissue suggests that vitamin D acts on muscle via a
genomic transcriptional effect. Mechanistically, it has been suggested that 1,25-dihydroxyvitamin D
binds to the nuclear VDR in muscle resulting in de novo protein synthesis [132]. Salles et al. have
reported an anabolic effect of vitamin D in murine C2C12 myotubes through an increased insulin
receptor and VDR mRNA expression [133]. Both the transcriptional induction of these genes and the
enhancement of the insulin and leucine action on the related protein is one of the cardinal processes of
vitamin D effect on skeletal muscle anabolism [133].
Furthermore, vitamin D signalling via VDR regulates gene transcription and activates further
intracellular signalling pathways involved in calcium metabolism and it has been suggested to
be involved in myoblast proliferation and differentiation [134]. Proximal myopathy (proximal
weakness), characterizes patients with VDR-dependent rickets, an evidence arisen from studies in
either older or younger populations [128]. Additionally, VDR-knockout mice are characterized by
abnormal muscle morphology/physical function, while VDR polymorphisms have been associated
with differences in muscle strength [135]. Muscle and bone VDR and 1-alpha hydroxylase expression
decrease with aging [131,136,137] and it might be involved in intramuscular inflammation, since it
has been associated with an increase of IL-6 and TNF-alpha levels in human skeletal muscle [138].
This process leads to the inhibition of muscle protein synthesis, to skeletal muscle apoptosis [139]
and increased differentiation of myogenic precursor cells into adipocytes [140]. Recently, several
authors have demonstrated that vitamin D supplementation can modulate VDR expression [131].
From a pathogenic point of view, reversible atrophy of type II muscle fibres and fatty infiltration
of skeletal muscles have been reported in patients with vitamin D deficiency [131,141]. In younger
adults, serum 25(OH)D concentration is inversely related to muscle fat infiltration, independently
from body mass index and physical activity [142]. Such changes in muscle lipid content may have
important implications for musculoskeletal function. Hence, since low vitamin D status is common
in many elderly populations [143], attention should be paid to the potential therapeutic benefits
of its supplementation. To this regard, European guidance for the diagnosis and management of
osteoporosis in postmenopausal women recommends a daily intake of at least 1000 mg/day for
calcium, 800 IU/day for vitamin D and 1 g/kg body weight of protein for all women aged over
50 years [29]. On the whole, vitamin D deficiency is associated with a loss of muscle mass and strength
in elderly people and with a decline in physical performance. A nutritional intervention of vitamin
D and amino acid supplementation could be a strategy to support muscle protein availability and
synthesis in sarcopenia condition.
6. Conclusions
Osteoporosis and sarcopenia are two disorders affecting elderly people; their increasing incidence,
due to the longer life expectancy in most western countries, might become an uncontrolled clinical
and financial burden in the next few years. Early diagnosis, prevention and treatment of these
disorders represent a very current but actually unmet, social and medical need. The evidence of
profound interactions between bone and muscle causes a sort of negative resonance between the two
tissues when they are simultaneously affected by osteoporosis and sarcopenia, respectively. Indeed, the
coexistence of this twin condition in ageing leads to an accelerated worsening of the quality of life, poor
clinical perspectives and high utilization of health resources. Due to the age- and/or gender-associated
prevalence of sarcopenia and osteoporosis, postmenopausal women are potentially more prone to
such a joint clinical situation. Nutritional and lifestyle factors may positively affect muscle and bone
mass and function and have the advantage to be cheap and safe. To this regard, protein, vitamin D
and calcium supplementation combined with a specifically-designed training protocol, emphasizing
progressive RET, are capable of directly targeting some of the major physio-pathological causes of the
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twin condition progression and could simultaneously and coherently delay or revert the vicious cycle
leading to the reciprocally-induced deterioration and wasting of osteoporotic bone and sarcopenic
muscle (Figure 1).
Figure 1. Menopause-related factors affecting muscle and bone and their possible prevention through
a rationale strategy based on protein and vitamin D supplementation regimens in combination with
specifically-designed training protocols.
The medical and social relevance of strategies alternative to HRT targeting both sarcopenia and
osteoporosis progression based on a female-specific rationale would be invaluable. To this regard,
the development of controlled and selected protein and vitamin D supplementation regimens in
combination with specifically-designed exercise training protocols may represent a cheaper and safer
alternative to oestrogen replacement therapies.
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Abstract: The role of dietary protein intake on muscle mass and physical function in older adults is
important for the prevention of age-related physical limitations. The aim of the present study was to
elucidate links between dietary protein intake and muscle mass and physical function in older women
meeting current guidelines of objectively assessed physical activity. In 106 women (65 to 70 years old),
protein intake was assessed using a 6-day food record and participants were classified into high and
low protein intake groups using two Recommended Dietary Allowance (RDA) thresholds (0.8 g·kg−1
bodyweight (BW) and 1.1 g·kg−1 BW). Body composition, aerobic fitness, and quadriceps strength
were determined using standardized procedures, and self-reported physical function was assessed
using the SF-12 Health Survey. Physical activity was assessed by accelerometry and self-report.
Women below the 0.8 g·kg−1 BW threshold had a lower muscle mass (p < 0.05) with no differences in
physical function variables. When based on the higher RDA threshold (1.1 g·kg−1 BW), in addition
to significant differences in muscle mass, women below the higher threshold had a significantly
(p < 0.05) higher likelihood of having physical limitations. In conclusion, the present study supports
the RDA threshold of 0.8 g·kg−1 BW of proteins to prevent the loss of muscle mass and emphasizes
the importance of the higher RDA threshold of at least 1.1 g·kg−1 BW to infer additional benefits on
constructs of physical function. Our study also supports the role of protein intake for healthy ageing,
even in older adults meeting guidelines for physical activity.
Keywords: elderly; muscle strength; nutrition; physical activity; physical functioning; Recommended
Dietary Allowance (RDA); sarcopenia
1. Introduction
A large body of research has highlighted the role of dietary proteins as primary anabolic stimuli
responsible for the maintenance of muscle mass. At an adult population level, a protein intake
of 0.8 g·kg−1 of bodyweight (BW) represents a recommended daily allowance (RDA) of protein
needed for preservation of muscle mass and strength [1–3]. However, given the reduced anabolic
response to protein ingestion that seems to occur in older adults, an increased protein allowance in
the range of 1.0–1.2 g·kg−1 BW has been proposed [4]. Indeed, accelerated decline in muscle mass
and strength occurs in old adults and is related to impaired physical function, disability, and reduced
quality of life [5]. Interestingly, inter-individual variability in the rate of muscle mass wasting and
functional decline suggests that lifestyle behaviors, including diet and physical activity, may be key
factors for the promotion of health ageing [6]. Therefore, the study of the influence of dietary protein
intake on muscle mass and physical function in older adults has received growing attention. It has
been shown that a higher protein intake can be associated with preservation of muscle mass [7,8].
For example, a lower protein intake at baseline was associated with a greater loss of lean mass over a
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3-year follow-up period in older adults [7]. In contrast, a higher body mass including both fat and lean
mass was reported in older women with a protein intake below 0.8 g·kg−1 BW [9]. Besides muscle
mass, whether protein intake may confer positive effects on functional capacity is important to clarify
given the age-related impairment in physical function. Interestingly, higher protein intake has been
associated with reduced risk of frailty in older women [10–13]. Beneficial effects of higher protein intake
on physical function, including handgrip strength [8,14,15], the short physical performance battery
(SPPB) scores [9], and self-reported physical function [8,15–17] have also been reported. However,
results from others do not support a significant impact of total protein intake on muscle strength,
SPPB scores, and walking speed [18–21]. These conflicting results may be explained by several factors
obscuring the link between dietary protein intake, muscle mass, and physical function. For example,
different methods to assess dietary protein intake, including the use of RDA thresholds for classification
of high and low intakes, will affect study outcomes. Likewise, which dimension of the physical
function and whether objective or self-report assessment methods are used are other relevant factors.
In addition, variations in health status among the elderly population must be taken into consideration
when evaluating the impact of protein intake on muscle mass and physical function. Differences in
study samples regarding the prevalence of diseases and physical impairment likely limit comparability
between studies. Noteworthy, as physical function is partly determined by body composition,
variations in muscle mass must be considered in order to determine the true impact of protein
intake on measures of physical function. Furthermore, physical activity (PA) is a lifestyle behavior with
the potential to have a substantial impact on physical function. Indeed, PA has been recognized as an
important anabolic stimulus for the regulation of muscle mass [22]. Therefore, when investigating links
between protein intake, body composition, and physical function, the influence of PA level should be
taken into consideration. However, most previous studies rely on self-reported PA, which is prone
to recall bias and less accurate than objective methods [23]. Alongside total weekly amount of PA,
accounting for strengthening activities according to PA guidelines for healthy ageing could further
clarify the true impact of protein on physical function.
Therefore, the aim of the present study was to elucidate links between dietary protein intake,
muscle mass, and objective and self-reported measures of physical function in older community-
dwelling women meeting current guidelines of objectively assessed PA.
2. Materials and Methods
2.1. Subjects
One hundred and twenty-two women aged between 65 and 70 years old were recruited through
local advertisement and were subsequently screened for inclusion in the study. To be included in the
study, participants had to meet the current guidelines of 150 min per week of moderate-to-vigorous
physical activity and be free of diagnosed coronary heart disease, diabetes mellitus, have no
disability with respect to mobility, and be non-smokers. A total of 106 women fulfilled inclusion
criteria. All procedures were conducted according to standards set by the Declaration of Helsinki.
Written informed consent was obtained from all participants and the study was approved by the
regional ethics committee of Uppsala (2011/033).
2.2. Anthropometry and Body Composition
Body weight (kg) and height (cm) were measured using a digital scale and a portable stadiometer
to the nearest 0.1 kg and 0.5 cm, respectively. Subjects having a body mass index (BMI) ≥ 25 kg·m−2
were classified as overweight. Skeletal muscle mass index (SMI) was assessed using bioelectrical
impedance analysis (BIA) and derived using the equation by Janssen et al. [24].
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2.3. Assessment of Physical Function
A standardized submaximal exercise on a cycle ergometer (model 874 E; Monark, Varberg, Sweden)
was performed during 6 min at a constant workload to assess aerobic fitness [25]. Maximal isometric
quadriceps strength was measured using a force sensor (K. TOYO 333A, Toyo-Korea, Seoul, Korea)
as previously described [26]. Self-reported physical function limitation was assessed by the 12-item
Short Form Health Survey (SF-12) [27]. Participants answered two questions related to the ability to
accomplish various daily activities questions on a three-item response scale (limited a lot; limited a
little; not limited at all). Participants who reported “limited a little” or “limited a lot” on at least one
of the two questions were classified as having a physical limitation, and all other participants were
subsequently classified as not having any physical limitation.
2.4. Assessment of Adherence to Physical Activity Guidelines
Accelerometer-based assessment of PA during a week was performed using the Actigraph
GT3x activity monitor (Actigraph, Pensacola, FL, USA) as previously described [28]. A cut-point
of >1324 counts per minute, specifically developed for women over 60 years of age [29], was used to
define time spent in moderate-to-vigorous PA (MVPA). Engagement in strengthening activities during
the past 12 months was assessed using the EPAQ2 questionnaire [30]. From a list of strengthening
activities, such as resistance exercise, participants reported the frequency and average time spent per
session. Subsequently, we classified participants in two groups based on whether they engaged in
strengthening activities at least twice a week or not.
2.5. Dietary Protein Intake
Dietary intake was monitored using a food record over a period of 6 days. Participants were
instructed by a nutritionist on how to register their daily food intake with the assistance of a portion size
guide developed by the Swedish National Food Agency. Total energy intake and relative macronutrient
intakes (E%) were derived using Dietist XP software (Kost och Näringsdata, Bromma, Sweden).
Daily protein intake was normalized to bodyweight and expressed as g.kg-1 bodyweight. In accordance
with guidelines for protein intake (0.8 g·kg−1 BW or 1.1 g·kg−1 BW) [1–4], participants were classified
into higher or lower protein intakes.
2.6. Statistics
Data are presented as mean ± standard deviation. All variables were checked for normality and
transformed when necessary. Between-group differences in continuous variables were first assessed
by using independent samples t-test. Since variations in body composition were related to physical
function, adjustment for SMI was performed using analysis of covariance. Binary logistic regression
was used to examine the likelihood of having physical limitations in the two protein intake groups
based on different RDA thresholds. The model was further adjusted for SMI. A priori statistical power
calculations showed that moderate effect sizes were detectable with a power of ≥80% when based on
our sample size. Statistical significance was set at p < 0.05 and all procedures were performed using
SPSS software version 24 (IBM Corporation, New York, NY, USA).
3. Results
3.1. Characteristics of the Study Population
The mean age, weight, and BMI of the study sample was 67.5 ± 1.8 years, 67.9 ± 11.6 kg,
and 25.1 ± 4.0 kg·m−2, respectively. The average time spent in MVPA was 67 ± 25 min·day−1.
Aerobic fitness and isometric quadriceps strength averaged 28.7 ± 7.2 mL O2·min−1·kg−1 BW and
2.7 ± 0.7 N·kg−1 BW, respectively. A total of 31.4% reported physical limitations. Compared to women
without physical limitations, those reporting limitations had a higher BMI (24.2 ± 3.7 vs. 27.1 ± 3.9;
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p < 0.05), lower SMI (31.4 ± 4.1 vs. 29.2 ± 3.1; p < 0.05), lower aerobic fitness (30.1 ± 7.4 vs. 25.2 ± 6.1;
p < 0.05), and lower isometric quadriceps strength (2.8 ± 0.7 vs. 2.5 ± 0.6; p < 0.05). A total of 34%
of women reported engagement in strengthening activities at least twice a week and there were no
significant differences in body composition variables nor physical function measures between those
involved and not involved in this type of activities.
The average energy intake of the study population was 1705 ± 380 kcal·day−1, with 46% ± 6%,
34% ± 5%, and 17% ± 2% of the energy derived from carbohydrates, fat, and protein, respectively.
There were no significant differences in energy distribution of macronutrients (E%) between groups of
protein intakes regardless of whether based on the lower (0.8 g·kg−1 BW) or the higher (1.1 g·kg−1 BW)
protein intake guideline. There were no significant differences in total energy intake or energy
distribution of macronutrients (E%) between physically limited and not limited older women.
3.2. Influence of Protein Intake on Muscle Mass and Physical Function
The average daily protein intake of the entire sample was 1.03 ± 0.26 g·kg−1 BW.
When categorizing participants in high and low protein intake based on the lower RDA threshold
of 0.8 g·kg−1 BW, women in the low protein intake group had a higher BMI and a lower SMI (Table 1)
regardless of total energy intake. Similar differences in body composition variables were observed
between protein groups based on the higher RDA threshold (1.1 g·kg−1 BW). In addition, SMI was
significantly lower in those with an intake of <0.8 g·kg−1 BW compared to those having an intake
of ≥1.1 g·kg−1 BW (28.5 ± 3.3 vs. 32.4 ± 3.9, p < 0.05).
Table 1. Participant characteristics by groups of protein intake.
Protein Intake c
<0.8 ≥0.8 <1.1 ≥1.1
N 22 84 67 39
Protein intake, g·day−1 54.0 ± 9.6 72.4 ± 13.6 * 61.9 ± 10.8 80.2 ± 13.7 *
Relative protein intake, g·kg−1 BW·day−1 0.71 ± 0.09 1.12 ± 0.23 * 0.87 ± 0.14 1.31 ± 0.18 *
Total energy intake, Kcal·day−1 1304 ± 306 1810 ± 324 * 1551 ± 316 1968 ± 336 *
Carbohydrate, % of energy 45.4 ± 6.4 46.2 ± 6.2 46.6 ± 6.1 45.2 ± 6.3
Fat, % of energy 34.0 ± 5.2 34.5 ± 5.3 33.8 ± 5.1 35.3 ± 5.3
Protein, % of energy 17.3 ± 3.5 16.4 ± 2.0 16.5 ± 2.5 16.7 ± 2.1
Body composition
Weight, kg 76.1 ± 12.6 65.7 ± 10.3 * 71.7 ± 11.5 61.4 ± 8.4 *
Height, cm 164 ± 5 164 ± 6 165 ± 5 164 ± 6
BMI, kg·m−2 28.1 ± 4.2 24.3 ± 3.6 * 26.4 ± 4.0 22.9 ± 3.1 *
SMI, % BW 28.5 ± 3.3 31.4 ± 3.9 * 29.9 ± 3.8 32.4 ± 3.9 *
Objective Physical Performance
VO2 max, mlO2·kg−1 BW·min−1 a 27.5 ± 7.9 29.0 ± 7.1 28.0 ± 6.7 29.8 ± 7.9
Isometric Quadriceps Strength, N·kg−1 BW 2.5 ± 0.7 2.8 ± 0.7 2.6 ± 0.7 3.0 ± 0.7 *
Self-Reported Physical Limitation, % yes b 55.0 25.6 * 42.9 12.8 *
BW, Body Weight; BMI, Body Mass Index; SMI, Skeletal Muscle Index. a Based on n = 94. b Based on n = 102.
c g·kg−1 of BW per day. Data expressed as mean ± standard deviation, unless indicated. * p < 0.05.
When comparing objective measures of physical function between protein intake groups,
the significant difference in isometric quadriceps strength observed when based on the 1.1 g·kg−1 BW
threshold (Table 1) became attenuated (p = 0.081) after SMI adjustment. No corresponding differences
were observed when based on the lower protein intake threshold (0.8 g·kg−1 BW).
When based on the lower RDA threshold (0.8 g·kg−1 BW), women in the low protein intake group
had a higher likelihood of having physical limitations. However, adjustment for SMI attenuated the
observed effect (Table 2). Interestingly, when further comparing those below 0.8 g·kg−1 BW to those
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with an intake of ≥1.1 g·kg−1 BW exclusively, a significantly higher likelihood of having physical
limitations was found in the former group (Odds ratio: 5.48, 95% Confidence interval: 1.34–22.43) even
after SMI adjustment. When based on the protein intake threshold of 1.1 g·kg−1 BW, those with lower
intakes showed a higher likelihood of having physical limitations compared to those meeting this
threshold even after SMI adjustment (Table 2).
Finally, we reanalyzed all data adjusted for overweight status (BMI ≥ 25 kg·m−2) instead of SMI,
which left the results unchanged.
Table 2. Odds ratios (OR, 95% CI) of having a physical limitation for women below the RDA thresholds
with those above set as reference.
Model 1 Model 2
OR 95% CI p OR 95% CI p
Protein intake
<0.8 g·kg−1 BW 3.55 (1.29–9.76) 0.014 2.56 (0.88–7.42) 0.083
<1.1 g·kg−1 BW 5.10 (1.76–14.77) 0.003 3.94 (1.31–11.83) 0.015
CI, Coefficient Interval; BW, Body Weight; RDA, Recommended Dietary Allowance. Model 1: unadjusted. Model 2:
adjusted for SMI.
4. Discussion
This study highlights the detrimental effects of not meeting the lowest RDA guideline of protein
intake on both muscle mass and physical function in elderly women. Importantly, while beneficial
effects on muscle mass are obtained by meeting the lower RDA level, meeting the higher RDA intake
seems necessary to infer an additional impact on physical function. As all women were physically
active, our findings support the role of protein intake for healthy ageing even in older adults meeting
guidelines for PA.
Estimation of the daily protein intake necessary to infer beneficial effects on body composition and
physical function in the ageing population is a debated question, since the RDA threshold for proteins
of 0.8 g·kg−1 BW is based on the single endpoint of nitrogen balance [31]. Our findings support the
assumption that meeting the RDA intake of 0.8 g·kg−1 BW per day is a key factor to prevent the decline
in muscle mass in older adults. This is in line with recent data suggesting that reaching this threshold
was associated with higher percentage of fat free mass among older men and women [32]. Additionally,
a 6-month randomized controlled trial in functionally limited older men indicated that adherence to the
RDA of 0.8 g·kg−1 BW for protein was sufficient to maintain lean body mass, whereas an intake above
1.3 g·kg−1 BW did not infer additional effects on muscle mass or enhance the testosterone-induced
anabolic response [33]. While an RDA of 0.8 g·kg−1 BW seems to be a protein amount sufficient to
prevent sarcopenic loss of muscle mass, our findings indicate that this threshold is insufficient to
preserve physical function. Indeed, not meeting an intake of 1.1 g·kg−1 BW was associated with a
higher likelihood of having physical limitations and lower muscle strength. Conflicting results exist
regarding the role and amount of dietary proteins in the maintenance of physical function in older
adults. For instance, while ten Haaf et al. failed to demonstrate a relationship between total protein
intake, SPPB scores, and handgrip strength in a sample of older community dwelling adults [20],
Gregorio et al. reported a significant impact of higher protein intakes on SPPB but not on the physical
component of the quality of life questionnaire or handgrip strength [9]. In contrast, lower decreases
in handgrip strength were reported in older men and women with higher protein intakes during a
6-year follow-up [14]. In our study, physical function was assessed using both objective measures
and self-reported constructs, and women reporting physical limitations had poorer aerobic fitness
and strength. Meeting the RDA for proteins was not related to aerobic fitness in our sample of older
women, which underlines that protein intake may not be a main factor determining cardiovascular
health. Together with data from previous studies, it is suggested that associations between protein
intake and physical function are partly dependent on the selected aspect of physical capability.
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It is important to note that variations in muscle mass are likely to exert a considerable influence on
physical function [34] and it may thus confound the link between protein intake and function. Indeed,
associations between protein intake and physical function have been shown to become attenuated
following adjustment for body composition [35]. In our study, the association between leg strength
and protein intake was attenuated after accounting for variations in muscle mass, which indicates
that protein intake may indirectly influence muscle strength through its impact on muscle mass.
Importantly, by considering a construct covering a broad range of physical capabilities rather than a
single aspect of physical function, our data show that those meeting the higher RDA threshold were
less likely to have physical limitations compared to the lower intake group regardless of variation in
body composition.
A novel approach used in this study was to exclusively include older women meeting current PA
guidelines for good health in order to attenuate the well documented effects of PA on muscle mass and
physical function. To further consider the potential influence of PA, we additionally assessed regular
engagement in strengthening activities. Based on this approach, our findings support the assumption
that protein intake plays an important role in the maintenance of muscle mass and preservation of
physical function even in older individuals adhering to health-related PA behaviors.
Although the dietary record method is a widely accepted standard method for assessing energy
intakes, under-reporting is likely to have occurred, which may underestimate true means of total energy
intake. Notably, average levels of total energy intake and macronutrient distribution presented in our
study were within the range of reference data reported for corresponding age and gender groups [36].
Furthermore, because our sample exclusively comprised apparently healthy and physically active
women, our conclusions do not cover groups with more sedentary lifestyles or with overt disease.
Of note, skeletal muscle mass was assessed using bioelectrical impedance analysis. In this respect,
despite the higher accuracy of other body composition methods including computed tomography
or magnetic resonance imaging, bioelectrical impedance analysis is widely used in the diagnosis
of sarcopenia. When performed under standardized conditions and using age-specific cross-validated
equations, bioelectrical impedance analysis is currently considered to be an accurate measurement
of functioning muscle mass in clinical settings and epidemiological studies. Another aspect worth
highlighting is that previous studies either did not consider the role of PA or typically relied on crude
measures of self-reported PA. In our study, PA levels were objectively assessed and information on
specific types of activities relevant for the study outcomes was additionally collected by self-report.
Finally, the cross-sectional design of the study prevents us from making inference on causality.
Therefore, study outcomes suggesting causal relationships should be interpreted with caution and
experimental settings are warranted to determine the true nature of such relationships.
In conclusion, the present study supports the RDA of 0.8 g·kg−1 BW of proteins to prevent the loss
of muscle mass and physical function in the elderly. Our findings also emphasize that a higher intake
of at least 1.1 g·kg−1 BW is required to infer additional benefits on constructs of physical function
preventing the occurrence of physical limitations in the elderly. Finally, our findings were evident in
women who met guidelines for PA, supporting the role of dietary habits in general and protein intake
in particular in the promotion of healthy ageing.
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Abstract: (1) Background: The present work aims to conduct a systematic review and meta-analysis
of observational studies, in order to investigate the association of relative protein intake and physical
function in older adults; (2) Methods: Observational studies, that investigated the association between
protein intake and physical function in older adults, were retrieved from MEDLINE, SCOPUS,
CINAHL, AgeLine, EMBASE, and Cochrane-CENTRAL. Two independent researchers conducted
study selection and data extraction; (3) Results: Very high protein intake (≥1.2 g/kg/day) and
high protein intake (≥1.0 g/kg/day) groups showed better lower limb physical functioning and
walking speed (WS) performance, respectively, in comparison to individuals who present relative low
protein (<0.80 g/kg/day) intake. On the other hand, relative high protein intake does not seem to
propitiate a better performance on isometric handgrip (IHG) and chair rise in comparison to relative
low protein intake. In addition, there were no significant differences in the physical functioning of
high and middle protein intake groups; (4) Conclusions: In conclusion, findings of the present study
indicate that a very high (≥1.2 g/kg/day) and high protein intake (≥1.0 g/kg/day) are associated
with better lower-limb physical performance, when compared to low protein (<0.80 g/kg/day)
intake, in community-dwelling older adults. These findings act as additional evidence regarding
the potential need to increase protein guidelines to above the current recommendations. However,
large randomized clinical trials are needed to confirm the addictive effects of high-protein diets
(≥1.0 g/kg/day) in comparison to the current recommendations on physical functioning. All data
are available in the Open ScienceFramework.
Keywords: sarcopenia; protein intake; physical function
1. Introduction
Sarcopenia is a geriatric condition characterized by progressive muscle atrophy accompanied
by loss of muscle strength and/or function [1]. The incidence of sarcopenia rises with aging and
its prevalence is markedly increased in older subjects [2]. In the absence of targeted interventions,
the clinical course of sarcopenia is marked by higher odds of mobility disability, loss of independence,
and mortality [3–6]. In this sense, adequate protein intake and physical exercise have been suggested
as the two main strategies to counteract sarcopenia, and prevent its deleterious effects [7,8].
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Although protein supplementation may be advisable in the management of sarcopenia,
the optimal protein requirement for older adults is presently unclear. Indeed, the established guidelines
recommended for a number of agencies, such as the Dietary Allowance (RDA), RDI (recommended
daily intake) [9], and the RNI (reference nutrient intake) [10] have been questioned, and researchers
have discussed if the recommended protein intake is enough to maintain the functional status or even
prevent its decline and muscle atrophy in older adults [11,12]. Most critical are regarding the RDA,
so that the main concern is that the amount of protein recommended is based on nitrogen balance
studies, which may be associated with a methodological bias [11,13].
Opinion articles and consensus statements have argued that older people should be encouraged to
consume greater quantities of protein than the RDA (1.0–1.5 g/kg) [11–14]. Findings from observational
studies are in line with these inferences, since higher protein consumption is associated with lower
risk of frailty, loss of lean body mass, slow walking speed, dynapenia, and poor balance [15–18].
Nevertheless, there is a lack of direct evidence testing the proposed cut-off points for protein
consumption. The few available studies have reported incongruent results regarding the association of
protein intake and physical function [17,19–21]. However, to the best of our knowledge, meta-analyses
have not been performed to determine the pool of results.
Therefore, the present work aimed at conducting a systematic review and meta-analysis of
observational studies to investigate the association of relative protein intake and physical function in
older adults.
2. Materials and Methods
We conducted a systematic review and meta-analysis of observational studies to assess the
association between relative protein intake and physical function in older adults. The study was
fully performed by investigators and no librarians were part of the team. This study complies with
the criteria proposed by the Primary Reporting Items for Systematic Reviews and Meta-analyses
(PRISMA) Statement [22], and the Meta-analysis of Observational Studies in Epidemiology (MOOSE)
guidelines [23]. All data are available in the Open Science Framework at https://doi.org/10.17605/
OSF.IO/JP5SB.
2.1. Eligibility Criteria
The inclusion criteria consisted of: (a) Observational studies, including cross-sectional and
case-control studies, which investigated as primary or secondary outcome the association of relative
protein intake and physical function in older adults. Longitudinal cohort studies were also included
if crude baseline data were available; (b) participant age of 60 years or older; (c) direct assessment
of at least one physical function domain (studies provided self-reported physical function were
excluded); (d) provided the comparison of at least two groups with different relative protein intakes;
(e) mean values and a measure of dispersion (standard deviation or confidence interval) were
provided; (f) published studies (English language). We excluded randomized-clinical trials (RCTs),
quasi-experimental, cross-over studies and any kind of investigation that examined the effects of a
nutritional intervention associated or not with other interventions (e.g., physical exercise) on physical
function. Studies that enrolled institutionalized participants or non-institutionalized participants with
cognitive impairment and/or disorder, gastrointestinal and/or renal diseases, anorexia, cancer or
any kind of condition that may directly impair protein metabolism (e.g., maple syrup urine disease,
tyrosinemia) were also excluded. Sarcopenic and frailty older people were included.
2.2. Search Strategy and Selection Criteria
Studies published on or before August 2018 were retrieved from the following three electronic
databases by one investigator (H.J.C.J): (1) MEDLINE (PubMed interface); (2) the Cochrane Library
(Wiley interface); (3) SCOPUS (Elsevier interface); (4) CINAHL (EBSCO interface); (5) AgeLine (EBSCO
interface); and (6) EMBASE (EBSCO interface). Reference lists for reviews and retrieved articles for
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additional studies were checked and citation searches on key articles were performed in Google
Scholar and ResearchGate for additional reports. Initially, a search strategy was designed using
keywords, MeSH terms, and free text words, such as protein consumption, physical function, older adults.
Additionally, keywords and subject headings were exhaustively combined using Boolean operators.
The complete search strategy used for the PubMed is shown in List S1. Only eligible full texts in
English language were considered for review. Authors were contacted if necessary.
2.3. Data Extraction and Quality Assessment
Titles and abstracts of retrieved articles were screened for eligibility by two researchers (H.J.C.-J.
and B.R.). If an abstract did not provide enough information for evaluation, the full-text was retrieved.
Disagreements were solved by a third reviewer (M.U.). Reviewers were not blinded to authors,
institutions, or manuscript journals. Studies that provided data for more than two groups—for example,
low, middle, high, and very high relative protein intake were also added—since the volunteers were not
shared among the groups. Data extraction were independently performed by two reviewers (H.J.C.-J.
and L.M.-T) using a standardized coding form. Disagreements were solved by a third reviewer (M.U.).
Coded variables included methodological quality and the characteristics of the studies, including:
Year, authors, country, study design, setting, sample size (n), age, prevalence of female, body mass
index (BMI), lean mass, appendicular muscle mass, dietary intake assessment method, total protein
intake, relative protein intake.
Afterwards, studies were allocated into four different groups (low (<0.8 g/kg/day), middle
(0.8–0.99 g/kg/day), high (≥1.0 g/kg/day), and very high (≥1.2 g/kg/day) protein intake). These
cutoffs were selected according to previous research. Indeed, longitudinal [24,25] and review [11–14]
studies have arguing that older adults should consume at least 1.0 g/kg/day of protein (i.e., high) to
maintain muscle mass and optimal physical functioning, so that values below the RDA (<0.8 g/kg/day)
may be considered low, while values higher than the RDA, but lower than the recommended for these
aforementioned studies may be considered middle. In addition, some evidence has proposed that a
minimum of 1.2 g/kg/day of protein should be consumed by older adults in attempt to avoid poor
health-related outcomes and maintain functional performance, regardless the presence of chronic
diseases [26,27]. In this sense, investigations that showed a mean protein intake of at least 1.2 g/kg/day
were allocated in the very high group.
The quality of reporting for each study was performed by two researchers (H.J.C.-J. and
L.M.-T) using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
instrument [28]. The agreement rate between reviewers was κ = 0.96 for quality assessment.
2.4. Statistical Analysis
Meta-analyses were conducted using Revman V.5. Effect size (ES) were measured using standard
mean difference (SMD) and mean difference and are reported with 95% confidence intervals (95% CI).
SMD was used in the comparisons between High protein intake and Very high protein intake versus
Low protein intake in relation to Mobility and Lower limb physical functioning, respectively, since the
investigations assessed the same outcome, but using different tools. However, the mean difference
was used in the remaining comparisons, since all the other studies used the same outcome. If the
required outcome metric was not reported in the study, values were calculated using available data.
Due to the different characteristics of the included studies, a random-effect model was used to calculate
the pooled ES. Heterogeneity across studies was tested using Q-statistics and I2 index was used to
assess inconsistency [29]. The I2 index was classified as not important (0–40%), moderate (30–60%),
substantial (50–90%), and considerable (75–100%).
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3. Results
3.1. Characteristics and Quality of Included Studies
Table 1 provides a general description of the included studies. Of the 4392 registers recovered
from electronic databases and hand search, 4253 records were excluded based on duplicate data, title
or abstract. One hundred thirty-nine studies were fully reviewed and assessed for eligibility. Finally,
seven studies met the inclusion criteria (Figure 1).
Included studies were published between 2014 and 2018, the majority had a prospective
longitudinal cohort design [17,30–32], while two had a cross-sectional design [20,33] and one study was
a case-control [21]. Overall, a total of 8754 community-dwelling older adults from six different countries
were included. Volunteers were characterized as healthy in three studies [17,31,34], post-menopausal
in two studies [20,31], sarcopenic in one study [21], and diabetic in one study [32]. Mean age of the
subjects ranged from 67.8 to 83.0 years, and the percentage of women among total subject population
of various study groups varied from 10% to 100%. Mean BMI ranged from 23.7 kg/m2 to 29.5
kg/m2, so that one study investigated volunteers with normal BMI [34], while the other six studies
investigated overweight individuals [17,20,21,31–33]. Limited information was available regarding
the clinical characteristics of study participants. Nevertheless, osteoporosis, diabetes, hypertension,
depression, rheumatoid arthritis, and heart diseases were diagnosed among the included individuals.
Lean mass and appendicular skeletal muscle represented 55.8% and 24.4%, respectively, of the total
weight. Twenty-nine percent of the volunteers reported an episode of fall in the 12 months before the
investigations. Physical and functional evaluations included isometric handgrip strength (IHG), knee
extensor strength, one-leg stance, usual walking speed (WS), chair rise, tandem walk speed, narrow
walk speed, short physical performance battery (SPPB), and timed 8-foot walk. However, only IHG,
WS, knee extensor strength, SPPB, and chair rise were included in the final analysis, due to availability
of data. According to protein intake per kg of body weight, volunteers could be divided into four major
groups: Low (<0.8 g/kg/day), middle (0.8–0.99 g/kg/day), high (≥1.0 g/kg/day), and very high (≥1.2
g/kg/day). Methods to evaluate dietary intake included 24-h dietary recall (28.5%), 3-day dietary
intake record (28.5%), 4-day dietary intake record (14.3%), food frequency questionnaire (14.3%), and
the Semi Quantitative-Food Frequency Questionnaire (SQFFQ) (14.3%).
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Figure 1. Flowchart of the present study.
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Table 2 provides the general characteristics of the volunteers according to their relative protein
intake. All groups presented similar mean age (~73 years). The lowest sample size was observed in
the middle protein intake group, followed by the very high protein intake group, low protein intake
group and high protein intake group. The groups presented a similar mean lean mass and mean
appendicular mass. However, it is important to observe that High protein intake and Very high protein
intake groups showed a higher percentage of lean mass when compared to Low protein intake and
Middle protein intake groups. In addition, a greater performance in knee extensor strength and SPPB
was observed in High protein intake and Very high protein intake groups when compared to Low
protein intake group. Protein, carbohydrate and fat intake increased according to relative protein
intake. It should be stressed that these parameters were not reported by all the investigations.









Variables n = 2641 n = 395 n = 5619 n = 1145
Anthropometric characteristics
Age (years) 73.8 74.0 74.6 73.5
BMI (kg/m2) 29.1 26.7 27 27.1
Lean Mass (kg) (% in relation to
weight) 41.0 (53) 40.1 (56.1) 38.7 (58.7) 38.2 (58.1)
Appendicular Muscle Mass (kg)
(% in relation to weight) — 19.0 (25.5) 20.4 (24.7) 15.9 (24.2)
Physical functional tests
IHG (kg) 20.4 27.5 24.3 19.1
Knee Extensor Strength (lb) 54.5 44.5 52.1 57.5
One-Leg Stand (s) 13.5 19.3 18.4 15.3
Chair Rises (s) 11.4 10.6 11.8 13.5
Tandem Walk Speed for 6 m (m/s) 0.30 0.34 0.33 —
Usual Walking Speed (m/s) 1.1 1.2 1.2 1.07
SPPB (points) 9.9 9.0 11.0 10.6
Timed 8-Foot Walk (m/s) 1 — 1.1 1.1
Dietary factors
Protein (g/day) 58.8 67.4 85.4 87.2
Carbohydrate (g/day) 162.6 199.8 215.9 220.6
Fat (g/day) 43.6 58.6 64.4 —
BMI = body mass index; IHG = Isometric handgrip; SPPB = Short physical performance battery (i.e., combination
of results in gait speed, chair stand e balance tests; The final score ranged from 0 (worst performance) to 12 (best
performance). * Information was not available by all the included investigations.
Study quality results are shown in Table S1, while the point by point analysis is shown in Table
S2. The overall score ranged from 17 to 20. All studies reported the items required by the STROBE
criteria in relation to the abstract (items 1 and 2), clarity of the outcomes (items 7 and 15), methods
of assessment (item 8), handle of quantitative variables (item 11), statistical methods and analysis
(items 12, 16), discussion (items 18–21), and funding (item 22). However, 14.2% of the studies failed
to clearly state specific objectives, including any prespecified hypotheses (item 3), the main aim of
the investigation (item 4), describe the setting, locations and relevant dates of recruitment and data
collection (item 5) [25], give the characteristics of study participants (item 14); and report other analyses
done—e.g., analyses of subgroups and interactions, and sensitivity analyses (item 17). In turn, 28.5%
did not properly report the eligibility criteria, and the sources and methods of selection of participants
(item 6), 71.4% did not describe any efforts to address potential sources of bias (item 9), 57.1% explained
how the study size was arrived at (item 10) and reported numbers of individuals at each stage of study
(item 13).
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3.2. High Protein Intake verses Low Protein Intake
A total of four studies provided information to investigate the association of high and low
protein intake with physical function (Figure 2). It should be stressed, that Rahi et al. [32] provided
their data according to gender, and the results are presented accordingly. Upper-limb muscle
strength—Upper-limb muscle strength was measured by IHG in all studies. Three studies were
added in the meta-analysis [17,20,31]. Results did not demonstrate significant differences in IHG
between the groups, and a small non-significant ES was observed (ES = −0.36; 95% CI = −1.15 to
0.44, p = 0.38). Moderate heterogeneity was found across studies (χ2 = 4.16, df = 2, p= 0.12, I2= 52%)
(Figure 2a). Lower-limb muscle strength—Lower-limb muscle strength was evaluated by chair-rise and
knee extensor strength. A meta-analysis of three studies—but evaluating four subgroups—observed a
small non-significant difference between groups (ES = −0.09; 95% CI = −0.26 to 0.08, p = 0.30). A not
important heterogeneity was found across studies (χ2 = 3.75, df = 3, p = 0.29, I2 = 20%) (Figure 2b).
Figure 2. Mean difference in (a) Upper-limb muscle strength and Standardized mean difference in (b)
Lower-limb muscle strength according to protein intake. Squares represent study-specific estimates;
diamonds represent pooled estimates of random-effects meta-analyses.
3.3. Mobility
Mobility was evaluated by 10-m WS [17] and 6-m WS [34]. In the study of Chan et al. [34], three
out of four groups showed a high protein intake (≥1.0 g/kg/day). In this sense, groups will be
mentioned as Chan et al., 2014, 2014b, and 2014c, according to relative protein intake. In addition,
the groups were evaluated alone and grouped. A small ES were observed when the analysis was
performed with Chan et al. [34] (1.0 g/kg/day) and Isanejad et al. [17] (ES = 0.10; 95% CI= −0.06
to 0.27, p = 0.23, χ2 = 20.66, df = 1, p < 0.00001, I2 = 95%) (Figure 3a), as well as with Chan et al.
(2014b) (1.4 g/kg/day) and Isanejad et al. [15] (ES = 0.11; 95% CI = −0.05 to 0.26, p = 0.18, χ2 = 18.41,
df = 1, p < 0.00001, I2 = 95%) (Figure 3b). The combination of the groups—Chan et al. (2014 and
2014b)—changed the results, so that a small and significant ES was observed (ES = 0.07; 95% CI = 0.01
to 0.12, p = 0.02, χ2 = 20.84, df = 2, p < 0.00001, I2 = 90%) (Figure 3c). Significant results were also
observed when Chan et al. (2014c) was evaluated alone (ES = 0.13; 95% CI = 0.01 to 0.24, p = 0.04,
χ2 = 10.29, df = 1, p = 0.01, I2 = 90%) (Figure 3d) and with the other groups (ES = 0.06; 95% CI = 0.02 to
0.11, p = 0.003, χ2 = 27.52, df = 3, p < 0.00001, I2 = 89%) (Figure 3e).
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Figure 3. Mean differences in Mobility according to protein intake. (a) Chan et al., 2014, and Isanejad
et al., 2016; (b) Chan et al., 2014b, and Isanejad et al., 2016; (c) Chan et al., 2014ab, and Isanejad
et al., 2016; (d) Chan et al., 2014c, and Isanejad et al., 2016; (e) Chan et al., 2014abc, and Isanejad
et al., 2016. Squares represent study-specific estimates; diamonds represent pooled estimates of
random-effects meta-analyses.
3.4. Middle Protein Intake verses High Protein Intake
A total of four studies provided information to investigate the association of high and middle
protein intake with physical function (Figure 4). Upper-limb muscle strength—Upper-limb muscle
strength was measured by IHG in all studies. Three studies were added in the meta-analysis [17,21,33].
Results did not demonstrate significant differences in IHG between groups, and a large non-significant
ES was observed (ES = 1.09; 95% CI = −3.78 to 5.96, p = 0.66). A considerable heterogeneity was found
across studies (χ2 = 25.07, df = 2, p = < 0.00001, I2 = 92%) (Figure 4a). Mobility—Mobility was evaluated
in three studies. Pooling of results indicated a small and non-significant ES (ES = 0.17; 95% CI= −0.12
to 0.46, p = 0.26). A considerable heterogeneity was found across studies (χ2 = 56.46, df = 2, p = <
0.0001, I2 = 96%) (Figure 4b). Lower-limb muscle strength—Lower-limb muscle strength was evaluated by
chair-rise in all studies. A meta-analysis of two studies observe a moderate non-significant difference
between the groups (ES = 0.49; 95% CI= −0.01 to 0.99, p = 0.05). An insignificant heterogeneity was
found across studies (χ2 = 0.72, df = 1, p = 0.40, I2 = 0%) (Figure 4c).
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Figure 4. Mean difference in (a) Upper-limb muscle strength; (b) Mobility; and (c) Lower-limb muscle
strength according to protein intake. Squares represent study-specific estimates; diamonds represent
pooled estimates of random-effects meta-analyses.
3.5. Very High Protein Intake verses Low Protein Intake
A total of five investigations provided information to investigate the association of very high protein
intake and low protein intake with physical function (Figure 5). Due to the lack of available evidence, we
did not divide the evaluation according to the type of physical assessment, as was performed above,
and studies should assess at least one lower limb physical function to be included. The evaluations
included knee extensor strength [32], SPPB [20], and walking speed [34]. Pooling of results indicated a
small and significant ES (ES = 0.18; 95% CI = 0.01 to 0.35, p = 0.04). A considerable heterogeneity was
found across studies (χ2 = 15.56, df = 4, p = 0.004, I2 = 74%).
Figure 5. Standardized mean difference in Lower-limb muscle functioning according to protein
intake. Squares represent study-specific estimates; diamonds represent pooled estimates of
random-effects meta-analyses.
4. Discussion
The present study was designed to investigate the available evidence regarding the association of
relative protein intake and physical function in older adults. Findings of this investigation indicate
that individuals with relatively very high (≥1.2 g/kg/day) and high (≥1.0 g/kg/day) protein intakes
show higher mobility and lower limb physical functioning, respectively, in comparison to those with
relative low protein (<0.80 g/kg/day) intake.
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The assessment of study quality demonstrated that reports were of very good quality and scored
between 17 and 20. The main bias associated with the studies was the lack of adequate description
about the efforts to address potential sources of bias (item 9), the design of the study size (item 10),
and the report regarding the number of participants in all the phases of the study (item 13).
Although in recent years several study groups have strongly recommended that older adults
consume greater levels of protein intake than the RDA, there is a lack of direct evidence testing this
hypothesis [11,13]. Several observational studies have demonstrated incongruent results, so that it
is possible to observe null [19,33,34] and positive [17,20,21] associations between protein intake and
physical function in older adults.
To the best of our knowledge, this is the first study that directly compared the physical function
of older adults with different relative protein intakes. Our findings support at least partially the need
to increase protein guidelines to above the current RDA in older adults, since the very high and high
protein intake groups showed better muscular health when compared to the low protein intake group.
The plausibility behind these findings is based on the anabolic resistance hypothesis, according to
which the muscular anabolic response to appropriate stimulation would be blunted in advanced age (to
review, see Calvani et al. [14]; Landi et al. [35]). This idea is supported by the observation that the aging
muscle presents diminished muscle protein synthesis in response to small amount of essential amino
acids (EAAs) [36], the key nutrient for the stimulation of protein synthesis. This would eventually lead
to muscle catabolism, loss on lean body mass, dynapenia, and impairment on muscle function [35].
Higher availability of EAAs, mainly leucine, seems to be necessary to reverse overcome the anabolic
resistance of muscle [37]. Therefore, the greater physical performance observed in the groups with
higher protein intake levels (i.e., very high and high) might be ascribed to a larger EAAs availability.
Although our findings demonstrated that very high and high protein intakes were associated with
greater physical functioning in comparison to low protein intake, there were no differences between
high and middle protein intake groups. These results are interesting and deserve concern because the
middle group represented the level of protein intake recommended by the RDA.
The main motivation for considering changes from a minimum of 0.8 g/kg/day to 1.0 g/kg/day
has been the findings of longitudinal studies that demonstrated preserved muscle mass [24] and lower
risk of frailty [25] in older adults who had a protein intake ≥1.0 g/kg/day, as well as the evidence that
showed a significant reduction on muscle mass of older adults who consumed the current RDA of
protein for a long period [38]. However, no previous studies had directly comparing these proposed
protein cutoffs, and the lack of significant differences between high and middle groups may occur,
because the values of protein intake are similar, according to ten Haaf et al. [33].
Nonetheless, some researchers may argue that very high protein intake could be sufficient to
elicit significant differences, since the studies of Vellas et al. [26] and Mustafa et al. [27] demonstrated
that a very high protein intake was associated with a lower risk to poor health-related outcomes and
physical disability. However, there was no available evidence to compare very high and middle protein
intake groups. Taken together, these data suggest that a protein intake higher than 1.0 g/kg/day
causes beneficial effects when compared to protein intake levels lower than 0.8 g/kg/day, but more
studies are still necessary to precisely define the different effects of very high and high protein intakes in
comparison to middle protein intake.
Conversely, from a practical point of view, the consumption of high protein intake by older
adults has been the subject of intense scientific debate and a frequent concern of health professionals.
Nowadays, has been accepted that older adults without a previous history of kidney disease show
a lower risk of poor-health outcomes in response to high-protein diets [13,39]. However, although
higher glomerular filtration rate seems to be a normal mechanism in response to the elevated amount
of protein in the physiological system of patients with normal kidney function, an increased protein
intake may collaborate to decline in the renal function of patients with a pre-existing renal disease [39].
Therefore, findings of the present study should be carefully extrapolated for other populations than
healthy older adults.
116
Nutrients 2018, 10, 1330
On the other hand, data of the present study demonstrated that high protein intake was not
associated with better performance on the IHG and chair rise when compared to low protein intake
group. These findings support the inferences that a higher protein intake may be associated with better
scores on some, but not all physical tests [19].
One possible explanation for these results is that a greater intake of protein might promote
better functioning of systems other than the neuromuscular system. It should be stressed that the
performance on the IHG and chair-rise seems to be mainly dictated by the neuromuscular system. On
the other hand, walking ability needs a larger integration among the body systems in comparison with
sit and stand up or tightening an object. Indeed, walking is a complex activity involving a variety of
neural process (e.g., sensory, cortical cognitive, temporal) [40,41], cerebral and peripheral vascular
beds [42,43], as well as lung [44], cardiac and muscular functions [45], to list a few. Consequently,
walking ability represents the functioning of multiple organ systems instead of just one system [46],
and marked disturbances in gait pattern may occur in response to cardiovascular, neurological and
neuromuscular pathologies [40,41].
Regarding the relationship between protein intake and neural functioning, for example, evidence
has demonstrated that an insufficient protein intake may impair spatial learning and memory and cause
brain atrophy [47], while high protein intake decreases markers of oxidative stress (lipid peroxidation)
in the brain of rats [48], and is associated with low levels of insoluble amyloid-β protein (Aβ) in older
adults [49]. In addition, a systematic review showed that protein intake was positively associated with
cognitive function in older adults [50]. Furthermore, increased protein intake may cause changes in the
vessel wall structure and in cardiovascular control exerted by the central nervous system, consequently
mediating the negative association between protein intake and blood pressure [51,52].
Physical activity levels [33], vitamin intake [31], inflammation [15], mood disorders [53], and
the prevalence of chronic conditions (e.g., sarcopenia) [17] may also affect the relationship between
protein intake and physical function. In the study by Isanejad et al. [17], for example, higher protein
intake and physical function were significantly associated in non-sarcopenic, but not in sarcopenic
older women. These inferences are in keeping with the hypothesis that individuals suffering from
illness, physical stress, sarcopenia and/or frailty may require higher protein levels (1.2–1.5 g/kg)
than healthy older adults [11,12,14]. In the present investigation, a considerable heterogeneity (I2)
was observed in most of the studies. Although we tried to explore heterogeneity among the studies
performing the analysis with random effects, the investigations did not offer sufficient details about
the samples, as indicated in the quality assessment and food intake limiting the analysis of subgroups
and meta-regression (see Table 2). Therefore, our results should be taken with caution and should be
confirmed with further studies.
In this context, future studies aimed at investigating the association of protein intake and
physical function should collect a number of data allowing better inferences and an inclusion in
future systematic reviews and meta-analysis, including total and appendicular muscle mass, the
prevalence of morbidities, frailty and sarcopenia assessment, physical activity levels, and an extensive
report on food consumption (e.g., amino acid content, protein source) and not just the consumption of
macronutrients. Other limitations of the present study include the lack of comparison between low
and middle protein intake, as well as very high and middle protein intake (due to the lack of available
data), and the use of the mean protein intake to identify the groups.
In relation to the latter, we allocated the groups mentioned in the studies into low, middle, high,
and very high according to the mean protein intake reported. Nevertheless, it is possible that some
individuals showed higher or lower protein intake levels. One possible way to solve this problem
would be that future studies designed the groups based on proposed cut-offs for older adults [11,12,14],
instead of separatrix measures (e.g., quartiles), since a low quartile does not necessarily represent a
low protein intake.
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5. Conclusions
In conclusion, findings of the present study indicate that a very high (≥1.2 g/kg/day) and
high protein intake (≥1.0 g/kg/day) are associated with better lower-limb physical performance
when compared to low protein (<0.80 g/kg/day) intake in community-dwelling older adults. These
findings add evidence regarding the potential need to increase protein guidelines to above the current
recommendations. However, large randomized clinical trials are needed to confirm the addictive
effects of high-protein diets (≥1.0 g/kg/day) in comparison to the current recommendations on
physical functioning.
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Abstract: (1) Background: Several factors have been suggested to be associated with the
physiopathology of frailty in older adults, and nutrition (especially protein intake) has been attributed
fundamental importance in this context. The objective of this study was to conduct a systematic
review and meta-analysis to investigate the relationship between protein intake and frailty status
in older adults. (2) Methods: A search of scientific studies was conducted in the main databases
(Medline, Scopus, Cochrane library), and in the reference lists of selected articles. The search terms
included synonyms and Medical Subject Headings and involved the use of Boolean operators which
allowed the combination of words and search terms. Observational studies—cross-sectional and
longitudinal—that met the eligibility criteria were included in the review. Article selection and data
extraction were performed by two independent reviewers. Meta-analyses with random effects were
performed. Publication bias was measured using the Strengthening the Reporting of Observational
Studies in Epidemiology instrument. (3) Results: In the final sample, 10 articles, seven cross-sectional
and three longitudinal, were included in the present study. Overall, studies investigated a total
of 50,284 older adults from three different continents between 2006 and 2018. Four cross-sectional
studies were included in the meta-analyses. The results demonstrated that a high protein intake was
negatively associated with frailty status in older adults (odds ratio: 0.67, confidence interval = 0.56 to
0.82, p = 0.0001). (4) Conclusions: Our findings suggest that a high consumption of dietary protein is
inversely associated with frailty in older adults.
Keywords: frailty; protein intake; older adults
1. Introduction
The aging process is a continuous phenomenon characterized by alterations in major physiological
systems, accompanied by the development of chronic diseases and geriatric syndromes, such as frailty.
Frailty may be conceptualized as a multidimensional geriatric clinical state that involves multiple signs
and symptoms leading to extreme vulnerability to stressors and resulting in increased risk of negative
health-related outcomes (e.g., functional decline, disability, falls, hospitalization, institutionalization,
death) [1,2].
Nutrition is acknowledged as a major factor in the context of frailty. In fact, malnutrition is
considered one of the pillars for the development of this condition [3], since it can influence all
diagnostic criteria for frailty (i.e., unintentional weight loss, low muscle strength, exhaustion, reduced
physical activity levels, and slow walking speed) [4]. Three previous systematic reviews have been
Nutrients 2018, 10, 1334; doi:10.3390/nu10091334 www.mdpi.com/journal/nutrients122
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conducted on the association between nutrition and frailty. Authors observed that several factors
might be responsible for this close relationship between frail and nutrition, including oral health,
nutritional status, dietary patterns, diet quality, the antioxidant capacity of the diet, micronutrients
and macronutrients intake [3,5]. Nevertheless, protein intake might be the main factor behind this
relationship, through its actions on muscle mass and strength.
Indeed, human skeletal muscle protein turnover comprises the process of muscle protein synthesis
and muscle protein breakdown [6–8]. On one hand, muscle hypertrophy occurs when the rates
of protein synthesis exceed protein breakdown, which may be elicited by hyper amino acidemia
induced by dietary protein intake; on the other hand, an inadequate protein intake leads to lower
protein synthesis rate, resulting in net protein breakdown and muscle catabolism [6–8]. During aging,
numerous process collaborate to a reduced protein intake, such as lack of hunger, impaired oral
health, and loss of acuity in taste, smell and sight, to quote a few [9]; consequently, collaborating
to muscle catabolism [9]. In addition, evidence has demonstrated that the anabolic response to
hyper aminoacidemia may be blunted in older adults [10,11], which indicate that this population
should consume larger amounts of protein in comparison to young adults in an attempt to maintain
muscle protein synthesis. Nevertheless, over time, the lack of adequate protein intake leads to a
state called as sarcopenia [9,12,13], which is characterized by marked muscle atrophy, dynapenia,
and reduced physical function, all variables encompassed on frailty definition [14]. If there is no
immediate intervention to reduce sarcopenia and frailty progression, as well as improve protein intake,
the patients will develop a severe physical disability and consequently exhaustion and sedentary
behavior [1,15].
It should be stressed that other pathways besides sarcopenia may be also responsible for the
association between protein intake and frailty, since evidence has demonstrated that protein intake is
associated with dementia, global cognitive scores, visuospatial skill, nonverbal memory, and logical
memory in older adults [16–18]; all aspects linked with frailty [1].
However, investigations on the association between protein intake and frailty have shown positive,
negative and even null results. In addition, to the best of our knowledge, there is a lack of systematic
reviews and meta-analysis dedicated to investigating the relationship between protein intake and
frailty in older adults.
Therefore, the present study was conducted to perform a systematic review to identify and
compare studies reporting the relationship between frailty status and protein intake in older adults.
Additionally, data were combined to calculate the pooled overall relationship between frailty status
and protein intake.
2. Materials and Methods
We conducted a systematic review and meta-analysis of observational studies to investigate
and quantify the association between protein intake and frailty in older adults. The study was fully
performed by investigators and no librarian was part of the team. This study complies with the criteria
of the Primary Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Statement [19]
and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines [20].
2.1. Eligibility Criteria
The inclusion criteria of the present study consisted of: (a) observational studies, including
cross-sectional, case-control and longitudinal studies, which investigated as primary or secondary
outcome the association of protein intake and frailty in older adults; (b) study sample 60 years or older;
(c) frailty defined by a validated scale; (d) reported information on the proportion of frailty among
those with high and low levels of protein intake; (e) published studies (English language). To be
included in the meta-analysis, in addition to the aforementioned inclusion criteria, the investigations
had to provide: (f) at least two groups divided according to protein intake (e.g., high and low),
(g) the prevalence of frailty in each group, (h) and the total sample size in each group. We excluded
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randomized-clinical trials (RCTs), quasi-experimental, cross-over studies and any kind of investigation
which examined the effects of a nutritional intervention associated or not with other interventions
(e.g., physical exercise) on frailty. Studies that classified the volunteers as frail according to reduced
physical/or cognitive function were also excluded.
2.2. Search Strategy and Selection Criteria
Studies published on or before July 2018 were retrieved from the following three electronic
databases by one investigator: (1) PubMed, (2) the Cochrane Library, and (3) SCOPUS. Reference lists
for reviews and retrieved articles for additional studies were checked and citation searches on key
articles were performed on Google Scholar and ResearchGate for additional reports. Initially, a search
strategy was designed using keywords, MeSH terms, and free text words such as protein intake, frailty,
older adults. Additionally, keywords and subject headings were exhaustively combined using Boolean
operators. The complete search strategy used for the PubMed can be shown in List S1. Only eligible
full texts in English language were considered for review. Authors were contacted if necessary.
2.3. Data Extraction and Quality Assessment
Titles and abstracts of retrieved articles were screened for eligibility by two researchers. If an
abstract did not provide enough information for evaluation, the full-text was retrieved. Disagreements
were solved by a third reviewer. Reviewers were not blinded to authors, institutions, or manuscript
journals. Data extraction was independently performed by two reviews using a standardized coding
form. Disagreements were solved by a third reviewer. Coded variables included methodological
quality and the characteristics of the studies. The quality of reporting for each study was performed
by two researchers using the Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) instrument [21]. The agreement rate between reviewers was κ = 0.98 for quality assessment.
2.4. Statistical Analysis
The meta-analysis was conducted using Revman V.5. Effect sizes (ESs) were measured using odds
ratio (OR) and 95% confidence intervals (CIs). The OR indicates the risk for frailty according to protein
intake, high in relation to low. A significant OR is required to have a 95% confidence interval (CI 95%)
that did not include the value of 1 and a p value for the test of significance of the total overall effect (Z)
lower than 0.05. An inverse variance random-effect model was used to calculate the pooled ES since
the studies demonstrated different characteristics regarding the main aspects associated with frailty
(e.g., modified frailty criteria), protein intake (e.g., different cut-offs for high and low protein intake
definition), and covariates (e.g., energy intake). Funnel plots and Egger’s regression analysis were
used to evaluate the publication bias. Heterogeneity across studies was tested using the Q-statistics
and I2 index was used to assess inconsistency [22]. Additionally, I2 index was classified as might not
be important (0–40%), may represent moderate heterogeneity (30–60%), may represent substantial
heterogeneity (50–90%), and considerable heterogeneity (75–100%) [22]. Forest plots were used to
illustrate summary statistics and the variation (heterogeneity) across studies.
3. Results
3.1. Literature Search
Of the 2555 registers recovered from electronic databases and hand search, 2523 records were
excluded based on duplicate data, title or abstract. Thirty-two studies were fully reviewed and assessed
for eligibility. Finally, 10 studies met the inclusion criteria (Figure 1).
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Figure 1. Flow chart of the present study.
3.2. Characteristics of the Included Studies
Table 1 provides a general description of the included studies. Overall, a total of
18,120 community-dwelling older adults from five different countries (France, Germany, Italy, Japan,
and the United States of America) were investigated between 2006 and 2018 in the cross-sectional
studies. Frailty assessment was performed with two tools. The frailty phenotype proposed by
Fried et al. (2001) was used in six of the seven studies [23–28], while one study used the Kihon
checklist (KCL) [29]. However, it is important to mention that the frailty phenotype [14] was modified
in 5 of the 6 studies. Indeed, weight loss criterion was modified in the studies of Rahi et al. [28]
and Shikany et al. [27], while Bartali et al. [23] removed this variable. In turn, in the investigations
performed by Kobayashi et al. [24,25], slowness and weakness were indirectly measured based on a
questionnaire. Slowness assessment was also modified in the study of Rahi et al. [28]. Dietary intake
was primarily assessed by population-specific food-frequency questionnaires (FFQ) (57.1%) [23,26,27],
followed by self-administered diet history questionnaires (28.6%) [24,25], and the 24 h dietary recall
(14.3%) [28]. High and low protein intake was differently defined in the investigations. Measures of
centrality (e.g., tertiles, quartiles, quintiles) were used in 6 of the 7 studies [23–27], while Rahi et al. [28]
performed the analysis based on a pre-established cut-off (i.e., protein intake levels ≥ 1 g/kg of body
weight). Regarding longitudinal studies, 32,164 community-dwelling older adults were investigated
between 2010 and 2016. The studies were conducted in North America (United States of America) and
Europe (Spain). The mean duration of follow-up was 3.7 years (3.0–4.6 years). The frailty phenotype
was used in all studies for frailty assessment. However, as was observed in cross-sectional studies,
the frailty phenotype was modified in 2 of the 3 longitudinal studies. Shikany et al. [27] considered
the loss of appendicular lean mass as a measurement of weight loss. In turn, Beasley et al. [30] used
a modified version of frailty phenotype as they measured muscle weakness and slowness using the
Rand-36 Physical function scale. FFQ (66.6%) and computerized face-to-face diet history (33.3%) were
used for a dietary intake assessment. In longitudinal studies, all investigations used measures of
centrality (i.e., quartile and quintile) to determine the levels of protein intake.
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3.3. Quality Assessment
The overall score of the quality assessment of cross-sectional and longitudinal studies is shown
in Table 1 and the analysis of each variable is detailed in Tables S1 and S2, respectively. The point
by point analysis is shown in Table S3. The overall score of cross-sectional studies ranged from 19 to
22. All studies reported the items required by the STROBE criteria in relation to the abstract (items
1 and 2), objectives and hypothesis (items 3 and 4), described the settings, locations, relevant dates,
eligibility criteria and the source and methods of selection of participants (items 5 and 6), clarity of
the outcomes (items 7), methods of assessment (item 8), handle of the quantitative variables (item
11), give the characteristics of study participants (item 14), reported the number of outcome events
(item 15), statistical methods and analysis (items 12, 16, 17), and discussion (items 18–21).However,
57.1% of the studies failed to clearly report the efforts performed to address potential sources of bias
(item 9) [24,26–28], 42.9% did not properly explain how the study size arrived at (item 10) [26–28],
and 14.3% did not show the number of individuals at each stage of study (item 13) [26].
Similar results were seen in longitudinal studies, in which all investigations received a STROBE
score of 20. None of the studies adequately presented a description of how the study was arrived at
(item 10), while 66.6% failed to describe any efforts to address potential sources of bias (item 9) [27,31],
and 33.3% did not show the number of individuals at each stage of study (item 13) [30].
3.4. Association between Protein Intake and Frailty
3.4.1. Protein Intake and Frailty Prevalence (i.e., Cross-Sectional Studies)
A total of four studies provided information regarding different intakes of protein in at least two
groups, the prevalence of frailty in each group, and the total sample size in each group; therefore,
they were added in the meta-analysis (Figure 2). Two aspects should be mentioned before the
presentation of data. First of all, Nanri et al. [29] provided the data according to gender, and the
results are presented accordingly. In turn, the investigations performed by Kobayashi et al. [24,
25] used the same database (i.e., Three-generation Study of Women on Diets and Health), so that
the studies were not analyzed in combination. The overall meta-analysis results showed a 0.67
OR (Figure 2a) and a 0.66 OR (Figure 2b) for frailty (95% CI = 0.56 to 0.82, p = 0.0001; 95% CI =
0.54 to 0.80, p = 0.0001) in older adults with high protein intake compared with low protein intake
according to the inclusion of Kobayashi et al. [24] or Kobayashi et al. [25], respectively. When the
study of Kobayashi et al. [25] was not in the analysis, it was possible to observe an I2 lower than 40%
accompanied by a p = 0.18, indicating that this heterogeneity might not be important [22]. However,
when the study of Kobayashi et al. [24] was removed, the I2 increased to 49% and p value was of 0.12,
which can indicate a moderate heterogeneity [22].
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Figure 2. Odds ratio (OR) of the prevalence of frailty in older adults with high and low protein intake.
Squares represent study-specific estimates; diamonds represent pooled estimates of random-effects
meta-analyses. (a) The analysis was performed included Kobayashi et al. 2013; (b) The analysis was
performed included Kobayashi et al. 2017.
Figure 3 shows the funnel plots (a) and (b) based on the primary outcome according to
the inclusion of Kobayashi et al. [24] or Kobayashi et al. [25], respectively. The figures are
asymmetrical indicating that potential publication bias might influence the results of this review.
Egger’s linear regression test indicated possible publication bias for the association when the study of
Kobayashi et al. [24] was included (p = 0.02), but not Kobayashi et al. [25] (p = 0.09).
Figure 3. Funnel plots including (a) Kobayashi et al. 2013 and (b) Kobayashi et al. 2017 OR.
3.4.2. Protein Intake and Frailty Risk (i.e., Longitudinal Studies)
We found three studies that evaluated the longitudinal relationship between protein intake and
frailty risk. The findings demonstrate that two of the three studies observed that higher protein intake
was negatively associated with frailty risk.
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4. Discussion
Frailty is a multifactorial condition associated with poor prognosis. Low protein intake has been
proposed among the factors possibly involved in the pathogenesis of frailty. We, therefore, performed
a systematic review and meta-analysis to investigate the relationship between protein intake and frailty
in older adults. The main findings of the present study indicate that low protein intake is associated
with frailty prevalence in older adults.
Study quality assessment demonstrated that reports were of very good quality, such that
cross-sectional studies scored between 19 and 22 and all longitudinal studies scored 20. Interestingly,
cross-sectional and longitudinal studies did not provide the same items, including efforts to address
potential sources of bias (item 9), the design of the study size (item 10), and the report regarding the
number of participants in all the phases of the study (item 13).
Some recent systematic and descriptive reviews have investigated the relationship between
nutrition and frailty [3,4,32,33]. However, none of these studies was specifically designed to investigate
the role of protein intake in this phenomenon and the findings were not quantitatively assessed.
Thus, to the best of our knowledge, this is the first systematic review and meta-analysis designed to
investigate the relationship between protein intake and frailty in older adults.
The results of the present study may be at least partially explained by the theoretical overlap
between sarcopenia and physical frailty [34,35]. Indeed, physical frailty, as measured by the
Fried’s criteria [14,36], encompasses features as slowness, weakness, exhaustion, and sedentary
behavior, which are strongly associated with the sarcopenia condition [34,35]. Slowness
(i.e., slow walking speed) and weakness (i.e., low upper-limb muscle strength), for example, are
proposed as diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in
Older Persons (EWGSOP) [15], while exhaustion and sedentary behavior are common consequences of
sarcopenia progression [37]. Indeed, Landi et al. [35] suggested that sarcopenia may be envisioned as a
central mechanism for the development of physical frailty. In another word, physical frailty may be the
final pathway of sarcopenia progression [35]. This idea is further supported by the higher prevalence
of sarcopenia in pre-frail and frail older adults when compared to non-frail peers [38,39].
Sufficient protein consumption may cause a shifting on net balance in favor of muscle protein
synthesis [7,40]. Protein supplementation per se has been shown to prevent the progression of physical
decline in frail older adults [30,41]. In addition, protein intake has a key role in the physiological
adaptations elicited by the resistance training on the neuromuscular apparatus since a greater muscle
protein synthesis is expected when both non-pharmacological therapies are offered in combination [6,7].
Taken together, these findings suggest that sufficient protein intake may reverse or at least prevent
functional decline in frail older adults.
However, this kind of inference deserves caution since not all evidence has demonstrated the
positive effects of protein supplementation on the sarcopenia aspects associated with frailty, such
as muscle mass, muscle strength and physical function [42,43]. Finally, it should be noted that the
changes observed after protein supplementation may be different from those observed in response to
dietary protein intake.
It is worth mentioning, that our main findings are based on cross-sectional studies and
causal extrapolations should be performed carefully. Unfortunately, there were no available data
from longitudinal studies to perform a meta-analysis. Overall, findings are still controversial.
Shikany et al. [27] observed that protein intake was inversely associated with the risk of transitioning
from robust to pre-frail status in a range of 4.6 years, while there were no significant associations
between protein and frailty status. However, Sandoval-Insausti et al. [31] reported that total protein
and animal protein intake were inversely associated with frailty and its components (i.e., slowness)
over a mean follow-up of 3.5 years. Similarly, Beasley et al. [30] concluded that higher protein intake
was associated with reduced risk of frailty in community-dwelling older women.
Interestingly, the main variables investigated in the present study were differently defined across
the investigations. Regarding frailty, although this variable was assessed using the frailty phenotype
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in most investigations, adaptations of some of the criteria were observed in 5 of the 6 cross-sectional
studies, as well as in 2 of the 3 longitudinal studies. In fact, weight loss criterion was modified in
the trial of Rahi et al. [28], in which researchers included volunteers with self-reported unintentional
loss > 3 kg or as a body mass index < 21 kg/m2, while Shikany et al. [27] included subjects who
lost appendicular muscle mass. In turn, Bartali et al. [23] removed the weight loss criterion of their
investigation. Slowness and weakness were also modified. In this case, Kobayashi et al. [24,25],
Beasley et al. [30], and Rahi et al. [28] (only slowness) used self-reported questionnaires instead of
direct evaluations. It is also possible to observe that different cutoffs to define high a low protein intake
(i.e., tertiles, quartiles, quintiles and pre-established values) were used in the investigations.
These modifications have direct implications in the findings of the present study. Although
scales and questionnaires may offer more information in a shorter period when compared to
performance-based measurements, evidence has demonstrated the limited capacity of these tools
to reflect different measures of physical status [44,45]. This probably occurs because the results
of patient-reported questionnaires may be biased due to mood, motivation, fatigue, health status,
fluctuations in memory, and the specific knowledge and familiarity with the questionnaires and
scales [44,45]. In this sense, different results than those observed in the present study could occur
if the investigations were performance based on direct measures, as proposed by Fried et al. [14].
Furthermore, the use of different cut-offs to define protein intake levels leads to disagreements and
restrict the proposal of public health recommendations to older adults due to the range of approaches
used by the studies.
Taken together, these differences may also explain the heterogeneity of results observed among
the longitudinal studies. Nevertheless, different settings, eligibility criteria, gender, sarcopenia status,
dietary assessment methods, and follow-up periods of the various studies may also explain this
variability. In this sense, more well-controlled cross-sectional and longitudinal studies are still necessary
to improve the actual knowledge about frailty and protein intake in older adults, as well as to confirm
our findings.
We should state the absence of subgroup analyses as the major limitation of the present study.
Indeed, the use of crude OR limits interpretation of our meta-analysis, since the influence of important
covariates (e.g., age, type of protein [animal, vegetal], sarcopenia) were not taken into consideration
in the results, and we recommend that readers interpret our results carefully. The main aspect that
prevented us to perform the analysis was the lack of available data in the included studies. Regarding
dietary assessment, it is worth mentioning that total protein intake, which was used in all studies for
comparisons, is probably not the best parameter to represent adequate protein consumption, since
investigations in the context of physical function and sarcopenia have used relative protein intake
(g/kg/day) [46–48]. In addition, recent evidence has demonstrated that a spread distribution of protein
intake during the main meals is better associated with gait speed than relative protein intake [49].
Providing support to the importance of the distribution of protein intake, Loenneke et al. [50] observed
that a frequent consumption of meals containing at least 30 g of protein was associated with greater
lean mass and lower-limb muscle strength in middle-aged and older adults. The role of animal and
plant-based protein sources on variables associated with frailty has also been the object of discussion
among researchers [51,52]. Therefore, although future investigations are still necessary to confirm our
findings, the present study may serve as a guide for future studies in this field; so that investigation
should include more information regarding the factors that may interfere in the relationship between
protein intake and frailty, taking into account the variables that have been investigated by other studies.
In addition, funnel plots and Egger’s linear regression test indicated that biases from publications
and other factors may have had a significant influence on the results of our meta-analysis mainly
when the study of Kobayashi et al. [24] was included. Possible explanations for this publication bias
included the small number of studies investigated, multiple publication bias, and heterogeneity [22].
Finally, another aspect of the present study that deserves concerns is the use of STROBE instrument
as a tool to quality assessment. As discussed by da Costa et al. [53], STROBE was primarily developed
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to improve the reporting of observational studies. Thus, some may argue that another tool should
have been used in the present study. However, it should be stressed that there is no gold standard tool
to assess the risk of bias in non-randomized studies, as well as some of the STROBE questions may
represent an evaluation of risk of bias; consequently, making it a tool commonly used in systematic
reviews and meta-analysis [53].
In conclusion, our findings support the need for increased protein intake in older adults in an
attempt to avoid frailty development.
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Abstract: Physical frailty and sarcopenia (PF&S) are hallmarks of aging that share a common
pathogenic background. Perturbations in protein/amino acid metabolism may play a role in the
development of PF&S. In this initial report, 68 community-dwellers aged 70 years and older, 38 with
PF&S and 30 non-sarcopenic, non-frail controls (nonPF&S), were enrolled as part as the “BIOmarkers
associated with Sarcopenia and Physical frailty in EldeRly pErsons” (BIOSPHERE) study. A panel of
37 serum amino acids and derivatives was assayed by UPLC-MS. Partial Least Squares–Discriminant
Analysis (PLS-DA) was used to characterize the amino acid profile of PF&S. The optimal complexity
of the PLS-DA model was found to be three latent variables. The proportion of correct classification
was 76.6 ± 3.9% (75.1 ± 4.6% for enrollees with PF&S; 78.5 ± 6.0% for nonPF&S). Older adults
with PF&S were characterized by higher levels of asparagine, aspartic acid, citrulline, ethanolamine,
glutamic acid, sarcosine, and taurine. The profile of nonPF&S participants was defined by higher
concentrations of α-aminobutyric acid and methionine. Distinct profiles of circulating amino acids
and derivatives characterize older people with PF&S. The dissection of these patterns may provide
novel insights into the role played by protein/amino acid perturbations in the disabling cascade and
possible new targets for interventions.
Keywords: aging; muscle; protein; metabolism; metabolomics; profiling; biomarkers; multi-marker;
physical performance; multivariate
1. Introduction
Over the last decades, sarcopenia, the progressive and generalized decline in skeletal muscle
mass and function with age, has become a “blockbuster” condition in geriatrics, given its increasing
prevalence in a globally aging world and its clinical relevance [1–4]. Indeed, this condition conveys
a broad spectrum of negative health-related outcomes, including disability, loss of independence,
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institutionalization, and mortality [5,6]. Frailty has been defined as a geriatric “multidimensional
syndrome characterized by decreased reserve and diminished resistance to stressors,” and is often
envisioned as a pre-disability condition [7]. Sarcopenia overlaps with the clinical picture of frailty,
especially in its physical domain, and may represent both the biological substratum of physical frailty
(PF) and the pathophysiologic basis upon which the negative health outcomes of PF develop [8,9].
The two conditions have therefore been merged into a new entity (i.e., PF and sarcopenia; PF&S) [10]
that was operationalized in the context of the “Sarcopenia and Physical fRailty IN older people:
multi-componenT Treatment strategies” (SPRINTT) project [11,12].
Although the pathophysiology of PF&S is complex and multifactorial, the central role attributed
to muscle wasting suggests that biomarkers related to sarcopenia may be used to support the diagnosis
and track the evolution of PF&S, unveil its underlying mechanisms, and identify meaningful targets
for interventions [13,14].
Dietary protein intake and circulating amino acids play a pivotal role in muscle plasticity
and trophism [15], but also modulate several biological processes (including inflammation, insulin
sensitivity, and redox homeostasis) that may be involved in age-related muscle atrophy and
dysfunction [16,17]. Hence, perturbations in protein-amino acid metabolism may represent a major
mechanism in sarcopenia [18,19].
Amino acid profiling, especially when coupled with multivariate statistical analysis, may serve
as a powerful analytical approach to explore the possible role of protein-amino acid networks in
PF&S [20]. Recently, distinct amino acid signatures were associated with muscle mass in older
adults with functional limitations [21] and low muscle quality [22] in the Baltimore Longitudinal
Study of Aging. Moreover, reduced non-fasting plasma concentrations of the branched-chain amino
acids (BCAAs) leucine and isoleucine were detected in Norwegian older community-dwellers with
sarcopenia [23], while higher proline concentrations were independently associated with sarcopenia in
older Japanese people [24]. Finally, low plasma levels of essential amino acids (EAAs) characterized
the amino acid profile of severely frail Japanese older people compared with non-frail peers [25].
The “BIOmarkers associated with Sarcopenia and Physical frailty in EldeRly pErsons”
(BIOSPHERE) study was designed to determine and validate a panel of PF&S biomarkers
encompassing systemic inflammation, oxidative stress, muscle remodeling, neuromuscular junction
dysfunction, and amino acid metabolism through multivariate statistical modeling [26]. In the
present work, we report the initial results obtained through the simultaneous analysis of an array of
circulating amino acids and derivatives coupled with Partial Least Squares–Discriminant Analysis
(PLS-DA). This innovative approach allowed identifying distinct patterns of circulating amino acids
and derivatives that characterize older adults with and without PF&S. This may represent a first
relevant step towards the integration of specific biochemical measurements into the assessment of
PF&S in research and clinical settings.
2. Materials and Methods
2.1. Study Design and Population
BIOSPHERE was conceived as a cross-sectional, case-control study [26]. The study protocol
was approved by the Ethics Committee of the Università Cattolica del Sacro Cuore (Rome, Italy;
protocol number: 8498/15) and is thoroughly described elsewhere [26]. Briefly, after obtaining written
informed consent, 200 older persons, 100 cases (individuals with PF&S) and 100 non-physically frail,
non-sarcopenic (nonPF&S) controls aged 70+ were enrolled. Selection criteria are reported in Table S1.
Candidates were diagnosed with PF&S when presenting the following parameters: (a) low physical
performance, defined as a summary score on the Short Physical Performance Battery (SPPB) [27]
between 3 and 9; (b) low appendicular muscle mass (aLM) according to the criteria recommended by
the Foundation for the National Institutes of Health (FNIH) sarcopenia project [28]; and (c) absence of
major mobility disability, operationalized as an inability to walk 400 m in 15 min at a usual pace [29].
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This initial analysis involved 68 participants (38 cases and 30 controls) in whom circulating amino
acids and derivatives were measured.
2.2. Measurement of Appendicular Lean Mass by Dual X-Ray Absorptiometry (DXA)
Whole-body DXA scans were obtained on a Hologic Discovery A densitometer (Hologic, Inc.,
Bedford, MA, USA). Scan acquisition and analysis were performed according to manufacturer’s
directions. Candidates were considered to be eligible if presenting with an aLM to body mass index
(BMI) ratio (aLMBMI) <0.789 or <0.512 in men and women, respectively. When the aLMBMI criterion
was not met, candidates were tested with the alternative criterion (i.e., crude aLM < 19.75 kg in men
and <15.02 kg in women) [28].
2.3. Blood Sample Collection
Blood samples were collected in the morning by venipuncture of the median cubital vein after
overnight fasting, using commercial collection tubes (BD Vacutainer®; Becton, Dickinson and Co.,
Franklin Lakes, NJ, USA). For serum separation, samples were left at room temperature for 20 min and
subsequently centrifuged at 1000× g for 10 min at 4 ◦C. Aliquots of serum were subsequently stored at
−80 ◦C until analysis.
2.4. Amino Acids Profiling
Thirty-seven amino acids and derivatives (1-methylhistidine, 3-methylhistidine, 4-hydroxyproline,
α-aminobutyric acid, β-alanine, β-aminobutyric acid, γ-aminobutyric acid, alanine, aminoadipic acid,
anserine, arginine, asparagine, aspartic acid, carnosine, citrulline, cystathionine, cystine, ethanolamine,
glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine,
phosphoethanolamine, phosphoserine, proline, sarcosine, serine, taurine, threonine, tryptophan,
tyrosine, valine) were measured in serum through a ultraperformance liquid chromatography/mass
spectrometry (UPLC/MS) validated methodology. Briefly, 50 μL of sample were mixed with 100 μL
10% (w/v) sulfosalicylic acid containing an internal standard mix (50 μM) (Cambridge Isotope
Laboratories, Inc., Tewksbury, MA, USA) and centrifuged at 1000× g for 15 min. Ten microliters
of the supernatant were transferred into a vial containing 70 μL of borate buffer to which 20 μL of AccQ
Tag reagents (Waters Corporation, Milford, MA, USA) were subsequently added. Samples were then
vortexed for 10 s and heated at 55 ◦C for 10 min. The chromatographic separation was performed by
ACQUITY H-Class (Waters Corporation) using a CORTECS UPLC C18 column 1.6 μm 2.1 × 150 mm
(Waters Corporation) eluted at a flow rate of 500 μL/min with a linear gradient (9 min) from 99 to 1
water 0.1% formic acid in acetonitrile 0.1% formic acid. The mass spectrometer was an ACQUITY QDa
single quadrupole equipped with electrospray source operating in positive mode (Waters Corporation).
The analytical process was monitored using amino acid controls (level 1 and level 2) manufactured by
the MCA laboratory of the Queen Beatrix Hospital (Winterswijk, The Netherlands).
2.5. Statistical Analysis
All analyses were performed using in-house routines running under MATLAB R2015b
environment (The MathWorks, Natick, MA, USA).
2.5.1. Descriptive Statistics
Differences in demographic, anthropometric, clinical, and functional characteristics between
cases and controls were assessed via t-test statistics and χ2 or Fisher exact tests, for continuous and
categorical variables, respectively. All tests were two-sided, with statistical significance set at p < 0.05.
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2.5.2. Partial Least Squares–Discriminant Analysis
The strategy for the identification and validation of potential biomarkers for PF&S relied on
the building of discriminant models to differentiate cases from controls. The approach chosen for
the present study was based on PLS-DA [30], because of its versatility and ability to deal with
highly correlated predictors. Briefly, PLS-DA is a classification method based on the PLS regression
algorithm [31]. PLS-DA builds the linear relation between a set of responses Y and a matrix of
predictors X by projecting the latter onto a low-dimensional space of latent (abstract) variables
(LVs) that are characterized by having the highest covariance with the responses to be predicted.
The statistical reliability of the PLS-DA model was subsequently verified by a double cross-validation
(DCV) procedure and by means of randomization tests [32]. Three figures of merit were considered in
the present study: (i) the number of misclassifications (NMC); (ii) the area under the receiver operating
characteristic (ROC) curve (AUROC); and (iii) the value of the discriminant Q2 (DQ2) [33].
For the identification of potential biomarkers, two approaches aimed at highlighting the
experimental variables contributing the most to the classification model were followed, and they
involved inspecting variable importance in projection (VIP) indices [31] and rank product
(RP) [34], respectively. A more detailed description of the PLS-DA statistics is provided as
supplementary material.
3. Results
3.1. Descriptive Characteristics of the Study Population
The study population included 38 older adults with PF&S and 30 nonPF&S controls. The main
demographic, anthropometric, clinical, and functional characteristics of the study population according
to the presence of PF&S are presented in Table 1. No differences between groups were observed with
regard to age, gender distribution, number of co-morbid conditions, and number of prescription
medications. The distribution of specific disease conditions and the prevalence of use of individual
drug classes are shown in Table S2. As expected, physical performance, as assessed by the SPPB,
was lower in PF&S participants (SPPB score: 7.4 ± 1.5) relative to controls (11.3 ± 0.9) (p < 0.0001).
Similarly, aLM, either absolute or adjusted for BMI, was smaller in the PF&S group compared with
nonPF&S enrollees.
Table 1. Main characteristics of BIOmarkers associated with Sarcopenia and Physical frailty in EldeRly
pErsons (BIOSPHERE) participants according to the presence of physical frailty and sarcopenia (PF&S).
PF&S (n = 38) nonPF&S (n = 30) p
Age, years (mean ± SD) 76.4 ± 4.9 74.6 ± 4.3 0.1067
Gender (female), n (%) 25 (65.8) 16 (53.3) 0.4280
BMI, kg/m2 (mean ± SD) 29.1 ± 4.4 26.7 ± 2.4 0.0112
SPPB (mean ± SD) 7.4 ± 1.5 11.3 ± 0.9 <0.0001
aLM, kg (mean ± SD) 16.2 ± 3.2 19.4 ± 3.9 0.0004
aLMBMI (mean ± SD) 0.554 ± 0.120 0.795 ± 0.264 <0.0001
Number of disease conditions * (mean ± SD) 2.3 ± 1.5 1.8 ± 1.4 0.1448
Number of medications (mean ± SD) 3.2 ± 1.8 2.8 ± 1.9 0.4115
* Includes hypertension, coronary artery disease, prior stroke, peripheral vascular disease, diabetes, chronic
obstructive pulmonary disease, and osteoarthritis. BMI: body mass index; SPPB: Short Physical Performance Battery;
aLM: appendicular lean mass; PF&S: physical frailty and sarcopenia; nonPF&S: non physically frail, non sarcopenic;
SD: standard deviation.
3.2. Participant Classification According to PLS-DA
In order to verify the existence of a specific pattern of amino acids in participants with PF&S,
a PLS-DA classification model was constructed and validated. The optimal PLS-DA model was built
using three LVs that accounted for more than 44% of the variance originally present in the X block.
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As indicated by the DCV procedure, the model allowed to correctly predict the presence of PF&S in
95.7 ± 2.1% of participants in the calibration phase (94.7 ± 3.8% for PF&S and 96.7 ± 4.6% for controls),
84.1 ± 2.7% in the internal validation stage (82.6 ± 3.6% for PF&S and 86.0 ± 4.8% for controls),
and 76.6 ± 3.9% in external validation (75.1 ± 4.6% for PF&S; 78.5 ± 6.0% for nonPF&S). Figure 1,
which depicts the projection of participants onto the space spanned by the first two LVs of the PLS-DA
model, shows a clear separation between participants with and without PF&S.
Figure 1. Scores plot showing the separation of participants according to the serum concentrations
of amino acids and derivatives in the space spanned by the two latent variables (LV1 and LV2),
as determined by Partial Least Squares–Discriminant Analysis (PLS-DA).
The classification ability of the PLS-DA model was further validated by comparing the results
of the DCV with the distributions of NMC, AUROC and DQ2 under the null hypothesis (Figure 2).
For each of the three figures of merits considered, the values obtained on the real dataset fell outside of
the corresponding null hypothesis distribution, which corresponds to a p < 0.05.
Figure 2. Distribution of (a) number of misclassifications (NMC), (b) area under the receiver operating
characteristic (ROC) curve (AUROC), and (c) discriminant Q2 (DQ2) values under their respective null
hypothesis as estimated by permutation tests (blue histograms) and the corresponding values obtained
by the PLS-DA model on unpermuted data (red circles). Values obtained on the real dataset (red circles)
fall outside of the corresponding null hypothesis distribution (blue histograms), corresponding to
a p < 0.05.
In order to identify the metabolites that were mostly involved in discriminating between cases
and controls, the values of the VIP indices were inspected. The variables corresponding to a VIP
greater than one are reported in Table 2. Nine amino acids were found to contribute significantly to
the discrimination model. Participants with PF&S were characterized by higher levels of asparagine,
aspartic acid, citrulline, ethanolamine, glutamic acid, sarcosine, and taurine. Conversely, the profile of
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non-PF&S individuals was defined by higher levels of α-aminobutyric acid (AABA) and methionine.
Serum concentrations of non-discriminant amino acids are reported in Table S3.
Table 2. Serum concentrations of discriminant analytes, variable importance in projection (VIP) values,
and rank product (RP) values in BIOSPHERE participants with and without physical frailty and
sarcopenia (PF&S). Serum concentrations are shown as mean ± standard deviation.
PF&S (n = 38) nonPF&S (n = 30) VIP RP
α-aminobutyric acid (μmol/L) 20.0 ± 4.9 22.3 ± 5.7 2.2 8.0
Asparagine (μmol/L) 91.0 ± 12.6 77.8 ± 13.4 3.4 2.0
Aspartic Acid (μmol/L) 24.6 ± 5.4 17.0 ± 4.0 5.8 2.6
Citrulline (μmol/L) 44.8 ± 12.1 36.8 ± 11.5 2.1 2.8
Ethanolamine (μmol/L) 10.3 ± 1.7 9.0 ± 2.2 1.7 9.9
Glutamic acid (μmol/L) 71.7 ± 16.6 54.3 ± 21.2 2.3 8.5
Methionine (μmol/L) 22.6 ± 2.8 23.4 ± 5.7 1.3 6.3
Sarcosine (μmol/L) 1.9 ± 0.6 1.5 ± 0.5 1.4 8.0
Taurine (μmol/L) 220.1 ± 36.5 189.5 ± 47.2 1.8 6.7
4. Discussion
In the present study, we report the first results from the BIOSPHERE study. The most relevant
finding was that older individuals with PF&S showed a distinct profile of circulating amino acids
characterized by higher serum levels of asparagine, aspartic acid, citrulline, ethanolamine, glutamic
acid, sarcosine, and taurine. Conversely, the profile of nonPF&S participants was defined by higher
levels of AABA and methionine.
The existence of an amino acid signature in the setting of PF&S suggests that specific metabolic
alterations might be involved in the pathogenesis of this condition. Indeed, PF&S was associated
with lower circulating levels of the EAA methionine. EAAs are defined as those amino acids
that must be provided with the diet to meet optimal requirements [35]. The reduction of serum
concentrations of a number of EAAs (including methionine) with age was reported in both genders
and was purportedly associated with decreases in total energy and protein intake [36]. In addition,
low plasma levels of EAA were found in severely frail older people [25]. These findings may be
linked to malnutrition (both quantitative and qualitative), a common causative factor of frailty and
sarcopenia [37,38]. The concomitant low serum concentration of the non-essential non-proteinogenic
amino acid AABA seems to corroborate the previous finding since AABA may derive from the
catabolism of methionine [39]. Furthermore, plasma levels of AABA were found to be associated
with both the quality and amount of dietary protein [40,41]. Although these findings seem to point
towards a poor-quality protein diet or (selective) malabsorption, further studies are needed to clarify
the relationship between diet and circulating EAA levels in the context of PF&S.
Methionine is also involved in one-carbon metabolism, a crucial pathway that modulates
multiple physiologic processes, including nucleotide biosynthesis, amino acid homeostasis,
epigenetic maintenance, and redox balance [42]. Not surprisingly, alterations in one-carbon
metabolism were observed in aging and age-related diseases, such as cancer, cardiovascular disease,
and neurodegeneration [42,43]. Sarcosine, the N-methyl-derivative of glycine, is another relevant
intermediate of one-carbon metabolism [42]. Sarcosine is formed from dietary choline and the
metabolism of methionine [44,45], and can be found in muscles and other body tissues. A recent
metabolomics study showed that circulating sarcosine levels were reduced with aging both in rodents
and humans, while dietary restriction prevented this decline in both species [46]. Counterintuitively,
sarcosine levels were higher in persons with PF&S relative to controls. However, circulating sarcosine
may increase in case of folate deficiency, because folate mediates the conversion of sarcosine to
glycine [45]. Thus, this finding might be linked to insufficient folate ingestion and/or perturbation in
folate/one-carbon metabolism.
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Sarcosine also activates autophagy in mouse fibroblasts in a dose-dependent manner [46],
and alterations in myocyte quality control mechanisms (including autophagy) may contribute to
sarcopenia [47–49]. In particular, defective autophagic clearance of damaged cellular constituents,
alterations in mitochondrial proteostasis and dynamics, and impaired mitochondriogenesis are thought
to be critically involved in age-related muscle degeneration [50]. In this context, the presence
of ethanolamine among the most discriminant metabolites for PF&S classification is of particular
interest. Ethanolamine is a naturally occurring amino alcohol that plays a pivotal role in the
synthesis of phosphatidylethanolamine, a central intermediate of lipid metabolism and a major
component of biological membranes [51]. Phosphatidylethanolamine is also directly involved in the
regulation of autophagy [52], and it is postulated that ethanolamine treatment or the consumption of
ethanolamine-rich foods may increase cellular phosphatidylethanolamine levels, induce autophagy,
and provide beneficial anti-aging effects across species [52]. While serum ethanolamine levels were
different between PF&S and controls, this did not result in a corresponding difference in serum
phosphatidylethanolamine concentrations, suggesting alterations in CDP-ethanolamine pathway,
the major route of phosphatidylethanolamine production [53]. Interestingly, the disruption of
CDP-ethanolamine pathway in muscle was associated with alterations in mitochondrial biogenesis
and muscle atrophy in mice [54].
Taurine is a ubiquitous non-proteinogenic sulfur-containing amino acid that represents the most
abundant free amino acid in the heart, retina, skeletal muscle, brain, and leukocytes, accounting
for approximately 0.1% of total body weight [55]. In skeletal muscle, which contains 70% of total
body taurine, this amino acid is involved in the regulation of ion channel function, membrane
stability, mitochondrial quality control, and calcium homeostasis [56–59]. In muscle, taurine also
serves osmoregulatory, anti-oxidant, and anti-inflammatory functions [56–59]. Given these multiple
actions, taurine has recently been proposed as a candidate therapeutic agent against sarcopenia [60].
While it is reported that serum taurine concentrations decline with age in men [36], increased levels
of serum taurine have been retrieved in the metabolic profiles of old wild-type mice from different
genetic backgrounds [61]. Circulating levels of taurine are regulated by the balance among different
factors, including dietary intake, intestinal absorption, bile acid conjugation, urinary excretion, and
endogenous synthesis from methionine and cysteine [55]. Taurine may be released from cells following
osmotic perturbations, oxidative stress, and (chronic) inflammatory stimulation [58]. Further studies
are needed to unveil the mechanisms responsible for the high circulating taurine levels observed in
older adults with PF&S.
Citrulline is a non-essential non-protein amino acid with a key role in nitrogen homeostasis [62].
Citrulline is an end product of glutamine metabolism and an endogenous precursor of arginine [63].
For its capacity of promoting endothelial nitric oxide availability and vasodilation, “sparing” arginine
and glutamine from hepatic catabolism and the supposed ability to activate mTORC1 signaling [64],
citrulline was proposed as a pharmaconutrient to counteract sarcopenia [65]. Several reports have
shown that serum citrulline increases with age [36,66,67]. In addition, in a metabolomics study
assessing the individual variability in human blood metabolites [68], citrulline was among the
circulating molecules that exhibit a remarkable age-related increase. The authors attributed this
finding to impairment in urea cycle efficiency due to the progressive decline of liver and renal
function with age [68]. However, no differences in kidney or liver function were observed between
participants belonging to the two BIOSPHERE study groups. Further investigation on interorgan
nitrogen homeostasis pathways are needed to explain the higher circulating values of citrulline found
in older adults with PF&S.
Asparagine, aspartic acid, and glutamic acid are among the six amino acids that are metabolized
in resting muscles [69]. These amino acids provide the amino groups and the ammonia required
for the synthesis of glutamine and alanine, which are released following protein meals and in the
post-absorptive state [69]. The carbon skeletons of these metabolites may be used solely for de novo
synthesis of TCA-cycle intermediates and glutamine [70]. The higher levels of asparagine, aspartic
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acid, and glutamic acid observed in persons with PF&Ss may be suggestive of perturbations in muscle
energy metabolism associated with muscle wasting. Interestingly, a pattern of metabolic changes
accompany muscle remodeling after disuse, including energy substrate accumulation (e.g., asparagine)
in atrophied muscles [71,72].
As opposed to EAAs, no significant differences were observed between groups in the serum
levels of BCAAs. It should however be considered that the absorption of dietary proteins is
influenced by several factors, which may impact their bioavailability and circulating concentrations.
In particular, whether PF&S is associated with changes in the expression of amino acid transporters
and gastrointestinal physicochemical properties is presently unknown. Furthermore, the lower
splanchnic extraction of BCAAs might offset subtle differences in their systemic concentrations
between groups [73]. Notwithstanding, our finding on BCAAs is not consistent with previous
investigations that reported changes in BCAA concentrations in relation to sarcopenia, low muscle
mass, and functional limitation [21–23]. These discrepancies may be due to differences in operational
definitions adopted and experimental designs among studies. In addition, heterogeneity in eating
habits among participants of the different studies may contribute to the contrasting results.
The present study has some limitations that should be acknowledged. First, the study population
was relatively small, and a great number of experimental variables were included in the analyses.
However, the innovative analytical approach implemented in the study, based on PLS-DA plus DCV,
is an ideal strategy to cope with this issue. The study sample was exclusively comprised of Caucasian
individuals, which impedes generalizing the findings to other ethnic groups. Other factors that might
affect circulating amino acid levels include lifestyle and eating habits [74,75]. For instance, regular
participation in physical activity has been associated with reduced circulating levels of BCAAs as well
as alanine and proline across a wide age spectrum [76]. Furthermore, exercise training has shown to
increase the plasma levels of glycine and citrulline in overweight adults [77]. Although only people
not engaged in regular exercise were enrolled in the present study, the amount of physical activity
of participants was not quantified. Hence, the possible influence of physical activity on amino acid
profiles in the context of PF&S could not be established. The same applies to the possible influence of
different nutritional patterns and amino acid intakes. However, as recently highlighted, differences in
circulating amino acids are less marked than those between amino acid intakes [74]. The cross-sectional
design of the study does not allow inference to be drawn on the time course of changes of the variables
considered and on cause-effect relationships. Finally, although a fairly large number of amino acids
and derivatives was assayed, it cannot be excluded that more powerful biomarkers of PF&S might be
obtained through the analysis of a larger range of biomediators.
5. Conclusions
In the present study, a PLS-DA-based approach allowed distinct patterns of circulating amino acids
and derivatives to be identified in older persons with and without PF&S. The pathways unveiled by
this initial investigation may be used to generate new mechanistic hypotheses on the pathophysiology
of PF&S. Furthermore, the longitudinal implementation of the proposed analytical strategy could
facilitate the tracking of PF&S condition over time and the monitoring of response to treatments.
This may represent a first relevant step towards the integration of specific biochemical measurements
into the assessment of PF&S, both in clinical and research settings.
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